name,category,terms2'-5'-oligoadenylate synthetase 2, 69/71kDa,INTERPRO[450002588$IPR002934:Nucleotidyltransferase, 450005548$IPR006116:2-5-oligoadenylate synthetase, ubiquitin-like region, 450005549$IPR006117:2-5-oligoadenylate synthetase, conserved site, 450017222$IPR018952:2'-5'-oligoadenylate synthetase 1, domain 2/C-terminal]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000881$lipoprotein, 790000959$microsome, 790000969$mitochondrion, 790001004$myristate, 790001063$nucleotide-binding, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001304$repeat, 790001339$rna-binding, 790001547$transferase]
2'-5'-oligoadenylate synthetase 2, 69/71kDa,UP_SEQ_FEATURE[850001029$chain:2'-5'-oligoadenylate synthetase 2, 850102588$compositionally biased region:Pro-rich (linker), 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850113824$region of interest:OAS domain 1, 850113825$region of interest:OAS domain 2, 850117294$sequence conflict, 850118574$splice variant]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,INTERPRO[450001187$IPR001345:Phosphoglycerate/bisphosphoglycerate mutase, 450002719$IPR003094:Fructose-2,6-bisphosphatase, 450011723$IPR013078:Phosphoglycerate mutase, 450011724$IPR013079:6-phosphofructo-2-kinase, 450014584$IPR016260:Bifunctional 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,KEGG_PATHWAY[470038729$hsa00051:Fructose and mannose metabolism]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,PIR_SUPERFAMILY[630000821$PIRSF000709:6PFK_2-Ptase, 630000822$PIRSF000709:bifunctional 6-phosphofructo-2-kinase/fructose-2,6-bisphosphate 2-phosphatase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000825$kinase, 790000993$multifunctional enzyme, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000158$active site:Tele-phosphohistidine intermediate, 850000362$binding site:Fructose-6-phosphate, 850002499$chain:6-phosphofructo-2-kinase/fructose-2,6- biphosphatase 2, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850110612$region of interest:6-phosphofructo-2-kinase, 850111707$region of interest:Fructose-2,6-bisphosphatase, 850117294$sequence conflict, 850118574$splice variant]
A kinase (PRKA) anchor protein 11,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa]
A kinase (PRKA) anchor protein 11,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 11,UP_SEQ_FEATURE[850002960$chain:A-kinase anchor protein 11, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 3,INTERPRO[450007659$IPR008382:A-kinase anchor 110 kDa, 450016576$IPR018292:A-kinase anchor 110 kDa, C-terminal, 450016733$IPR018459:RII binding domain]
A kinase (PRKA) anchor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
A kinase (PRKA) anchor protein 3,UP_SEQ_FEATURE[850002965$chain:A-kinase anchor protein 3, 850106258$modified residue, 850106259$mutagenesis site, 850114057$region of interest:PKA-RII subunit binding domain, 850117294$sequence conflict, 850117295$sequence variant]
A kinase (PRKA) anchor protein 7,INTERPRO[450017747$IPR019510:Protein kinase A anchor protein, nuclear localisation signal domain, 450017748$IPR019511:Protein kinase A anchor protein, RI-RII subunit-binding domain]
A kinase (PRKA) anchor protein 7,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001212$polymorphism]
A kinase (PRKA) anchor protein 7,UP_SEQ_FEATURE[850002970$chain:A-kinase anchor protein 7 isoform gamma, 850002971$chain:A-kinase anchor protein 7 isoforms alpha and beta, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850114237$region of interest:Required for apical membrane localization, 850114425$region of interest:Required for membrane localization, 850114538$region of interest:RII-binding, 850117295$sequence variant, 850118574$splice variant]
ADP-ribosylation factor 1,BIOCARTA[30000022$h_arapPathway:ADP-Ribosylation Factor, 30000242$h_ptdinsPathway:Phosphoinositides and their downstream targets.]
ADP-ribosylation factor 1,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor 1,KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
ADP-ribosylation factor 1,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor 1,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000510$er-golgi transport, 790000624$golgi apparatus, 790000639$gtp-binding, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
ADP-ribosylation factor 1,UP_SEQ_FEATURE[850004004$chain:ADP-ribosylation factor 1, 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850118575$strand, 850118624$turn]
ADP-ribosylation factor-like 2,INTERPRO[450004692$IPR005225:Small GTP-binding protein, 450006098$IPR006688:ADP-ribosylation factor, 450006099$IPR006689:ARF/SAR superfamily]
ADP-ribosylation factor-like 2,PIR_SUPERFAMILY[630001857$PIRSF001711:ADP-ribosylation factor]
ADP-ribosylation factor-like 2,SMART[760000151$SM00177:ARF]
ADP-ribosylation factor-like 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000189$blocked amino end, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000639$gtp-binding, 790000811$isopeptide bond, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001059$nucleotide binding, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001592$ubl conjugation]
ADP-ribosylation factor-like 2,UP_SEQ_FEATURE[850000387$binding site:GTP; via amide nitrogen, 850004038$chain:ADP-ribosylation factor-like protein 2, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850105852$helix, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),SMART[760000240$SM00268:ACTIN]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000950$methylated amino acid, 790000957$microfilament, 790000973$mitosis, 790001063$nucleotide-binding]
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast),UP_SEQ_FEATURE[850004743$chain:Alpha-centractin, 850106258$modified residue]
ATH1, acid trehalase-like 1 (yeast),INTERPRO[450004658$IPR005195:Glycoside hydrolase family 65, central catalytic, 450011039$IPR012341:Six-hairpin glycosidase]
ATH1, acid trehalase-like 1 (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000617$glycosidase, 790000743$hydrolase]
ATH1, acid trehalase-like 1 (yeast),UP_SEQ_FEATURE[850003437$chain:Acid trehalase-like protein 1, 850102581$compositionally biased region:Poly-Ser, 850117294$sequence conflict, 850118574$splice variant]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,INTERPRO[450007946$IPR008689:ATPase, F0 complex, subunit D, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,PIR_SUPERFAMILY[630005438$PIRSF005514:ATPase_F0_D_mt, 630005439$PIRSF005514:F-type ATP synthase, subunit d, mitochondrial]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000281$cf(0), 790000356$complete proteome, 790000445$direct protein sequencing, 790000739$Hydrogen ion transport, 790000798$ion transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001558$transport]
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d,UP_SEQ_FEATURE[850006509$chain:ATP synthase subunit d, mitochondrial, 850106258$modified residue, 850118574$splice variant]
ATP-grasp domain containing 1,INTERPRO[450003342$IPR003806:ATP-grasp fold, DUF201-type, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450010588$IPR011761:ATP-grasp fold]
ATP-grasp domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000906$manganese, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
ATP-grasp domain containing 1,UP_SEQ_FEATURE[850006752$chain:ATP-grasp domain-containing protein 1, 850103068$domain:ATP-grasp, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ATP/GTP binding protein-like 2,INTERPRO[450000726$IPR000834:Peptidase M14, carboxypeptidase A]
ATP/GTP binding protein-like 2,SMART[760000546$SM00631:Zn_pept]
ATP/GTP binding protein-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000242$carboxypeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001648$zinc]
ATP/GTP binding protein-like 2,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850014082$chain:Cytosolic carboxypeptidase 2, 850106218$metal ion-binding site:Zinc, 850117295$sequence variant, 850118574$splice variant]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with GTPase domain, ankyrin repeat and PH domain 5; ArfGAP with GTPase domain, ankyrin repeat and PH domain 9; ArfGAP with GTPase domain, ankyrin repeat and PH domain 10; centaurin, gamma-like family, member 11 pseudogene,UP_SEQ_FEATURE[850006012$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 10, 850006020$chain:Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 9, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850110004$region of interest:2 X 23 AA tandem repeats of A-L-E-F-N- [LS]-S-A-N-P-E-A-S-T-I-F-Q-R-N-S-Q-T-D, 850115074$repeat:1, 850115273$repeat:2, 850115631$repeat:ANK, 850118762$zinc finger region:C4-type]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,INTERPRO[450001021$IPR001164:Arf GTPase activating protein, 450001635$IPR001849:Pleckstrin homology, 450001870$IPR002110:Ankyrin, 450010818$IPR011993:Pleckstrin homology-type]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,SMART[760000093$SM00105:ArfGap, 760000205$SM00233:PH, 760000220$SM00248:ANK]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000640$GTPase activation, 790000937$metal-binding, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
ArfGAP with coiled-coil, ankyrin repeat and PH domains 3,UP_SEQ_FEATURE[850006008$chain:Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3, 850103059$domain:Arf-GAP, 850104979$domain:PH, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850118574$splice variant, 850118762$zinc finger region:C4-type]
B-cell CLL/lymphoma 9,INTERPRO[450014104$IPR015668:B Cell Lymphoma 9]
B-cell CLL/lymphoma 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001642$wnt signaling pathway]
B-cell CLL/lymphoma 9,UP_SEQ_FEATURE[850007049$chain:B-cell CLL/lymphoma 9 protein, 850102565$compositionally biased region:Poly-Ala, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850111365$region of interest:CTNNB1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),OMIM_DISEASE[520000533$Bartter syndrome, type 4]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),SP_PIR_KEYWORDS[790000169$bartter syndrome, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
Bartter syndrome, infantile, with sensorineural deafness (Barttin),UP_SEQ_FEATURE[850007325$chain:Barttin, 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),INTERPRO[450008710$IPR009617:Adipose-regulatory protein, Seipin]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),OMIM_DISEASE[520002905$Lipodystrophy, congenital generalized, type 2, 520003610$Neuropathy, distal hereditary motor, type V, 520004483$Silver spastic paraplegia syndrome, 520004539$Spastic paraplegia 17 (autosomal dominant), 520004540$spastic paraplegia 17 (Silver syndrome), 520004549$Spastic paraplegia with amyotrophy of hands and feet (Silver syndrome), 520004595$Spinal muscular atrophy, distal, type V]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000362$congenital generalized lipodystrophy, 790000430$diabetes mellitus, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000675$hereditary spastic paraplegia, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane]
Bernardinelli-Seip congenital lipodystrophy 2 (seipin),UP_SEQ_FEATURE[850059230$chain:Seipin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
C-type lectin domain family 9, member A,INTERPRO[450001149$IPR001304:C-type lectin, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
C-type lectin domain family 9, member A,SMART[760000026$SM00034:CLECT]
C-type lectin domain family 9, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000848$Lectin, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane]
C-type lectin domain family 9, member A,UP_SEQ_FEATURE[850008740$chain:C-type lectin domain family 9 member A, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
C1q and tumor necrosis factor related protein 1,INTERPRO[450000941$IPR001073:Complement C1q protein, 450007490$IPR008160:Collagen triple helix repeat, 450008180$IPR008983:Tumour necrosis factor-like]
C1q and tumor necrosis factor related protein 1,SMART[760000097$SM00110:C1Q]
C1q and tumor necrosis factor related protein 1,SP_PIR_KEYWORDS[790000345$collagen, 790000356$complete proteome, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
C1q and tumor necrosis factor related protein 1,UP_SEQ_FEATURE[850012307$chain:Complement C1q tumor necrosis factor- related protein 1, 850103196$domain:C1q, 850103389$domain:Collagen-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide]
C2 calcium-dependent domain containing 3,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting]
C2 calcium-dependent domain containing 3,SMART[760000211$SM00239:C2]
C2 calcium-dependent domain containing 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
C2 calcium-dependent domain containing 3,UP_SEQ_FEATURE[850008791$chain:C2 domain-containing protein 3, 850103200$domain:C2 1, 850103201$domain:C2 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
CD22 molecule,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450011799$IPR013162:CD80-like, immunoglobulin C2-set, 450012396$IPR013783:Immunoglobulin-like fold]
CD22 molecule,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038867$hsa04640:Hematopoietic cell lineage, 470038870$hsa04662:B cell receptor signaling pathway]
CD22 molecule,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
CD22 molecule,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000152$B-cell, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000436$dimer, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000848$Lectin, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
CD22 molecule,UP_SEQ_FEATURE[850000550$binding site:Sialic acid, 850007061$chain:B-cell receptor CD22, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
CD247 molecule,BIOCARTA[30000072$h_CSKPathway:Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor, 30000075$h_ctla4Pathway:The Co-Stimulatory Signal During T-cell Activation, 30000076$h_ctlPathway:CTL mediated immune response against target cells , 30000150$h_IL12Pathway:IL12 and Stat4 Dependent Signaling Pathway in Th1 Development, 30000151$h_il17Pathway:IL 17 Signaling Pathway, 30000205$h_no2il12Pathway:NO2-dependent IL 12 Pathway in NK cells, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents, 30000284$h_tcapoptosisPathway:HIV Induced T Cell Apoptosis, 30000285$h_tcraPathway:Lck and Fyn tyrosine kinases in initiation of TCR Activation, 30000286$h_tcrmolecule:T Cell Receptor and CD3 Complex, 30000287$h_tcrPathway:T Cell Receptor Signaling Pathway, 30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
CD247 molecule,INTERPRO[450002734$IPR003110:Phosphorylated immunoreceptor signaling ITAM]
CD247 molecule,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038869$hsa04660:T cell receptor signaling pathway]
CD247 molecule,OMIM_DISEASE[520002611$Immunodeficiency due to defect in CD3-zeta]
CD247 molecule,PIR_SUPERFAMILY[630021605$PIRSF028738:CD3, zeta type]
CD247 molecule,SMART[760000067$SM00077:ITAM]
CD247 molecule,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000733$host-virus interaction, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001481$T-cell receptor, 790001555$transmembrane, 790001556$transmembrane protein]
CD247 molecule,UP_SEQ_FEATURE[850063404$chain:T-cell surface glycoprotein CD3 zeta chain, 850102883$disulfide bond, 850104484$domain:ITAM 1, 850104485$domain:ITAM 2, 850104486$domain:ITAM 3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
COMM domain containing 9,INTERPRO[450008972$IPR009886:HCaRG, 450016234$IPR017920:COMM domain]
COMM domain containing 9,SP_PIR_KEYWORDS[790000356$complete proteome]
COMM domain containing 9,UP_SEQ_FEATURE[850012281$chain:COMM domain-containing protein 9, 850103407$domain:COMM, 850117294$sequence conflict]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),BIOCARTA[30000138$h_hifPathway:Hypoxia-Inducible Factor in the Cardiovascular System]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),INTERPRO[450000475$IPR000555:Mov34/MPN/PAD-1]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),PIR_SUPERFAMILY[630013144$PIRSF016373:hypothetical protein, Caenorhabditis elegans B0547.1 type]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),SMART[760000204$SM00232:JAB_MPN]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001065$nucleus, 790001252$Protease, 790001410$signalosome]
COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis),UP_SEQ_FEATURE[850012530$chain:COP9 signalosome complex subunit 5, 850104794$domain:MPN, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117527$short sequence motif:JAMM motif]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),INTERPRO[450003320$IPR003780:Cytochrome oxidase assembly]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038802$hsa00860:Porphyrin and chlorophyll metabolism]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),OMIM_DISEASE[520000810$Cardiomyopathy, hypertrophic, early-onset fatal, 520002807$Leigh syndrome due to cytochrome c oxidase deficiency]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
COX15 homolog, cytochrome c oxidase assembly protein (yeast),UP_SEQ_FEATURE[850013512$chain:Cytochrome c oxidase assembly protein COX15 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
CUB domain containing protein 2,INTERPRO[450000750$IPR000859:CUB]
CUB domain containing protein 2,SMART[760000034$SM00042:CUB]
CUB domain containing protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
CUB domain containing protein 2,UP_SEQ_FEATURE[850012807$chain:CUB domain-containing protein 2, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103453$domain:CUB 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
D-2-hydroxyglutarate dehydrogenase,COG_ONTOLOGY[90000064$Energy production and conversion]
D-2-hydroxyglutarate dehydrogenase,INTERPRO[450003627$IPR004113:FAD-linked oxidase, C-terminal, 450005528$IPR006094:FAD linked oxidase, N-terminal, 450011734$IPR013090:Phospholipase A2, active site, 450014512$IPR016166:FAD-binding, type 2, 450014513$IPR016167:FAD-binding, type 2, subdomain 1]
D-2-hydroxyglutarate dehydrogenase,OMIM_DISEASE[520001308$D-2-hydroxyglutaric aciduria]
D-2-hydroxyglutarate dehydrogenase,PIR_SUPERFAMILY[630006095$PIRSF006165:glycolate oxidase chain GlcD]
D-2-hydroxyglutarate dehydrogenase,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000559$Flavoprotein, 790000969$mitochondrion, 790001092$oxidoreductase, 790001212$polymorphism, 790001550$transit peptide]
D-2-hydroxyglutarate dehydrogenase,UP_SEQ_FEATURE[850014158$chain:D-2-hydroxyglutarate dehydrogenase, mitochondrial, 850103738$domain:FAD-binding PCMH-type, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,INTERPRO[450001461$IPR001650:DNA/RNA helicase, C-terminal, 450010405$IPR011545:DNA/RNA helicase, DEAD/DEAH box type, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012608$IPR014014:RNA helicase, DEAD-box type, Q motif, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SMART[760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001331$ribosome biogenesis, 790001339$rna-binding, 790001345$rrna processing]
DEAD (Asp-Glu-Ala-Asp) box polypeptide 56,UP_SEQ_FEATURE[850041119$chain:Probable ATP-dependent RNA helicase DDX56, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117383$short sequence motif:DEAD box, 850117676$short sequence motif:Q motif]
DENN/MADD domain containing 2C,INTERPRO[450001049$IPR001194:DENN, 450004581$IPR005112:dDENN, 450004582$IPR005113:uDENN]
DENN/MADD domain containing 2C,SMART[760000702$SM00799:DENN, 760000703$SM00800:uDENN, 760000704$SM00801:dDENN]
DENN/MADD domain containing 2C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
DENN/MADD domain containing 2C,UP_SEQ_FEATURE[850014829$chain:DENN domain-containing protein 2C, 850103503$domain:dDENN, 850103514$domain:DENN, 850105606$domain:uDENN, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DIP2 disco-interacting protein 2 homolog B (Drosophila),COG_ONTOLOGY[90000086$Lipid metabolism / Secondary metabolites biosynthesis, transport, and catabolism]
DIP2 disco-interacting protein 2 homolog B (Drosophila),INTERPRO[450000762$IPR000873:AMP-dependent synthetase and ligase, 450009560$IPR010506:DMAP1-binding]
DIP2 disco-interacting protein 2 homolog B (Drosophila),OMIM_DISEASE[520003170$Mental retardation, FRA12A type]
DIP2 disco-interacting protein 2 homolog B (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
DIP2 disco-interacting protein 2 homolog B (Drosophila),UP_SEQ_FEATURE[850015260$chain:Disco-interacting protein 2 homolog B, 850102565$compositionally biased region:Poly-Ala, 850102585$compositionally biased region:Poly-Val, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),INTERPRO[450001128$IPR001279:Beta-lactamase-like, 450010027$IPR011084:DNA repair metallo-beta-lactamase]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
DNA cross-link repair 1B (PSO2 homolog, S. cerevisiae),UP_SEQ_FEATURE[850015510$chain:DNA cross-link repair 1B protein, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),BIOCARTA[30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000082$h_deathPathway:Induction of apoptosis through DR3 and DR4/5 Death Receptors , 30000084$h_DNAfragmentPathway:Apoptotic DNA fragmentation and tissue homeostasis, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling, 30000268$h_setPathway:Granzyme A mediated Apoptosis Pathway, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),INTERPRO[450003076$IPR003508:Caspase-activated nuclease CIDE-N, 450013753$IPR015311:Apoptosis, DNA fragmentation factor 40 kDa]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),KEGG_PATHWAY[470038843$hsa04210:Apoptosis]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SMART[760000238$SM00266:CAD]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001049$nuclease, 790001065$nucleus, 790001212$polymorphism]
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase),UP_SEQ_FEATURE[850015551$chain:DNA fragmentation factor subunit beta, 850103367$domain:CIDE-N, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
E74-like factor 4 (ets domain transcription factor),INTERPRO[450000358$IPR000418:Ets, 450010816$IPR011991:Winged helix repressor DNA-binding]
E74-like factor 4 (ets domain transcription factor),SMART[760000360$SM00413:ETS]
E74-like factor 4 (ets domain transcription factor),SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
E74-like factor 4 (ets domain transcription factor),UP_SEQ_FEATURE[850018052$chain:ETS-related transcription factor Elf-4, 850102913$DNA-binding region:ETS, 850106258$modified residue, 850114563$region of interest:RUNX1-binding, 850117294$sequence conflict]
EF-hand calcium binding domain 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 2,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001304$repeat]
EF-hand calcium binding domain 2,UP_SEQ_FEATURE[850016943$chain:EF-hand calcium-binding domain-containing protein 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117294$sequence conflict, 850118574$splice variant]
EF-hand calcium binding domain 4A,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450016534$IPR018249:EF-HAND 2]
EF-hand calcium binding domain 4A,SMART[760000046$SM00054:EFh]
EF-hand calcium binding domain 4A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
EF-hand calcium binding domain 4A,UP_SEQ_FEATURE[850016945$chain:EF-hand calcium-binding domain-containing protein 4A, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850117295$sequence variant, 850118574$splice variant]
ER degradation enhancer, mannosidase alpha-like 2,INTERPRO[450001227$IPR001382:Glycoside hydrolase, family 47]
ER degradation enhancer, mannosidase alpha-like 2,PIR_SUPERFAMILY[630014256$PIRSF017531:mannosyl-oligosaccharide 1,2-alpha-mannosidase, 1A type]
ER degradation enhancer, mannosidase alpha-like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001595$unfolded protein response]
ER degradation enhancer, mannosidase alpha-like 2,UP_SEQ_FEATURE[850017746$chain:ER degradation-enhancing alpha- mannosidase-like 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
F-box protein 9,INTERPRO[450001603$IPR001810:Cyclin-like F-box]
F-box protein 9,SMART[760000228$SM00256:FBOX]
F-box protein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
F-box protein 9,UP_SEQ_FEATURE[850018511$chain:F-box only protein 9, 850103725$domain:F-box, 850117118$repeat:TPR, 850118574$splice variant]
FERM domain containing 6,INTERPRO[450000257$IPR000299:FERM domain, 450010818$IPR011993:Pleckstrin homology-type, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
FERM domain containing 6,SMART[760000266$SM00295:B41]
FERM domain containing 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein]
FERM domain containing 6,UP_SEQ_FEATURE[850019182$chain:FERM domain-containing protein 6, 850102581$compositionally biased region:Poly-Ser, 850102584$compositionally biased region:Poly-Tyr, 850103760$domain:FERM, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
FIG4 homolog (S. cerevisiae),INTERPRO[450001784$IPR002013:Synaptojanin, N-terminal]
FIG4 homolog (S. cerevisiae),OMIM_DISEASE[520000280$Amyotrophic lateral sclerosis 11, 520000969$Charcot-Marie-Tooth disease, type 4J]
FIG4 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000080$amyotrophic lateral sclerosis, 790000289$charcot-marie-tooth disease, 790000356$complete proteome, 790000446$disease mutation, 790000501$endosome, 790000743$hydrolase, 790000919$membrane, 790001015$neurodegeneration, 790001020$neuropathy, 790001212$polymorphism]
FIG4 homolog (S. cerevisiae),UP_SEQ_FEATURE[850039945$chain:Polyphosphoinositide phosphatase, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850105248$domain:SAC, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
FXYD domain containing ion transport regulator 2,BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
FXYD domain containing ion transport regulator 2,INTERPRO[450000237$IPR000272:Ion-transport regulator, FXYD region]
FXYD domain containing ion transport regulator 2,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction]
FXYD domain containing ion transport regulator 2,OMIM_DISEASE[520002525$Hypomagnesemia-2, renal]
FXYD domain containing ion transport regulator 2,PIR_SUPERFAMILY[630021015$PIRSF027828:PIRSF027828]
FXYD domain containing ion transport regulator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000798$ion transport, 790000919$membrane, 790001226$potassium, 790001229$potassium transport, 790001240$primary hypomagnesemia, 790001418$Sodium, 790001421$Sodium transport, 790001422$sodium/potassium transport, 790001555$transmembrane, 790001558$transport]
FXYD domain containing ion transport regulator 2,UP_SEQ_FEATURE[850061295$chain:Sodium/potassium-transporting ATPase subunit gamma, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
FYN binding protein (FYB-120/130),INTERPRO[450001294$IPR001452:Src homology-3 domain, 450010373$IPR011511:Variant SH3, 450016415$IPR018115:Xylose isomerase, active site]
FYN binding protein (FYB-120/130),SMART[760000295$SM00326:SH3]
FYN binding protein (FYB-120/130),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
FYN binding protein (FYB-120/130),UP_SEQ_FEATURE[850020201$chain:FYN-binding protein, 850102580$compositionally biased region:Poly-Pro, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850112832$region of interest:Interaction with SKAP1, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850117706$short sequence motif:SH2-binding, 850117709$short sequence motif:SH2-binding; to FYN, 850117710$short sequence motif:SH2-binding; to LCP2, 850118575$strand, 850118624$turn]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),BBID[10000076$56.Macrophage_regulation_of_CD4+T_cells]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038916$hsa05322:Systemic lupus erythematosus]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),OMIM_DISEASE[520002972$Lupus erythematosus, systemic, susceptibility, 520003622$Neutropenia, alloimmune neonatal, 520005034$Viral infections, recurrent]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),PIR_SUPERFAMILY[630002118$PIRSF001980:Fc gamma receptor III]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SMART[760000357$SM00409:IG]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000761$igg-binding protein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
Fc fragment of IgG, low affinity IIIa, receptor (CD16a),UP_SEQ_FEATURE[850029060$chain:Low affinity immunoglobulin gamma Fc region receptor III-A, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
Fc receptor-like 5,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
Fc receptor-like 5,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
Fc receptor-like 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
Fc receptor-like 5,UP_SEQ_FEATURE[850019117$chain:Fc receptor-like protein 5, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850104404$domain:Ig-like C2-type 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117522$short sequence motif:ITIM motif 3, 850117523$short sequence motif:ITIM motif 4, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 68,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450004847$IPR005389:OGR1 sphingosylphosphorylcholine receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
G protein-coupled receptor 68,PIR_SUPERFAMILY[630005778$PIRSF005853:GPR4-like G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
G protein-coupled receptor 68,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001580$tumor suppressor]
G protein-coupled receptor 68,UP_SEQ_FEATURE[850036439$chain:Ovarian cancer G-protein coupled receptor 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,INTERPRO[450014108$IPR015672:G-protein coupled receptor 89-related]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,PIR_SUPERFAMILY[630011150$PIRSF013287:uncharacterized conserved protein]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
G protein-coupled receptor 89C; G protein-coupled receptor 89B; G protein-coupled receptor 89A,UP_SEQ_FEATURE[850046312$chain:Protein GPR89, 850053876$chain:Putative protein GPR89C, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
GDP dissociation inhibitor 2,INTERPRO[450000699$IPR000806:Rab GDI protein, 450001776$IPR002005:Rab GTPase activator, 450016490$IPR018203:GDP dissociation inhibitor]
GDP dissociation inhibitor 2,PIR_SUPERFAMILY[630016226$PIRSF019647:GDP dissociation inhibitor XAP-4]
GDP dissociation inhibitor 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790000919$membrane, 790001162$phosphoprotein]
GDP dissociation inhibitor 2,UP_SEQ_FEATURE[850056509$chain:Rab GDP dissociation inhibitor beta, 850106258$modified residue, 850117294$sequence conflict]
GRB2-associated binding protein 2,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450010818$IPR011993:Pleckstrin homology-type]
GRB2-associated binding protein 2,KEGG_PATHWAY[470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038910$hsa05220:Chronic myeloid leukemia]
GRB2-associated binding protein 2,OMIM_DISEASE[520001954$GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers]
GRB2-associated binding protein 2,SMART[760000205$SM00233:PH]
GRB2-associated binding protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
GRB2-associated binding protein 2,UP_SEQ_FEATURE[850022390$chain:GRB2-associated-binding protein 2, 850104979$domain:PH, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant]
IKAROS family zinc finger 1 (Ikaros),COG_ONTOLOGY[90000073$General function prediction only]
IKAROS family zinc finger 1 (Ikaros),INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
IKAROS family zinc finger 1 (Ikaros),OMIM_DISEASE[520002832$Leukemia, acute lymphoblastic]
IKAROS family zinc finger 1 (Ikaros),SMART[760000323$SM00355:ZnF_C2H2]
IKAROS family zinc finger 1 (Ikaros),SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000258$cell cycle, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000466$dna-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
IKAROS family zinc finger 1 (Ikaros),UP_SEQ_FEATURE[850015926$chain:DNA-binding protein Ikaros, 850102576$compositionally biased region:Poly-Leu, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106258$modified residue, 850114251$region of interest:Required for binding PP1CC, 850114261$region of interest:Required for both high-affinity DNA binding and pericentromeric heterochromatin localization, 850117294$sequence conflict, 850118520$site:Required for both pericentromeric heterochromatin localization and complete DNA binding, 850118521$site:Required for both pericentromeric heterochromatin localization and DNA binding, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
IQ motif and Sec7 domain 2,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450000787$IPR000904:SEC7-like, 450001635$IPR001849:Pleckstrin homology]
IQ motif and Sec7 domain 2,KEGG_PATHWAY[470038841$hsa04144:Endocytosis]
IQ motif and Sec7 domain 2,SMART[760000009$SM00015:IQ, 760000194$SM00222:Sec7, 760000205$SM00233:PH]
IQ motif and Sec7 domain 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
IQ motif and Sec7 domain 2,UP_SEQ_FEATURE[850026751$chain:IQ motif and SEC7 domain-containing protein 2, 850102540$compositionally biased region:His-rich, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850104439$domain:IQ, 850104979$domain:PH, 850105336$domain:SEC7, 850106258$modified residue, 850118574$splice variant]
KIAA0090,COG_ONTOLOGY[90000070$Function unknown]
KIAA0090,INTERPRO[450010506$IPR011678:Protein of unknown function DUF1620]
KIAA0090,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
KIAA0090,UP_SEQ_FEATURE[850075488$chain:Uncharacterized protein KIAA0090, 850103554$domain:DUF1620, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
KIAA0284,INTERPRO[450000219$IPR000253:Forkhead-associated]
KIAA0284,SMART[760000212$SM00240:FHA]
KIAA0284,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000811$isopeptide bond, 790000960$microtubule, 790001162$phosphoprotein, 790001592$ubl conjugation]
KIAA0284,UP_SEQ_FEATURE[850046544$chain:Protein KIAA0284, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
KIAA1128,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like]
KIAA1128,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
KIAA1128,UP_SEQ_FEATURE[850045936$chain:Protein FAM190B, 850102540$compositionally biased region:His-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
KIAA1274,SP_PIR_KEYWORDS[790000356$complete proteome, 790000881$lipoprotein, 790001004$myristate, 790001212$polymorphism]
KIAA1274,UP_SEQ_FEATURE[850036738$chain:Paladin, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117295$sequence variant]
KIAA1409,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
KIAA1409,UP_SEQ_FEATURE[850048300$chain:Protein unc-79 homolog, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
Kv channel interacting protein 2,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
Kv channel interacting protein 2,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
Kv channel interacting protein 2,SMART[760000046$SM00054:EFh]
Kv channel interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001304$repeat, 790001558$transport, 790001631$voltage-gated channel]
Kv channel interacting protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850027659$chain:Kv channel-interacting protein 2, 850103582$domain:EF-hand 1; degenerate, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850112463$region of interest:Interaction with KCND2, 850117294$sequence conflict, 850118574$splice variant]
LEM domain containing 1,INTERPRO[450003412$IPR003887:Lamino-associated polypeptide 2/emerin]
LEM domain containing 1,SMART[760000480$SM00540:LEM]
LEM domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
LEM domain containing 1,UP_SEQ_FEATURE[850028239$chain:LEM domain-containing protein 1, 850104709$domain:LEM, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
LLP homolog, long-term synaptic facilitation (Aplysia); similar to LLP homolog; similar to hCG2013595,INTERPRO[450017056$IPR018784:Learning associated protein 18-like]
LLP homolog, long-term synaptic facilitation (Aplysia); similar to LLP homolog; similar to hCG2013595,SP_PIR_KEYWORDS[790000356$complete proteome]
LLP homolog, long-term synaptic facilitation (Aplysia); similar to LLP homolog; similar to hCG2013595,UP_SEQ_FEATURE[850046721$chain:Protein LLP homolog, 850102554$compositionally biased region:Lys-rich, 850117294$sequence conflict]
M-phase phosphoprotein 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
M-phase phosphoprotein 9,UP_SEQ_FEATURE[850029453$chain:M-phase phosphoprotein 9, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
MAS-related GPR, member F,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
MAS-related GPR, member F,PIR_SUPERFAMILY[630001858$PIRSF001712:mas-related G protein-coupled receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
MAS-related GPR, member F,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
MAS-related GPR, member F,UP_SEQ_FEATURE[850030541$chain:Mas-related G-protein coupled receptor member F, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
MLX interacting protein,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450010429$IPR011598:Helix-loop-helix DNA-binding]
MLX interacting protein,SMART[760000321$SM00353:HLH]
MLX interacting protein,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
MLX interacting protein,UP_SEQ_FEATURE[850032243$chain:MLX-interacting protein, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104712$domain:Leucine-zipper, 850106258$modified residue, 850113353$region of interest:Mediates heterotypic interactions between MLXIP and MLX and is required for cytoplasmic localization, 850114279$region of interest:Required for cytoplasmic localization, 850114898$region of interest:Transactivation domain, 850117295$sequence variant, 850118574$splice variant]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),COG_ONTOLOGY[90000008$Amino acid transport and metabolism / Cell envelope biogenesis, outer membrane]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),INTERPRO[450001969$IPR002220:Dihydrodipicolinate synthetase, 450012397$IPR013785:Aldolase-type TIM barrel]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),KEGG_PATHWAY[470038770$hsa00520:Amino sugar and nucleotide sugar metabolism]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000232$carbohydrate metabolism, 790000356$complete proteome, 790000407$cytoplasm, 790000891$lyase, 790001357$Schiff base]
N-acetylneuraminate pyruvate lyase (dihydrodipicolinate synthase),UP_SEQ_FEATURE[850000152$active site:Schiff-base intermediate with substrate, 850033220$chain:N-acetylneuraminate lyase, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118380$site:Involved in proton transfer during cleavage, 850118574$splice variant]
N-terminal asparagine amidase,PIR_SUPERFAMILY[630019060$PIRSF023959:N-terminal asparagine amidohydrolase]
N-terminal asparagine amidase,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001212$polymorphism]
N-terminal asparagine amidase,UP_SEQ_FEATURE[850046976$chain:Protein N-terminal asparagine amidohydrolase, 850117295$sequence variant]
NIMA (never in mitosis gene a)-related kinase 4,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
NIMA (never in mitosis gene a)-related kinase 4,SMART[760000193$SM00220:S_TKc]
NIMA (never in mitosis gene a)-related kinase 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790000973$mitosis, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
NIMA (never in mitosis gene a)-related kinase 4,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850059871$chain:Serine/threonine-protein kinase Nek4, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
NmrA-like family domain containing 1,INTERPRO[450007368$IPR008030:NmrA-like, 450014426$IPR016040:NAD(P)-binding domain]
NmrA-like family domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000447$disulfide bond, 790001065$nucleus, 790001212$polymorphism]
NmrA-like family domain containing 1,UP_SEQ_FEATURE[850000461$binding site:NADP, 850000462$binding site:NADP; shared with dimeric partner, 850034468$chain:NmrA-like family domain-containing protein 1, 850102883$disulfide bond, 850105852$helix, 850106259$mutagenesis site, 850106307$nucleotide phosphate-binding region:NADP, 850112101$region of interest:Interaction with ASS1, 850117295$sequence variant, 850118575$strand, 850118624$turn]
OTU domain containing 7B,INTERPRO[450002353$IPR002653:Zinc finger, A20-type, 450002899$IPR003323:Ovarian tumour, otubain]
OTU domain containing 7B,SMART[760000231$SM00259:ZnF_A20]
OTU domain containing 7B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
OTU domain containing 7B,UP_SEQ_FEATURE[850036306$chain:OTU domain-containing protein 7B, 850104870$domain:OTU, 850106258$modified residue, 850106259$mutagenesis site, 850111190$region of interest:Catalytic, 850114894$region of interest:TRAF-binding, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118625$zinc finger region:A20-type]
PQ loop repeat containing 2,INTERPRO[450006023$IPR006603:Cystinosin/ERS1p repeat]
PQ loop repeat containing 2,SMART[760000590$SM00679:CTNS]
PQ loop repeat containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane]
PQ loop repeat containing 2,UP_SEQ_FEATURE[850040281$chain:PQ-loop repeat-containing protein 2, 850105069$domain:PQ-loop 1, 850105070$domain:PQ-loop 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
PR domain containing 2, with ZNF domain,INTERPRO[450001068$IPR001214:SET, 450006475$IPR007087:Zinc finger, C2H2-type, 450008289$IPR009170:Predicted retinoblastoma binding protein (RIZ), 450014303$IPR015880:Zinc finger, C2H2-like]
PR domain containing 2, with ZNF domain,PIR_SUPERFAMILY[630002513$PIRSF002395:retinoblastoma binding protein (RIZ), 630002514$PIRSF002395:RIZ_SET]
PR domain containing 2, with ZNF domain,SMART[760000286$SM00317:SET, 760000323$SM00355:ZnF_C2H2]
PR domain containing 2, with ZNF domain,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000050$alternative initiation, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
PR domain containing 2, with ZNF domain,UP_SEQ_FEATURE[850040292$chain:PR domain zinc finger protein 2, 850102434$compositionally biased region:Arg/Lys-rich (basic), 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850105340$domain:SET, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114517$region of interest:Retinoblastoma protein binding, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118732$zinc finger region:C2H2-type 7; atypical, 850118735$zinc finger region:C2H2-type 8; atypical]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),INTERPRO[450002202$IPR002483:Splicing factor PWI, 450012478$IPR013881:Pre-mRNA-splicing factor 3]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),OMIM_DISEASE[520004290$Retinitis pigmentosa-18]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),SMART[760000281$SM00311:PWI]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001316$retinitis pigmentosa, 790001377$sensory transduction, 790001433$Spliceosome, 790001622$vision]
PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae),UP_SEQ_FEATURE[850067859$chain:U4/U6 small nuclear ribonucleoprotein PRP3, 850102585$compositionally biased region:Poly-Val, 850105125$domain:PWI, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118624$turn]
PTK2B protein tyrosine kinase 2 beta,BIOCARTA[30000004$h_achPathway:Role of nicotinic acetylcholine receptors in the regulation of apoptosis, 30000027$h_At1rPathway:Angiotensin II mediated activation of JNK Pathway via Pyk2 dependent signaling, 30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000052$h_Ccr5Pathway:Pertussis toxin-insensitive CCR5 Signaling in Macrophage, 30000077$h_cxcr4Pathway:CXCR4 Signaling Pathway, 30000133$h_HBxPathway:Calcium Signaling by HBx of Hepatitis B virus, 30000161$h_il7Pathway:IL-7 Signal Transduction, 30000166$h_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway, 30000186$h_metPathway:Signaling of Hepatocyte Growth Factor Receptor, 30000202$h_nkcellsPathway:Ras-Independent pathway in NK cell-mediated cytotoxicity, 30000218$h_Par1Pathway:Thrombin signaling and protease-activated receptors, 30000244$h_pyk2Pathway:Links between Pyk2 and Map Kinases]
PTK2B protein tyrosine kinase 2 beta,INTERPRO[450000257$IPR000299:FERM domain, 450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450004653$IPR005189:Focal adhesion targeting region, 450007559$IPR008266:Tyrosine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain]
PTK2B protein tyrosine kinase 2 beta,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038831$hsa04062:Chemokine signaling pathway, 470038868$hsa04650:Natural killer cell mediated cytotoxicity, 470038873$hsa04670:Leukocyte transendothelial migration, 470038883$hsa04912:GnRH signaling pathway]
PTK2B protein tyrosine kinase 2 beta,SMART[760000192$SM00219:TyrKc, 760000266$SM00295:B41]
PTK2B protein tyrosine kinase 2 beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase, 790001586$tyrosine-protein kinase]
PTK2B protein tyrosine kinase 2 beta,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850048623$chain:Protein-tyrosine kinase 2-beta, 850102586$compositionally biased region:Pro-rich, 850103760$domain:FERM, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850111692$region of interest:Focal adhesion targeting (FAT), 850112919$region of interest:Interaction with TGFB1I1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
Purkinje cell protein 2,INTERPRO[450002733$IPR003109:GoLoco motif]
Purkinje cell protein 2,SMART[760000342$SM00390:GoLoco]
Purkinje cell protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001304$repeat]
Purkinje cell protein 2,UP_SEQ_FEATURE[850048972$chain:Purkinje cell protein 2 homolog, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2]
Putative PRAME family member 24; PRAME family member 8,PIR_SUPERFAMILY[630029880$PIRSF038286:preferentially expressed antigen of melanoma (PRAME) family protein]
Putative PRAME family member 24; PRAME family member 8,SP_PIR_KEYWORDS[790000356$complete proteome, 790000853$leucine-rich repeat, 790001304$repeat]
Putative PRAME family member 24; PRAME family member 8,UP_SEQ_FEATURE[850040344$chain:PRAME family member 8, 850053795$chain:Putative PRAME family member 24, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3]
RAB25, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450003146$IPR003579:Ras small GTPase, Rab type, 450004692$IPR005225:Small GTP-binding protein, 450012373$IPR013753:Ras, 450014034$IPR015595:Rab11-related]
RAB25, member RAS oncogene family,SMART[760000149$SM00175:RAB]
RAB25, member RAS oncogene family,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation, 790001266$protein transport, 790001558$transport]
RAB25, member RAS oncogene family,UP_SEQ_FEATURE[850056775$chain:Ras-related protein Rab-25, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117441$short sequence motif:Effector region, 850118575$strand, 850118624$turn]
RAB42, member RAS oncogene family,INTERPRO[450001599$IPR001806:Ras GTPase, 450012373$IPR013753:Ras]
RAB42, member RAS oncogene family,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001063$nucleotide-binding, 790001236$prenylation]
RAB42, member RAS oncogene family,UP_SEQ_FEATURE[850054008$chain:Putative Ras-related protein Rab-42, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP]
RNA binding motif protein 17,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450003478$IPR003954:RNA recognition, region 1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450015287$IPR016967:Splicing factor, SPF45]
RNA binding motif protein 17,KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
RNA binding motif protein 17,PIR_SUPERFAMILY[630023617$PIRSF031066:splicing factor, SPF45 type, 630023618$PIRSF031066:Splicing_factor_SPF45]
RNA binding motif protein 17,SMART[760000328$SM00360:RRM, 760000329$SM00361:RRM_1, 760000389$SM00443:G_patch]
RNA binding motif protein 17,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001433$Spliceosome]
RNA binding motif protein 17,UP_SEQ_FEATURE[850062049$chain:Splicing factor 45, 850104022$domain:G-patch, 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
RNA binding motif protein 6,COG_ONTOLOGY[90000070$Function unknown]
RNA binding motif protein 6,INTERPRO[450000396$IPR000467:D111/G-patch, 450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014303$IPR015880:Zinc finger, C2H2-like]
RNA binding motif protein 6,SMART[760000323$SM00355:ZnF_C2H2, 760000328$SM00360:RRM, 760000389$SM00443:G_patch]
RNA binding motif protein 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
RNA binding motif protein 6,UP_SEQ_FEATURE[850058503$chain:RNA-binding protein 6, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850104022$domain:G-patch, 850105211$domain:RRM, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
Rab interacting lysosomal protein-like 1,INTERPRO[450017389$IPR019143:JNK/Rab-associated protein-1]
Rab interacting lysosomal protein-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein]
Rab interacting lysosomal protein-like 1,UP_SEQ_FEATURE[850058153$chain:RILP-like protein 1, 850105198$domain:RILP-like, 850106258$modified residue, 850118574$splice variant]
Rh blood group, CcEe antigens,INTERPRO[450001687$IPR001905:Ammonium transporter, 450001976$IPR002229:Blood group Rhesus C/E and D polypeptide]
Rh blood group, CcEe antigens,OMIM_DISEASE[520000615$Blood group, Rhesus, 520004327$Rh-null disease, amorph type]
Rh blood group, CcEe antigens,PIR_SUPERFAMILY[630014625$PIRSF017968:erythrocyte membrane protein RhD]
Rh blood group, CcEe antigens,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000194$blood group antigen, 790000356$complete proteome, 790000445$direct protein sequencing, 790000512$erythrocyte, 790000919$membrane, 790001212$polymorphism, 790001469$surface antigen, 790001555$transmembrane, 790001556$transmembrane protein]
Rh blood group, CcEe antigens,UP_SEQ_FEATURE[850008177$chain:Blood group Rh(CE) polypeptide, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
Rho-related BTB domain containing 1,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450001599$IPR001806:Ras GTPase, 450003145$IPR003578:Ras small GTPase, Rho type, 450004692$IPR005225:Small GTP-binding protein, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450012373$IPR013753:Ras]
Rho-related BTB domain containing 1,PIR_SUPERFAMILY[630030010$PIRSF038482:Rho-related BTB domain-containing protein]
Rho-related BTB domain containing 1,SMART[760000148$SM00174:RHO, 760000197$SM00225:BTB]
Rho-related BTB domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000639$gtp-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001304$repeat]
Rho-related BTB domain containing 1,UP_SEQ_FEATURE[850057593$chain:Rho-related BTB domain-containing protein 1, 850103178$domain:BTB 1, 850103179$domain:BTB 2, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850114526$region of interest:Rho-like]
SAFB-like, transcription modulator,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450002665$IPR003034:DNA-binding SAP, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
SAFB-like, transcription modulator,SMART[760000328$SM00360:RRM, 760000456$SM00513:SAP]
SAFB-like, transcription modulator,SP_PIR_KEYWORDS[790000012$acetylation, 790000109$Apoptosis, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001307$repressor, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation]
SAFB-like, transcription modulator,UP_SEQ_FEATURE[850058821$chain:SAFB-like transcription modulator, 850102415$compositionally biased region:Arg/Glu-rich, 850102507$compositionally biased region:Glu-rich, 850105211$domain:RRM, 850105257$domain:SAP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
SEC14-like 3 (S. cerevisiae),INTERPRO[450000939$IPR001071:Cellular retinaldehyde binding/alpha-tocopherol transport, 450001103$IPR001251:Cellular retinaldehyde-binding/triple function, C-terminal, 450007565$IPR008273:Cellular retinaldehyde-binding/triple function, N-terminal, 450008192$IPR009038:GOLD]
SEC14-like 3 (S. cerevisiae),SMART[760000458$SM00516:SEC14]
SEC14-like 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790000876$lipid-binding, 790001212$polymorphism, 790001558$transport]
SEC14-like 3 (S. cerevisiae),UP_SEQ_FEATURE[850059083$chain:SEC14-like protein 3, 850103410$domain:CRAL-TRIO, 850104069$domain:GOLD, 850117295$sequence variant]
SEC23 interacting protein,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450003687$IPR004177:DDHD]
SEC23 interacting protein,SMART[760000399$SM00454:SAM]
SEC23 interacting protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
SEC23 interacting protein,UP_SEQ_FEATURE[850059086$chain:SEC23-interacting protein, 850102586$compositionally biased region:Pro-rich, 850103504$domain:DDHD, 850105249$domain:SAM, 850106258$modified residue, 850112814$region of interest:Interaction with SEC23A, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SET domain containing 2,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450001068$IPR001214:SET, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450013566$IPR015119:Set2-Rpb1 interacting]
SET domain containing 2,KEGG_PATHWAY[470038751$hsa00310:Lysine degradation]
SET domain containing 2,SMART[760000286$SM00317:SET, 760000401$SM00456:WW, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
SET domain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790000953$methylation, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase]
SET domain containing 2,UP_SEQ_FEATURE[850024164$chain:Histone-lysine N-methyltransferase SETD2, 850102404$compositionally biased region:Arg-rich, 850102485$compositionally biased region:Gln-rich, 850102586$compositionally biased region:Pro-rich, 850103074$domain:AWS, 850105053$domain:Post-SET, 850105340$domain:SET, 850105731$domain:WW, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112689$region of interest:Interaction with POLR2A, 850113304$region of interest:Low charge region, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450006446$IPR007052:CS domain, 450007054$IPR007699:SGS, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450015774$IPR017447:CS, 450017972$IPR019734:Tetratricopeptide repeat]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),PIR_SUPERFAMILY[630028306$PIRSF036827:PIRSF036827]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SMART[760000020$SM00028:TPR]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat, 790001593$ubl conjugation pathway]
SGT1, suppressor of G2 allele of SKP1 (S. cerevisiae),UP_SEQ_FEATURE[850062991$chain:Suppressor of G2 allele of SKP1 homolog, 850103417$domain:CS, 850105345$domain:SGS, 850105852$helix, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand]
SH2 domain containing 1B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 1B,KEGG_PATHWAY[470038868$hsa04650:Natural killer cell mediated cytotoxicity]
SH2 domain containing 1B,PIR_SUPERFAMILY[630029284$PIRSF037711:SH2 domain protein 1B]
SH2 domain containing 1B,SMART[760000224$SM00252:SH2]
SH2 domain containing 1B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 1B,UP_SEQ_FEATURE[850060510$chain:SH2 domain-containing protein 1B, 850105346$domain:SH2, 850117295$sequence variant, 850118574$splice variant]
SH2 domain containing 4B,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 4B,SMART[760000224$SM00252:SH2]
SH2 domain containing 4B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 4B,UP_SEQ_FEATURE[850060515$chain:SH2 domain-containing protein 4B, 850102507$compositionally biased region:Glu-rich, 850105346$domain:SH2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
SH2B adaptor protein 3,INTERPRO[450000852$IPR000980:SH2 motif, 450001635$IPR001849:Pleckstrin homology, 450013461$IPR015012:Phenylalanine zipper]
SH2B adaptor protein 3,KEGG_PATHWAY[470038877$hsa04722:Neurotrophin signaling pathway]
SH2B adaptor protein 3,OMIM_DISEASE[520000886$Celiac disease, susceptiblity to, 13, 520001490$Diabetes mellitus, insulin-dependent, susceptibility to, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520003637$Newly identified genetic risk variants for celiac disease related to the immune response]
SH2B adaptor protein 3,SMART[760000205$SM00233:PH, 760000224$SM00252:SH2]
SH2B adaptor protein 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000430$diabetes mellitus, 790001162$phosphoprotein, 790001212$polymorphism, 790001397$SH2 domain]
SH2B adaptor protein 3,UP_SEQ_FEATURE[850060521$chain:SH2B adapter protein 3, 850104979$domain:PH, 850105346$domain:SH2, 850117294$sequence conflict, 850117295$sequence variant]
SNW domain containing 1,BIOCARTA[30000306$h_vdrPathway:Control of Gene Expression by Vitamin D Receptor]
SNW domain containing 1,INTERPRO[450003535$IPR004015:SKI-interacting protein SKIP, SNW domain, 450016181$IPR017862:SKI-interacting protein, SKIP]
SNW domain containing 1,KEGG_PATHWAY[470038818$hsa03040:Spliceosome, 470038848$hsa04330:Notch signaling pathway]
SNW domain containing 1,PIR_SUPERFAMILY[630012767$PIRSF015989:Caenorhabditis elegans hypothetical protein T27F2.1]
SNW domain containing 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001301$receptor, 790001433$Spliceosome]
SNW domain containing 1,UP_SEQ_FEATURE[850061161$chain:SNW domain-containing protein 1, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850114680$region of interest:SNW]
SP140 nuclear body protein,INTERPRO[450000665$IPR000770:SAND, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450004339$IPR004865:Sp100, 450009947$IPR010919:SAND-like, 450016644$IPR018359:Bromodomain, conserved site, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
SP140 nuclear body protein,OMIM_DISEASE[520000061$A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia]
SP140 nuclear body protein,SMART[760000221$SM00249:PHD, 760000230$SM00258:SAND, 760000267$SM00297:BROMO]
SP140 nuclear body protein,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000206$bromodomain, 790000356$complete proteome, 790000407$cytoplasm, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001648$zinc, 790001651$zinc-finger]
SP140 nuclear body protein,UP_SEQ_FEATURE[850034810$chain:Nuclear body protein SP140, 850102584$compositionally biased region:Poly-Tyr, 850103166$domain:Bromo, 850104153$domain:HSR, 850105253$domain:SAND, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118877$zinc finger region:PHD-type]
SPARC related modular calcium binding 2,INTERPRO[450000615$IPR000716:Thyroglobulin type-1, 450001814$IPR002048:Calcium-binding EF-hand, 450002091$IPR002350:Proteinase inhibitor I1, Kazal, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2, 450017814$IPR019577:SPARC/Testican, calcium-binding domain]
SPARC related modular calcium binding 2,SMART[760000046$SM00054:EFh, 760000184$SM00211:TY, 760000251$SM00280:KAZAL]
SPARC related modular calcium binding 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790001304$repeat, 790001363$Secreted, 790001405$signal]
SPARC related modular calcium binding 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850061581$chain:SPARC-related modular calcium-binding protein 2, 850102883$disulfide bond, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850104500$domain:Kazal-like, 850105486$domain:Thyroglobulin type-1 1, 850105489$domain:Thyroglobulin type-1 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
SRY (sex determining region Y)-box 9,INTERPRO[450000793$IPR000910:High mobility group, HMG1/HMG2]
SRY (sex determining region Y)-box 9,OMIM_DISEASE[520000092$Acampomelic campomelic dysplasia, 520000736$Campomelic dysplasia, 520000737$Campomelic dysplasia with autosomal sex reversal]
SRY (sex determining region Y)-box 9,SMART[760000349$SM00398:HMG]
SRY (sex determining region Y)-box 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
SRY (sex determining region Y)-box 9,UP_SEQ_FEATURE[850065337$chain:Transcription factor SOX-9, 850102501$compositionally biased region:Gln/Pro-rich, 850102580$compositionally biased region:Poly-Pro, 850102920$DNA-binding region:HMG box, 850105852$helix, 850117295$sequence variant, 850118575$strand]
SUMO1/sentrin specific peptidase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001252$Protease, 790001509$thiol protease, 790001593$ubl conjugation pathway]
SUMO1/sentrin specific peptidase 1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850059421$chain:Sentrin-specific protease 1, 850102540$compositionally biased region:His-rich, 850102597$compositionally biased region:Ser-rich, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850114140$region of interest:Protease, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
Sec61 alpha 2 subunit (S. cerevisiae),INTERPRO[450001958$IPR002208:SecY protein, 450017798$IPR019561:Translocon Sec61/SecY, plug domain]
Sec61 alpha 2 subunit (S. cerevisiae),KEGG_PATHWAY[470038896$hsa05110:Vibrio cholerae infection]
Sec61 alpha 2 subunit (S. cerevisiae),PIR_SUPERFAMILY[630004530$PIRSF004557:preprotein translocase Sec, SecY/Sec61-alpha subunit, 630004531$PIRSF004557:SecY]
Sec61 alpha 2 subunit (S. cerevisiae),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001266$protein transport, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
Sec61 alpha 2 subunit (S. cerevisiae),UP_SEQ_FEATURE[850048128$chain:Protein transport protein Sec61 subunit alpha isoform 2, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
StAR-related lipid transfer (START) domain containing 9,INTERPRO[450001552$IPR001752:Kinesin, motor region, 450002572$IPR002913:Lipid-binding START, 450018052$IPR019821:Kinesin, motor region, conserved site]
StAR-related lipid transfer (START) domain containing 9,SMART[760000111$SM00129:KISc, 760000206$SM00234:START]
StAR-related lipid transfer (START) domain containing 9,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000344$coiled coil, 790000356$complete proteome, 790000986$motor protein, 790001063$nucleotide-binding, 790001212$polymorphism]
StAR-related lipid transfer (START) domain containing 9,UP_SEQ_FEATURE[850062387$chain:StAR-related lipid transfer protein 9, 850102485$compositionally biased region:Gln-rich, 850102572$compositionally biased region:Poly-Glu, 850102581$compositionally biased region:Poly-Ser, 850103775$domain:FHA, 850104543$domain:Kinesin-motor, 850105403$domain:START, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,INTERPRO[450002837$IPR003228:Transcription initiation factor TFIID, 450008207$IPR009072:Histone-fold]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000050$alternative initiation, 790000356$complete proteome, 790000445$direct protein sequencing, 790001057$nucleosome, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa,UP_SEQ_FEATURE[850065451$chain:Transcription initiation factor TFIID subunit 12, 850105852$helix, 850106258$modified residue, 850118574$splice variant]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001271$Proto-oncogene]
TBC1 domain family, member 3E; TBC1 domain family, member 3F; TBC1 domain family, member 3G; TBC1 domain family member 3C-like protein ENSP00000341742; TBC1 domain family, member 3H; TBC1 domain family, member 3; TBC1 domain family, member 3I; TBC1 domain family, member 3B; TBC1 domain family, member 3C,UP_SEQ_FEATURE[850063671$chain:TBC1 domain family member 3, 850063672$chain:TBC1 domain family member 3-like protein LOC729837, 850063674$chain:TBC1 domain family member 3B/I, 850063675$chain:TBC1 domain family member 3C/3D, 850063676$chain:TBC1 domain family member 3G, 850105135$domain:Rab-GAP TBC, 850117294$sequence conflict]
TBC1 domain family, member 4,INTERPRO[450000166$IPR000195:RabGAP/TBC, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
TBC1 domain family, member 4,SMART[760000143$SM00164:TBC, 760000407$SM00462:PTB]
TBC1 domain family, member 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
TBC1 domain family, member 4,UP_SEQ_FEATURE[850063677$chain:TBC1 domain family member 4, 850102597$compositionally biased region:Ser-rich, 850104994$domain:PID 1, 850104995$domain:PID 2, 850105135$domain:Rab-GAP TBC, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TBC1 domain family, member 7,COG_ONTOLOGY[90000073$General function prediction only]
TBC1 domain family, member 7,INTERPRO[450000166$IPR000195:RabGAP/TBC]
TBC1 domain family, member 7,SMART[760000143$SM00164:TBC]
TBC1 domain family, member 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790000640$GTPase activation, 790001212$polymorphism]
TBC1 domain family, member 7,UP_SEQ_FEATURE[850063679$chain:TBC1 domain family member 7, 850105135$domain:Rab-GAP TBC, 850117295$sequence variant]
TERF1 (TRF1)-interacting nuclear factor 2,OMIM_DISEASE[520001589$Dyskeratosis congenita, autosomal dominant, 520004324$Revesz syndrome]
TERF1 (TRF1)-interacting nuclear factor 2,PIR_SUPERFAMILY[630030271$PIRSF038821:TERF1-interacting nuclear factor 2 (TINF2)]
TERF1 (TRF1)-interacting nuclear factor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000315$chromosomal protein, 790000356$complete proteome, 790000446$disease mutation, 790000476$dyskeratosis congenita, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001494$telomere]
TERF1 (TRF1)-interacting nuclear factor 2,UP_SEQ_FEATURE[850063842$chain:TERF1-interacting nuclear factor 2, 850106258$modified residue, 850114863$region of interest:TERF1-binding, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
THO complex 5,INTERPRO[450017409$IPR019163:THO complex,  subunit 5]
THO complex 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000988$mrna processing, 790000989$mrna splicing, 790000990$mRNA transport, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding, 790001558$transport]
THO complex 5,UP_SEQ_FEATURE[850064317$chain:THO complex subunit 5 homolog, 850106258$modified residue, 850112220$region of interest:Interaction with CSF1R, 850112946$region of interest:Interaction with THOC7, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,BIOCARTA[30000314$h_WNVpathway:West Nile Virus]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,COG_ONTOLOGY[90000073$General function prediction only]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SMART[760000328$SM00360:RRM]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000109$Apoptosis, 790000356$complete proteome, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding]
TIA1 cytotoxic granule-associated RNA binding protein-like 1,UP_SEQ_FEATURE[850035207$chain:Nucleolysin TIAR, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
TRAF-type zinc finger domain containing 1,INTERPRO[450014303$IPR015880:Zinc finger, C2H2-like]
TRAF-type zinc finger domain containing 1,OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
TRAF-type zinc finger domain containing 1,SMART[760000323$SM00355:ZnF_C2H2]
TRAF-type zinc finger domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001648$zinc, 790001651$zinc-finger]
TRAF-type zinc finger domain containing 1,UP_SEQ_FEATURE[850064872$chain:TRAF-type zinc finger domain-containing protein 1, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118936$zinc finger region:TRAF-type]
TRAF3 interacting protein 2,INTERPRO[450012192$IPR013568:SEFIR]
TRAF3 interacting protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
TRAF3 interacting protein 2,UP_SEQ_FEATURE[850003830$chain:Adapter protein CIKS, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),COG_ONTOLOGY[90000073$General function prediction only]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),INTERPRO[450002972$IPR003402:Protein of unknown function Met10]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000954$methyltransferase, 790001212$polymorphism, 790001547$transferase, 790001572$trna processing]
TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae),UP_SEQ_FEATURE[850066727$chain:tRNA (guanine-N(1)-)-methyltransferase, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
Tctex1 domain containing 2,INTERPRO[450004797$IPR005334:Tctex-1]
Tctex1 domain containing 2,PIR_SUPERFAMILY[630012582$PIRSF015816:dynein light chain, Tctex-type]
Tctex1 domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome]
Tctex1 domain containing 2,UP_SEQ_FEATURE[850063698$chain:Tctex1 domain-containing protein 2, 850117294$sequence conflict]
Thy-1 cell surface antigen,BIOCARTA[30000288$h_tcytotoxicPathway:T Cytotoxic Cell Surface Molecules, 30000295$h_thelperPathway:T Helper Cell Surface Molecules]
Thy-1 cell surface antigen,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011788$IPR013151:Immunoglobulin]
Thy-1 cell surface antigen,KEGG_PATHWAY[470038873$hsa04670:Leukocyte transendothelial migration]
Thy-1 cell surface antigen,PIR_SUPERFAMILY[630030239$PIRSF038777:Thy-1 membrane glycoprotein]
Thy-1 cell surface antigen,SMART[760000357$SM00409:IG]
Thy-1 cell surface antigen,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001291$Pyrrolidone carboxylic acid, 790001405$signal, 790001520$thymocyte, 790001556$transmembrane protein]
Thy-1 cell surface antigen,UP_SEQ_FEATURE[850064408$chain:Thy-1 membrane glycoprotein, 850102883$disulfide bond, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105859$lipid moiety-binding region:GPI-anchor amidated cysteine, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117814$signal peptide]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),OMIM_DISEASE[520001129$Common variants at 30 loci contribute to polygenic dyslipidemia, 520003638$Newly identified loci that influence lipid concentrations and risk of coronary artery disease, 520004490$Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),PIR_SUPERFAMILY[630005598$PIRSF005670:polypeptide N-acetylgalactosaminyltransferase]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2),UP_SEQ_FEATURE[850039925$chain:Polypeptide N- acetylgalactosaminyltransferase 2, 850039926$chain:Polypeptide N- acetylgalactosaminyltransferase 2 soluble form, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105852$helix, 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118450$site:Not glycosylated, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region, 850118624$turn]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),COG_ONTOLOGY[90000032$Cell envelope biogenesis, outer membrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),INTERPRO[450000667$IPR000772:Ricin B lectin, 450001029$IPR001173:Glycosyl transferase, family 2]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),KEGG_PATHWAY[470038768$hsa00512:O-Glycan biosynthesis]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),PIR_SUPERFAMILY[630005598$PIRSF005670:polypeptide N-acetylgalactosaminyltransferase]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),SMART[760000403$SM00458:RICIN]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),SP_PIR_KEYWORDS[790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000848$Lectin, 790000906$manganese, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6),UP_SEQ_FEATURE[850039931$chain:Polypeptide N- acetylgalactosaminyltransferase 6, 850102883$disulfide bond, 850105188$domain:Ricin B-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850111204$region of interest:Catalytic subdomain A, 850111205$region of interest:Catalytic subdomain B, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
UEV and lactate/malate dehyrogenase domains,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450001087$IPR001236:Lactate/malate dehydrogenase, 450001383$IPR001557:L-lactate/malate dehydrogenase, 450008125$IPR008883:Tumour susceptibility gene 101, 450014366$IPR015955:Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal, 450014426$IPR016040:NAD(P)-binding domain, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
UEV and lactate/malate dehyrogenase domains,PIR_SUPERFAMILY[630000119$PIRSF000102:Lac_mal_DH]
UEV and lactate/malate dehyrogenase domains,SMART[760000185$SM00212:UBCc]
UEV and lactate/malate dehyrogenase domains,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001006$nad, 790001593$ubl conjugation pathway]
UEV and lactate/malate dehyrogenase domains,UP_SEQ_FEATURE[850068113$chain:Ubiquitin-conjugating enzyme E2 variant 3, 850105607$domain:UEV, 850105852$helix, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
URB2 ribosome biogenesis 2 homolog (S. cerevisiae),INTERPRO[450017121$IPR018849:Nucleolar 27S pre-rRNA processing, Urb2/Npa2]
URB2 ribosome biogenesis 2 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism]
URB2 ribosome biogenesis 2 homolog (S. cerevisiae),UP_SEQ_FEATURE[850083009$chain:Unhealthy ribosome biogenesis protein 2 homolog, 850117295$sequence variant]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,INTERPRO[450000458$IPR000535:Major sperm protein, 450008175$IPR008962:PapD-like, 450015083$IPR016763:Vesicle-associated membrane protein]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,KEGG_PATHWAY[470038857$hsa04530:Tight junction]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,PIR_SUPERFAMILY[630016271$PIRSF019693:VAMP-associated]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa,UP_SEQ_FEATURE[850100248$chain:Vesicle-associated membrane protein- associated protein A, 850104795$domain:MSP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
WAS protein homolog associated with actin, golgi membranes and microtubules,INTERPRO[450002748$IPR003124:Actin-binding WH2]
WAS protein homolog associated with actin, golgi membranes and microtubules,SMART[760000218$SM00246:WH2]
WAS protein homolog associated with actin, golgi membranes and microtubules,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000408$cytoplasmic vesicle, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
WAS protein homolog associated with actin, golgi membranes and microtubules,UP_SEQ_FEATURE[850100706$chain:WASP homolog-associated protein with actin, membranes and microtubules, 850102586$compositionally biased region:Pro-rich, 850105699$domain:WH2 1, 850105700$domain:WH2 2, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850118574$splice variant]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,INTERPRO[450000618$IPR000719:Protein kinase, core, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,OMIM_DISEASE[520003613$Neuropathy, hereditary sensory and autonomic, type II, 520004158$Pseudohypoaldosteronism, type IIC]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,SP_PIR_KEYWORDS[790000052$alternative promoter usage, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000616$glycoprotein, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001388$serine/threonine-protein kinase, 790001547$transferase]
WNK lysine deficient protein kinase 1; hypothetical LOC100132369,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850060062$chain:Serine/threonine-protein kinase WNK1, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,INTERPRO[450000500$IPR000587:Creatinase, 450000865$IPR000994:Peptidase M24, structural domain, 450000992$IPR001131:Peptidase M24B, X-Pro dipeptidase/aminopeptidase P, conserved site]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,PIR_SUPERFAMILY[630006687$PIRSF006732:pig X-Pro aminopeptidase]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000069$Aminopeptidase, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000906$manganese, 790000937$metal-binding, 790000941$metalloprotease, 790001252$Protease]
X-prolyl aminopeptidase (aminopeptidase P) 1, soluble,UP_SEQ_FEATURE[850100987$chain:Xaa-Pro aminopeptidase 1, 850105852$helix, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
XRCC6 binding protein 1,INTERPRO[450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450017411$IPR019165:Peptidase M76, ATP23]
XRCC6 binding protein 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease]
XRCC6 binding protein 1,UP_SEQ_FEATURE[850031972$chain:Mitochondrial inner membrane protease ATP23 homolog, 850105995$metal ion-binding site:Divalent metal cation; catalytic, 850117295$sequence variant]
YEATS domain containing 4,INTERPRO[450004502$IPR005033:YEATS]
YEATS domain containing 4,OMIM_DISEASE[520002069$Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic, 520002110$Glioma, 520003072$Many sequence variants affecting diversity of adult human height]
YEATS domain containing 4,PIR_SUPERFAMILY[630013109$PIRSF016332:PIRSF016332]
YEATS domain containing 4,SP_PIR_KEYWORDS[790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000445$direct protein sequencing, 790000635$growth regulation, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
YEATS domain containing 4,UP_SEQ_FEATURE[850101127$chain:YEATS domain-containing protein 4, 850105744$domain:YEATS, 850112548$region of interest:Interaction with MLLT10, 850112897$region of interest:Interaction with TACC1, 850117294$sequence conflict]
YME1-like 1 (S. cerevisiae),INTERPRO[450000549$IPR000642:Peptidase M41, 450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005380$IPR005936:Peptidase M41, FtsH]
YME1-like 1 (S. cerevisiae),SMART[760000335$SM00382:AAA]
YME1-like 1 (S. cerevisiae),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001252$Protease, 790001648$zinc]
YME1-like 1 (S. cerevisiae),UP_SEQ_FEATURE[850006648$chain:ATP-dependent metalloprotease YME1L1, 850106244$metal ion-binding site:Zinc; catalytic, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850118574$splice variant]
abl-interactor 1,INTERPRO[450000090$IPR000108:Neutrophil cytosol factor 2, 450000626$IPR000727:Target SNARE coiled-coil region, 450001294$IPR001452:Src homology-3 domain, 450011527$IPR012849:Abl-interactor, homeo-domain homologous region]
abl-interactor 1,SMART[760000295$SM00326:SH3, 760000348$SM00397:t_SNARE]
abl-interactor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000263$cell junction, 790000267$cell projection, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001475$synapse, 790001477$Synaptosome]
abl-interactor 1,UP_SEQ_FEATURE[850003175$chain:Abl interactor 1, 850102586$compositionally biased region:Pro-rich, 850105350$domain:SH3, 850105459$domain:t-SNARE coiled-coil homology, 850106258$modified residue, 850114260$region of interest:Required for binding to WASF1, 850117294$sequence conflict, 850117295$sequence variant, 850117890$site:Breakpoint for translocation to form MLL- ABI1, 850118574$splice variant]
acid phosphatase 6, lysophosphatidic,INTERPRO[450000480$IPR000560:Histidine acid phosphatase]
acid phosphatase 6, lysophosphatidic,KEGG_PATHWAY[470038794$hsa00740:Riboflavin metabolism]
acid phosphatase 6, lysophosphatidic,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000743$hydrolase, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
acid phosphatase 6, lysophosphatidic,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850029336$chain:Lysophosphatidic acid phosphatase type 6, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
actin related protein 2/3 complex, subunit 5-like,INTERPRO[450006195$IPR006789:ARP2/3 complex 16 kDa subunit (p16-Arc)]
actin related protein 2/3 complex, subunit 5-like,KEGG_PATHWAY[470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038898$hsa05130:Pathogenic Escherichia coli infection]
actin related protein 2/3 complex, subunit 5-like,PIR_SUPERFAMILY[630013130$PIRSF016358:Caenorhabditis elegans hypothetical protein M01B12.3]
actin related protein 2/3 complex, subunit 5-like,SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein]
actin related protein 2/3 complex, subunit 5-like,UP_SEQ_FEATURE[850003632$chain:Actin-related protein 2/3 complex subunit 5-like protein, 850106258$modified residue, 850117294$sequence conflict]
actin, alpha, cardiac muscle 1,INTERPRO[450003522$IPR004000:Actin/actin-like, 450003523$IPR004001:Actin, conserved site]
actin, alpha, cardiac muscle 1,KEGG_PATHWAY[470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038922$hsa05414:Dilated cardiomyopathy]
actin, alpha, cardiac muscle 1,OMIM_DISEASE[520000450$Atrial septal defect 5, 520000780$Cardiomyopathy, dilated, 1R, 520000794$Cardiomyopathy, familial hypertrophic, 520000798$Cardiomyopathy, familial hypertrophic, 11]
actin, alpha, cardiac muscle 1,PIR_SUPERFAMILY[630002457$PIRSF002337:Actin]
actin, alpha, cardiac muscle 1,SMART[760000240$SM00268:ACTIN]
actin, alpha, cardiac muscle 1,SP_PIR_KEYWORDS[790000011$acetylated amino end, 790000012$acetylation, 790000138$atp-binding, 790000141$atrial septal defect, 790000244$cardiac muscle, 790000245$Cardiomyopathy, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790000646$heart, 790000950$methylated amino acid, 790000953$methylation, 790000996$muscle contraction, 790000997$muscle protein, 790001063$nucleotide-binding]
actin, alpha, cardiac muscle 1,UP_SEQ_FEATURE[850003516$chain:Actin, alpha cardiac muscle 1, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117295$sequence variant]
adaptor-related protein complex 4, beta 1 subunit,INTERPRO[450002270$IPR002553:Clathrin/coatomer adaptor, adaptin-like, N-terminal, 450010814$IPR011989:Armadillo-like helical, 450013598$IPR015151:Clathrin adaptor, beta-adaptin, appendage, C-terminal subdomain, 450014665$IPR016342:Adaptor protein complex, beta subunit]
adaptor-related protein complex 4, beta 1 subunit,KEGG_PATHWAY[470038840$hsa04142:Lysosome]
adaptor-related protein complex 4, beta 1 subunit,PIR_SUPERFAMILY[630002416$PIRSF002291:adaptor protein complex, beta subunit, 630002417$PIRSF002291:AP_complex_beta]
adaptor-related protein complex 4, beta 1 subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
adaptor-related protein complex 4, beta 1 subunit,UP_SEQ_FEATURE[850005738$chain:AP-4 complex subunit beta-1, 850117294$sequence conflict, 850117295$sequence variant]
adducin 3 (gamma),INTERPRO[450001148$IPR001303:Class II aldolase/adducin, N-terminal]
adducin 3 (gamma),SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000195$blood pressure control, 790000218$calmodulin-binding, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000679$heterodimer, 790000919$membrane, 790001162$phosphoprotein, 790001483$tail protein, 790001592$ubl conjugation]
adducin 3 (gamma),UP_SEQ_FEATURE[850020475$chain:Gamma-adducin, 850106258$modified residue, 850112141$region of interest:Interaction with calmodulin, 850117294$sequence conflict, 850118574$splice variant]
adenine phosphoribosyltransferase,INTERPRO[450000728$IPR000836:Phosphoribosyltransferase, 450002113$IPR002375:Purine/pyrimidine phosphoribosyl transferase, conserved site, 450005218$IPR005764:Adenine phosphoribosyl transferase]
adenine phosphoribosyltransferase,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
adenine phosphoribosyltransferase,OMIM_DISEASE[520004988$Urolithiasis, 2,8-dihydroxyadenine]
adenine phosphoribosyltransferase,PIR_SUPERFAMILY[630000566$PIRSF000479:adenine phosphoribosyltransferase]
adenine phosphoribosyltransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000619$glycosyltransferase, 790000701$homodimer, 790001116$pentosyltransferase, 790001162$phosphoprotein, 790001212$polymorphism, 790001280$purine salvage, 790001354$salvage pathway, 790001547$transferase]
adenine phosphoribosyltransferase,UP_SEQ_FEATURE[850003848$chain:Adenine phosphoribosyltransferase, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
aldehyde dehydrogenase 3 family, member B2,INTERPRO[450011082$IPR012394:Aldehyde dehydrogenase NAD(P)-dependent, 450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal, 450014511$IPR016163:Aldehyde dehydrogenase, C-terminal]
aldehyde dehydrogenase 3 family, member B2,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038753$hsa00340:Histidine metabolism, 470038754$hsa00350:Tyrosine metabolism, 470038755$hsa00360:Phenylalanine metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
aldehyde dehydrogenase 3 family, member B2,PIR_SUPERFAMILY[630027949$PIRSF036492:ALDH]
aldehyde dehydrogenase 3 family, member B2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001006$nad, 790001092$oxidoreductase, 790001212$polymorphism]
aldehyde dehydrogenase 3 family, member B2,UP_SEQ_FEATURE[850004333$chain:Aldehyde dehydrogenase family 3 member B2, 850106301$nucleotide phosphate-binding region:NAD, 850117294$sequence conflict, 850117295$sequence variant]
aldehyde dehydrogenase 6 family, member A1,INTERPRO[450009142$IPR010061:Methylmalonate-semialdehyde dehydrogenase, 450014029$IPR015590:Aldehyde dehydrogenase, 450014509$IPR016160:Aldehyde dehydrogenase, conserved site, 450014510$IPR016162:Aldehyde dehydrogenase, N-terminal]
aldehyde dehydrogenase 6 family, member A1,KEGG_PATHWAY[470038748$hsa00280:Valine, leucine and isoleucine degradation, 470038776$hsa00562:Inositol phosphate metabolism, 470038789$hsa00640:Propanoate metabolism]
aldehyde dehydrogenase 6 family, member A1,OMIM_DISEASE[520003265$Methylmalonate semialdehyde dehydrogenase deficiency]
aldehyde dehydrogenase 6 family, member A1,PIR_SUPERFAMILY[630000172$PIRSF000147:NAD-dependent aldehyde dehydrogenase]
aldehyde dehydrogenase 6 family, member A1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000446$disease mutation, 790000969$mitochondrion, 790001006$nad, 790001092$oxidoreductase, 790001550$transit peptide]
aldehyde dehydrogenase 6 family, member A1,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000454$binding site:NAD, 850031529$chain:Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial, 850106258$modified residue, 850106301$nucleotide phosphate-binding region:NAD, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),BIOCARTA[30000023$h_arenrf2Pathway:Oxidative Stress Induced Gene Expression Via Nrf2]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),INTERPRO[450001240$IPR001395:Aldo/keto reductase]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),PIR_SUPERFAMILY[630000111$PIRSF000097:aldo-keto reductase]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000624$golgi apparatus, 790001008$nadp, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism]
aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase),UP_SEQ_FEATURE[850000131$active site:Proton donor, 850000461$binding site:NADP, 850000555$binding site:Substrate, 850004119$chain:Aflatoxin B1 aldehyde reductase member 2, 850105852$helix, 850106258$modified residue, 850106307$nucleotide phosphate-binding region:NADP, 850117295$sequence variant, 850118396$site:Lowers pKa of active site Tyr, 850118575$strand, 850118624$turn]
alpha- and gamma-adaptin-binding protein p34,INTERPRO[450017579$IPR019341:Alpha- and gamma-adaptin-binding protein p34]
alpha- and gamma-adaptin-binding protein p34,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
alpha- and gamma-adaptin-binding protein p34,UP_SEQ_FEATURE[850004580$chain:Alpha- and gamma-adaptin-binding protein p34, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),INTERPRO[450005485$IPR006046:Glycoside hydrolase family 13, 450005486$IPR006047:Glycosyl hydrolase, family 13, catalytic region, 450005487$IPR006048:Alpha-amylase, C-terminal all beta, 450006009$IPR006589:Glycosyl hydrolase, family 13, subfamily, catalytic region, 450012394$IPR013780:Glycosyl hydrolase, family 13, all-beta, 450012395$IPR013781:Glycoside hydrolase, subgroup, catalytic core]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),KEGG_PATHWAY[470038765$hsa00500:Starch and sucrose metabolism]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),SMART[760000547$SM00632:Aamy_C, 760000557$SM00642:Aamy]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000232$carbohydrate metabolism, 790000295$chloride, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000937$metal-binding, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
amylase, alpha 1A (salivary); amylase, alpha 1B (salivary); amylase, alpha 1C (salivary),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850000281$binding site:Chloride, 850004698$chain:Alpha-amylase 1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106258$modified residue, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand, 850118624$turn]
ankyrin repeat domain 12,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 12,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 12,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat domain 12,UP_SEQ_FEATURE[850005362$chain:Ankyrin repeat domain-containing protein 12, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ankyrin repeat domain 28,COG_ONTOLOGY[90000073$General function prediction only]
ankyrin repeat domain 28,INTERPRO[450001870$IPR002110:Ankyrin]
ankyrin repeat domain 28,PIR_SUPERFAMILY[630002426$PIRSF002300:syphilis spirochete probable ankyrin]
ankyrin repeat domain 28,SMART[760000220$SM00248:ANK]
ankyrin repeat domain 28,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat]
ankyrin repeat domain 28,UP_SEQ_FEATURE[850060140$chain:Serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit A, 850106258$modified residue, 850106259$mutagenesis site, 850115632$repeat:ANK 1, 850115633$repeat:ANK 10, 850115634$repeat:ANK 11, 850115635$repeat:ANK 12, 850115636$repeat:ANK 13, 850115637$repeat:ANK 14, 850115638$repeat:ANK 15, 850115639$repeat:ANK 16, 850115640$repeat:ANK 17, 850115641$repeat:ANK 18, 850115642$repeat:ANK 19, 850115644$repeat:ANK 2, 850115645$repeat:ANK 20, 850115646$repeat:ANK 21, 850115647$repeat:ANK 22, 850115648$repeat:ANK 23, 850115649$repeat:ANK 24, 850115650$repeat:ANK 25, 850115651$repeat:ANK 26, 850115652$repeat:ANK 27, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850115657$repeat:ANK 6, 850115658$repeat:ANK 7, 850115659$repeat:ANK 8, 850115660$repeat:ANK 9, 850117294$sequence conflict, 850118574$splice variant]
annexin A11,INTERPRO[450001304$IPR001464:Annexin, 450007488$IPR008157:Annexin, type XI, N-terminal, 450013917$IPR015475:Annexin XI, 450016537$IPR018252:Annexin repeat, conserved site, 450016775$IPR018502:Annexin repeat]
annexin A11,PIR_SUPERFAMILY[630002478$PIRSF002360:annexin VII]
annexin A11,SMART[760000303$SM00335:ANX]
annexin A11,SP_PIR_KEYWORDS[790000012$acetylation, 790000088$annexin, 790000211$calcium, 790000212$calcium binding, 790000216$calcium/phospholipid-binding, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000473$duplication, 790000497$endonexin fold, 790000616$glycoprotein, 790001065$nucleus, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
annexin A11,UP_SEQ_FEATURE[850005451$chain:Annexin A11, 850106258$modified residue, 850115661$repeat:Annexin 1, 850115662$repeat:Annexin 2, 850115663$repeat:Annexin 3, 850115664$repeat:Annexin 4, 850117295$sequence variant]
apolipoprotein M,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000643$hdl, 790000875$lipid transport, 790000881$lipoprotein, 790001363$Secreted, 790001405$signal, 790001558$transport]
apolipoprotein M,UP_SEQ_FEATURE[850005829$chain:Apolipoprotein M, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117814$signal peptide, 850118575$strand]
armadillo repeat containing 5,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450000194$IPR000225:Armadillo, 450010814$IPR011989:Armadillo-like helical]
armadillo repeat containing 5,SMART[760000159$SM00185:ARM, 760000197$SM00225:BTB]
armadillo repeat containing 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
armadillo repeat containing 5,UP_SEQ_FEATURE[850006121$chain:Armadillo repeat-containing protein 5, 850103177$domain:BTB, 850115674$repeat:ARM 1, 850115683$repeat:ARM 2, 850115684$repeat:ARM 3, 850115685$repeat:ARM 4, 850115687$repeat:ARM 5, 850115688$repeat:ARM 6, 850115689$repeat:ARM 7, 850117295$sequence variant, 850118574$splice variant]
aryl hydrocarbon receptor nuclear translocator-like 2,INTERPRO[450000012$IPR000014:PAS, 450000935$IPR001067:Nuclear translocator, 450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450001428$IPR001610:PAC motif, 450010429$IPR011598:Helix-loop-helix DNA-binding, 450012276$IPR013655:PAS fold-3, 450012386$IPR013767:PAS fold]
aryl hydrocarbon receptor nuclear translocator-like 2,SMART[760000074$SM00086:PAC, 760000079$SM00091:PAS, 760000321$SM00353:HLH]
aryl hydrocarbon receptor nuclear translocator-like 2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000182$biological rhythms, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
aryl hydrocarbon receptor nuclear translocator-like 2,UP_SEQ_FEATURE[850006189$chain:Aryl hydrocarbon receptor nuclear translocator-like protein 2, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104880$domain:PAC, 850104897$domain:PAS 1, 850104898$domain:PAS 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
aryl-hydrocarbon receptor nuclear translocator 2,INTERPRO[450000012$IPR000014:PAS, 450000935$IPR001067:Nuclear translocator, 450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH, 450001428$IPR001610:PAC motif, 450010429$IPR011598:Helix-loop-helix DNA-binding, 450012276$IPR013655:PAS fold-3, 450012386$IPR013767:PAS fold]
aryl-hydrocarbon receptor nuclear translocator 2,KEGG_PATHWAY[470038899$hsa05200:Pathways in cancer, 470038901$hsa05211:Renal cell carcinoma]
aryl-hydrocarbon receptor nuclear translocator 2,PIR_SUPERFAMILY[630013920$PIRSF017155:aryl hydrocarbon receptor nuclear translocator]
aryl-hydrocarbon receptor nuclear translocator 2,SMART[760000074$SM00086:PAC, 760000079$SM00091:PAS, 760000321$SM00353:HLH]
aryl-hydrocarbon receptor nuclear translocator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
aryl-hydrocarbon receptor nuclear translocator 2,UP_SEQ_FEATURE[850006186$chain:Aryl hydrocarbon receptor nuclear translocator 2, 850102566$compositionally biased region:Poly-Arg, 850102570$compositionally biased region:Poly-Gln, 850102581$compositionally biased region:Poly-Ser, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850104880$domain:PAC, 850104897$domain:PAS 1, 850104898$domain:PAS 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ash1 (absent, small, or homeotic)-like (Drosophila),INTERPRO[450000898$IPR001025:Bromo adjacent region, 450001068$IPR001214:SET, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450003176$IPR003616:Post-SET zinc-binding region, 450005980$IPR006560:AWS, 450016267$IPR017956:AT hook, DNA-binding, conserved site, 450016644$IPR018359:Bromodomain, conserved site, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
ash1 (absent, small, or homeotic)-like (Drosophila),KEGG_PATHWAY[470038751$hsa00310:Lysine degradation, 470038857$hsa04530:Tight junction]
ash1 (absent, small, or homeotic)-like (Drosophila),SMART[760000221$SM00249:PHD, 760000267$SM00297:BROMO, 760000286$SM00317:SET, 760000336$SM00384:AT_hook, 760000385$SM00439:BAH, 760000451$SM00508:PostSET, 760000507$SM00570:AWS]
ash1 (absent, small, or homeotic)-like (Drosophila),SP_PIR_KEYWORDS[790000020$activator, 790000206$bromodomain, 790000263$cell junction, 790000311$chromatin regulator, 790000356$complete proteome, 790000811$isopeptide bond, 790000937$metal-binding, 790000954$methyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001528$Tight junction, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
ash1 (absent, small, or homeotic)-like (Drosophila),UP_SEQ_FEATURE[850042338$chain:Probable histone-lysine N- methyltransferase ASH1L, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850102889$DNA-binding region:A.T hook 3, 850103074$domain:AWS, 850103089$domain:BAH, 850103166$domain:Bromo, 850105053$domain:Post-SET, 850105340$domain:SET, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118877$zinc finger region:PHD-type]
asialoglycoprotein receptor 2,INTERPRO[450001149$IPR001304:C-type lectin, 450002094$IPR002353:Type II antifreeze protein, 450005088$IPR005640:Hepatic lectin, N-terminal, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
asialoglycoprotein receptor 2,PIR_SUPERFAMILY[630002543$PIRSF002424:hepatic lectin]
asialoglycoprotein receptor 2,SMART[760000026$SM00034:CLECT]
asialoglycoprotein receptor 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000447$disulfide bond, 790000496$Endocytosis, 790000616$glycoprotein, 790000848$Lectin, 790000881$lipoprotein, 790000885$liver, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001301$receptor, 790001409$Signal-anchor, 790001555$transmembrane, 790001556$transmembrane protein]
asialoglycoprotein receptor 2,UP_SEQ_FEATURE[850006245$chain:Asialoglycoprotein receptor 2, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850117294$sequence conflict, 850117444$short sequence motif:Endocytosis signal, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
beta-transducin repeat containing,BIOCARTA[30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
beta-transducin repeat containing,INTERPRO[450001490$IPR001680:WD40 repeat, 450001603$IPR001810:Cyclin-like F-box, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
beta-transducin repeat containing,KEGG_PATHWAY[470038835$hsa04114:Oocyte meiosis, 470038837$hsa04120:Ubiquitin mediated proteolysis, 470038846$hsa04310:Wnt signaling pathway, 470038849$hsa04340:Hedgehog signaling pathway]
beta-transducin repeat containing,SMART[760000228$SM00256:FBOX, 760000289$SM00320:WD40]
beta-transducin repeat containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000859$ligase, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001642$wnt signaling pathway]
beta-transducin repeat containing,UP_SEQ_FEATURE[850018848$chain:F-box/WD repeat-containing protein 1A, 850103725$domain:F-box, 850105852$helix, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
biogenesis of lysosomal organelles complex-1, subunit 2,INTERPRO[450017509$IPR019269:Biogenesis of lysosome-related organelles complex-1, subunit 2]
biogenesis of lysosomal organelles complex-1, subunit 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism]
biogenesis of lysosomal organelles complex-1, subunit 2,UP_SEQ_FEATURE[850008108$chain:Biogenesis of lysosome-related organelles complex 1 subunit 2, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
brain and reproductive organ-expressed (TNFRSF1A modulator),INTERPRO[450009421$IPR010358:Brain and reproductive organ-expressed]
brain and reproductive organ-expressed (TNFRSF1A modulator),PIR_SUPERFAMILY[630007027$PIRSF007150:anti-apoptotic protein BRE]
brain and reproductive organ-expressed (TNFRSF1A modulator),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001304$repeat]
brain and reproductive organ-expressed (TNFRSF1A modulator),UP_SEQ_FEATURE[850008344$chain:BRCA1-A complex subunit BRE, 850106258$modified residue, 850115008$region of interest:UEV-like 1, 850115009$region of interest:UEV-like 2, 850117294$sequence conflict, 850118574$splice variant]
calcium binding protein 2,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450014189$IPR015754:Calcium binding protein, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
calcium binding protein 2,SMART[760000046$SM00054:EFh]
calcium binding protein 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000624$golgi apparatus, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001304$repeat]
calcium binding protein 2,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850008971$chain:Calcium-binding protein 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850118574$splice variant]
calcium binding protein 39,INTERPRO[450012475$IPR013878:Mo25-like]
calcium binding protein 39,KEGG_PATHWAY[470038842$hsa04150:mTOR signaling pathway]
calcium binding protein 39,PIR_SUPERFAMILY[630008467$PIRSF009316:hypothetical protein, Saccharomyces cerevisiae YKL189w type]
calcium binding protein 39,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm]
calcium binding protein 39,UP_SEQ_FEATURE[850008973$chain:Calcium-binding protein 39, 850105852$helix, 850106258$modified residue, 850118624$turn]
calcium channel, voltage-dependent, beta 3 subunit,INTERPRO[450000497$IPR000584:Voltage-dependent calcium channel, L-type, beta subunit, 450001294$IPR001452:Src homology-3 domain, 450007416$IPR008079:Voltage-dependent calcium channel, L-type, beta-3 subunit, 450007478$IPR008145:Guanylate kinase/L-type calcium channel region]
calcium channel, voltage-dependent, beta 3 subunit,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038844$hsa04260:Cardiac muscle contraction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy]
calcium channel, voltage-dependent, beta 3 subunit,PIR_SUPERFAMILY[630012355$PIRSF015600:human voltage-dependent calcium channel beta chain]
calcium channel, voltage-dependent, beta 3 subunit,SMART[760000063$SM00072:GuKc, 760000295$SM00326:SH3]
calcium channel, voltage-dependent, beta 3 subunit,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain, 790001558$transport, 790001631$voltage-gated channel]
calcium channel, voltage-dependent, beta 3 subunit,UP_SEQ_FEATURE[850100538$chain:Voltage-dependent L-type calcium channel subunit beta-3, 850105350$domain:SH3, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calcium/calmodulin-dependent protein kinase II gamma,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000043$h_CaCaMPathway:Ca++/ Calmodulin-dependent Protein Kinase Activation, 30000070$h_crebPathway:Transcription factor CREB and its extracellular signals, 30000226$h_pgc1aPathway:Regulation of PGC-1a, 30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
calcium/calmodulin-dependent protein kinase II gamma,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012167$IPR013543:Calcium/calmodulin dependent protein kinase II, association-domain, 450014177$IPR015742:Calcium/calmodulin-dependent protein kinase II isoform, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
calcium/calmodulin-dependent protein kinase II gamma,KEGG_PATHWAY[470038828$hsa04012:ErbB signaling pathway, 470038829$hsa04020:Calcium signaling pathway, 470038835$hsa04114:Oocyte meiosis, 470038846$hsa04310:Wnt signaling pathway, 470038876$hsa04720:Long-term potentiation, 470038877$hsa04722:Neurotrophin signaling pathway, 470038879$hsa04740:Olfactory transduction, 470038883$hsa04912:GnRH signaling pathway, 470038885$hsa04916:Melanogenesis, 470038904$hsa05214:Glioma]
calcium/calmodulin-dependent protein kinase II gamma,PIR_SUPERFAMILY[630000701$PIRSF000594:calcium/calmodulin-dependent protein kinase II]
calcium/calmodulin-dependent protein kinase II gamma,SMART[760000193$SM00220:S_TKc]
calcium/calmodulin-dependent protein kinase II gamma,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000138$atp-binding, 790000218$calmodulin-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
calcium/calmodulin-dependent protein kinase II gamma,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850009093$chain:Calcium/calmodulin-dependent protein kinase type II subunit gamma, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850111164$region of interest:Calmodulin-binding, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cannabinoid receptor 2 (macrophage),BIOCARTA[30000049$h_cb1rPathway:Metabolism of Anandamide, an Endogenous Cannabinoid]
cannabinoid receptor 2 (macrophage),INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450001378$IPR001551:Cannabinoid receptor, type 2, 450001977$IPR002230:Cannabinoid receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cannabinoid receptor 2 (macrophage),KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
cannabinoid receptor 2 (macrophage),PIR_SUPERFAMILY[630030135$PIRSF038633:cannabinoid receptor 2, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cannabinoid receptor 2 (macrophage),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000775$inflammatory response, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane]
cannabinoid receptor 2 (macrophage),UP_SEQ_FEATURE[850009290$chain:Cannabinoid receptor 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
capping protein (actin filament) muscle Z-line, alpha 1,INTERPRO[450001942$IPR002189:F-actin capping protein, alpha subunit, 450016184$IPR017865:F-actin capping protein, alpha subunit, conserved site, 450016599$IPR018315:F-actin capping protein, alpha subunit, actin binding]
capping protein (actin filament) muscle Z-line, alpha 1,PIR_SUPERFAMILY[630005921$PIRSF005982:actin-capping protein alpha chain]
capping protein (actin filament) muscle Z-line, alpha 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000018$actin capping, 790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing]
capping protein (actin filament) muscle Z-line, alpha 1,UP_SEQ_FEATURE[850018460$chain:F-actin-capping protein subunit alpha-1, 850106258$modified residue, 850117294$sequence conflict]
capping protein (actin filament) muscle Z-line, beta,INTERPRO[450001504$IPR001698:F-actin capping protein, beta subunit, 450018006$IPR019771:F-actin capping protein, beta subunit conserved site]
capping protein (actin filament) muscle Z-line, beta,PIR_SUPERFAMILY[630002456$PIRSF002336:actin-capping protein beta chain]
capping protein (actin filament) muscle Z-line, beta,SP_PIR_KEYWORDS[790000012$acetylation, 790000018$actin capping, 790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790001162$phosphoprotein]
capping protein (actin filament) muscle Z-line, beta,UP_SEQ_FEATURE[850018463$chain:F-actin-capping protein subunit beta, 850106258$modified residue, 850118574$splice variant]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,INTERPRO[450000753$IPR000863:Sulfotransferase]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15,UP_SEQ_FEATURE[850009410$chain:Carbohydrate sulfotransferase 15, 850105770$glycosylation site:N-linked (GlcNAc...), 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
cation channel, sperm associated 1,INTERPRO[450005268$IPR005821:Ion transport]
cation channel, sperm associated 1,SP_PIR_KEYWORDS[790000211$calcium, 790000213$calcium channel, 790000215$calcium transport, 790000264$cell membrane, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000557$flagellum, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001426$spermatogenesis, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
cation channel, sperm associated 1,UP_SEQ_FEATURE[850009956$chain:Cation channel sperm-associated protein 1, 850102540$compositionally biased region:His-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118603$topological domain:Pore forming, 850118623$transmembrane region]
cell cycle exit and neuronal differentiation 1,PIR_SUPERFAMILY[630008836$PIRSF009834:pig BM88 antigen]
cell cycle exit and neuronal differentiation 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
cell cycle exit and neuronal differentiation 1,UP_SEQ_FEATURE[850010267$chain:Cell cycle exit and neuronal differentiation protein 1, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chaperonin containing TCP1, subunit 3 (gamma),INTERPRO[450001946$IPR002194:Chaperonin TCP-1, conserved site, 450002152$IPR002423:Chaperonin Cpn60/TCP-1, 450011398$IPR012719:T-complex protein 1, gamma subunit, 450016306$IPR017998:Chaperone, tailless complex polypeptide 1]
chaperonin containing TCP1, subunit 3 (gamma),PIR_SUPERFAMILY[630002698$PIRSF002584:molecular chaperone t-complex-type]
chaperonin containing TCP1, subunit 3 (gamma),SP_PIR_KEYWORDS[790000012$acetylation, 790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000976$molecular chaperone, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
chaperonin containing TCP1, subunit 3 (gamma),UP_SEQ_FEATURE[850063420$chain:T-complex protein 1 subunit gamma, 850102883$disulfide bond, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chemokine (C-X-C motif) ligand 2,INTERPRO[450000954$IPR001089:Small chemokine, C-X-C, 450001604$IPR001811:Small chemokine, interleukin-8-like, 450002193$IPR002473:Small chemokine, C-X-C/Interleukin 8, 450016352$IPR018048:Small chemokine, C-X-C, conserved site]
chemokine (C-X-C motif) ligand 2,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-X-C motif) ligand 2,PIR_SUPERFAMILY[630002641$PIRSF002522:CXC chemokine, 630030765$PIRSF500568:growth regulated protein, alpha/beta/gamma types]
chemokine (C-X-C motif) ligand 2,SMART[760000172$SM00199:SCY]
chemokine (C-X-C motif) ligand 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000774$inflammation, 790000775$inflammatory response, 790001137$pharmaceutical, 790001363$Secreted, 790001405$signal]
chemokine (C-X-C motif) ligand 2,UP_SEQ_FEATURE[850008778$chain:C-X-C motif chemokine 2, 850022424$chain:GRO-beta(5-73), 850102883$disulfide bond, 850117814$signal peptide, 850118575$strand, 850118624$turn]
chloride channel 6,INTERPRO[450000551$IPR000644:Cystathionine beta-synthase, core, 450001600$IPR001807:Chloride channel, voltage gated, 450001994$IPR002248:Chloride channel CLC-6, 450013194$IPR014743:Chloride channel, core]
chloride channel 6,PIR_SUPERFAMILY[630012791$PIRSF016017:PIRSF016017]
chloride channel 6,SMART[760000103$SM00116:CBS]
chloride channel 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000102$antiport, 790000138$atp-binding, 790000255$CBS domain, 790000295$chloride, 790000296$chloride channel, 790000356$complete proteome, 790000501$endosome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
chloride channel 6,UP_SEQ_FEATURE[850000281$binding site:Chloride, 850000287$binding site:Chloride; via amide nitrogen, 850011091$chain:Chloride transport protein 6, 850102480$compositionally biased region:Cys-rich, 850103311$domain:CBS 1, 850103312$domain:CBS 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112009$region of interest:In-membrane helix, 850112010$region of interest:In-membrane loop between two helices, 850117295$sequence variant, 850117701$short sequence motif:Selectivity filter part_1, 850117702$short sequence motif:Selectivity filter part_2, 850117703$short sequence motif:Selectivity filter part_3, 850118429$site:Mediates proton transfer from the outer aqueous phase to the interior of the protein; involved in linking H(+) and Cl(-) transport, 850118430$site:Mediates proton transfer from the protein to the inner aqueous phase, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
cholinergic receptor, muscarinic 1,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000041$h_botulinPathway:Blockade of Neurotransmitter Relase by Botulinum Toxin, 30000204$h_no1Pathway:Actions of Nitric Oxide in the Heart, 30000304$h_tubbyPathway:G-Protein Signaling Through Tubby Proteins]
cholinergic receptor, muscarinic 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000866$IPR000995:Muscarinic acetylcholine receptor, 450001975$IPR002228:Muscarinic acetylcholine receptor M1, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
cholinergic receptor, muscarinic 1,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038881$hsa04810:Regulation of actin cytoskeleton]
cholinergic receptor, muscarinic 1,PIR_SUPERFAMILY[630030053$PIRSF038548:muscarinic acetylcholine receptor, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
cholinergic receptor, muscarinic 1,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001026$neurotransmitter receptor, 790001162$phosphoprotein, 790001223$postsynaptic cell membrane, 790001301$receptor, 790001475$synapse, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
cholinergic receptor, muscarinic 1,UP_SEQ_FEATURE[850032812$chain:Muscarinic acetylcholine receptor M1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,INTERPRO[450007705$IPR008428:Chondroitin N-acetylgalactosaminyltransferase]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,KEGG_PATHWAY[470038772$hsa00532:Chondroitin sulfate biosynthesis]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000919$membrane, 790000937$metal-binding, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
chondroitin sulfate N-acetylgalactosaminyltransferase 1,UP_SEQ_FEATURE[850011240$chain:Chondroitin sulfate N- acetylgalactosaminyltransferase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105986$metal ion-binding site:Divalent metal cation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromodomain helicase DNA binding protein 4,INTERPRO[450000283$IPR000330:SNF2-related, 450000831$IPR000953:Chromo domain, 450001461$IPR001650:DNA/RNA helicase, C-terminal, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002185$IPR002464:DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site, 450008565$IPR009462:Protein of unknown function DUF1086, 450008566$IPR009463:Protein of unknown function DUF1087, 450011633$IPR012957:CHD, C-terminal 2, 450011634$IPR012958:CHD, N-terminal, 450012595$IPR014001:DEAD-like helicase, N-terminal, 450012615$IPR014021:Helicase, superfamily 1 and 2, ATP-binding, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
chromodomain helicase DNA binding protein 4,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000268$SM00298:CHROMO, 760000432$SM00487:DEXDc, 760000434$SM00490:HELICc]
chromodomain helicase DNA binding protein 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000311$chromatin regulator, 790000356$complete proteome, 790000466$dna-binding, 790000649$helicase, 790000743$hydrolase, 790000937$metal-binding, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
chromodomain helicase DNA binding protein 4,UP_SEQ_FEATURE[850011385$chain:Chromodomain-helicase-DNA-binding protein 4, 850102565$compositionally biased region:Poly-Ala, 850102568$compositionally biased region:Poly-Asp, 850102572$compositionally biased region:Poly-Glu, 850102576$compositionally biased region:Poly-Leu, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103362$domain:Chromo 1, 850103363$domain:Chromo 2, 850104106$domain:Helicase ATP-binding, 850104111$domain:Helicase C-terminal, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850117387$short sequence motif:DEAH box, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2]
chromosome 1 open reading frame 103,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 1 open reading frame 103,UP_SEQ_FEATURE[850073567$chain:Uncharacterized protein C1orf103, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 1 open reading frame 130,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 1 open reading frame 130,UP_SEQ_FEATURE[850073591$chain:Uncharacterized protein C1orf130, 850102585$compositionally biased region:Poly-Val, 850118623$transmembrane region]
chromosome 1 open reading frame 182,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 1 open reading frame 182,UP_SEQ_FEATURE[850073623$chain:Uncharacterized protein C1orf182, 850117295$sequence variant]
chromosome 1 open reading frame 85,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 1 open reading frame 85,UP_SEQ_FEATURE[850029379$chain:Lysosomal protein NCU-G1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
chromosome 10 open reading frame 140,INTERPRO[450002951$IPR003380:Transforming protein Ski]
chromosome 10 open reading frame 140,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 10 open reading frame 140,UP_SEQ_FEATURE[850045618$chain:Protein DLN-1, 850102378$compositionally biased region:Ala-rich, 850102507$compositionally biased region:Glu-rich, 850102540$compositionally biased region:His-rich, 850102565$compositionally biased region:Poly-Ala, 850102597$compositionally biased region:Ser-rich, 850117294$sequence conflict]
chromosome 10 open reading frame 2,INTERPRO[450007050$IPR007694:DNA helicase, DnaB-like, C-terminal]
chromosome 10 open reading frame 2,OMIM_DISEASE[520003344$Mitochondrial DNA depletion syndrome, hepatocerebral form, 520004102$Progressive external ophthalmoplegia with mitochondrial DNA deletions, 520004106$progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 3, 520004435$Sensory ataxia neuropathy, dysarthria, and ophthalmoparesis, 520004616$Spinocerebellar ataxia 8, 520004627$Spinocerebellar ataxia, infantile-onset, 520004628$Spinocerebellar ataxia, infantile-onset, with sensory neuropathy]
chromosome 10 open reading frame 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000446$disease mutation, 790000460$dna replication, 790000649$helicase, 790000743$hydrolase, 790000969$mitochondrion, 790001015$neurodegeneration, 790001020$neuropathy, 790001063$nucleotide-binding, 790001212$polymorphism, 790001244$progressive external ophthalmoplegia, 790001550$transit peptide]
chromosome 10 open reading frame 2,UP_SEQ_FEATURE[850067297$chain:Twinkle protein, mitochondrial, 850105342$domain:SF4 helicase, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
chromosome 10 open reading frame 26,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 10 open reading frame 26,UP_SEQ_FEATURE[850036312$chain:Outcome predictor in acute leukemia 1, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
chromosome 10 open reading frame 32,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 10 open reading frame 32,UP_SEQ_FEATURE[850098220$chain:UPF0693 protein C10orf32, 850106258$modified residue]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,PIR_SUPERFAMILY[630009558$PIRSF011010:Caenorhabditis elegans hypothetical protein R53.5]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
chromosome 10 open reading frame 58; chromosome 10 open reading frame 57,UP_SEQ_FEATURE[850066251$chain:Transmembrane protein C10orf57, 850072908$chain:Uncharacterized protein C10orf58, 850117294$sequence conflict, 850117814$signal peptide, 850118623$transmembrane region]
chromosome 10 open reading frame 72,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450012396$IPR013783:Immunoglobulin-like fold]
chromosome 10 open reading frame 72,SMART[760000357$SM00409:IG]
chromosome 10 open reading frame 72,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 10 open reading frame 72,UP_SEQ_FEATURE[850069979$chain:Uncharacterized Ig-like domain-containing protein C10orf72, 850102883$disulfide bond, 850104199$domain:Ig-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 11 open reading frame 24,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 11 open reading frame 24,UP_SEQ_FEATURE[850072958$chain:Uncharacterized protein C11orf24, 850102586$compositionally biased region:Pro-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 11 open reading frame 84,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 11 open reading frame 84,UP_SEQ_FEATURE[850072993$chain:Uncharacterized protein C11orf84, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117295$sequence variant]
chromosome 12 open reading frame 30,INTERPRO[450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017429$IPR019183:N-acetyltransferase B complex, non-catalytic subunit]
chromosome 12 open reading frame 30,OMIM_DISEASE[520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, 520004355$Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes]
chromosome 12 open reading frame 30,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
chromosome 12 open reading frame 30,UP_SEQ_FEATURE[850033292$chain:N-terminal acetyltransferase B complex subunit MDM20, 850102577$compositionally biased region:Poly-Lys, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 12 open reading frame 35,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 12 open reading frame 35,UP_SEQ_FEATURE[850073042$chain:Uncharacterized protein C12orf35, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 14 open reading frame 37,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
chromosome 14 open reading frame 37,UP_SEQ_FEATURE[850073183$chain:Uncharacterized protein C14orf37, 850102507$compositionally biased region:Glu-rich, 850102566$compositionally biased region:Poly-Arg, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
chromosome 14 open reading frame 38,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 14 open reading frame 38,UP_SEQ_FEATURE[850073185$chain:Uncharacterized protein C14orf38, 850117295$sequence variant]
chromosome 14 open reading frame 45,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 14 open reading frame 45,UP_SEQ_FEATURE[850073188$chain:Uncharacterized protein C14orf45, 850106258$modified residue, 850117295$sequence variant]
chromosome 14 open reading frame 68,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
chromosome 14 open reading frame 68,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
chromosome 14 open reading frame 68,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
chromosome 14 open reading frame 68,UP_SEQ_FEATURE[850023492$chain:Hepatocellular carcinoma down-regulated mitochondrial carrier protein, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850118574$splice variant, 850118623$transmembrane region]
chromosome 15 open reading frame 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001212$polymorphism, 790001426$spermatogenesis]
chromosome 15 open reading frame 2,UP_SEQ_FEATURE[850045290$chain:Protein C15orf2, 850102586$compositionally biased region:Pro-rich, 850117295$sequence variant]
chromosome 15 open reading frame 60,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 15 open reading frame 60,UP_SEQ_FEATURE[850073239$chain:Uncharacterized protein C15orf60, 850117295$sequence variant]
chromosome 16 open reading frame 92,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 16 open reading frame 92,UP_SEQ_FEATURE[850073325$chain:Uncharacterized protein C16orf92, 850118574$splice variant, 850118623$transmembrane region]
chromosome 19 open reading frame 2,INTERPRO[450003641$IPR004127:Prefoldin alpha-like]
chromosome 19 open reading frame 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
chromosome 19 open reading frame 2,UP_SEQ_FEATURE[850082989$chain:Unconventional prefoldin RPB5 interactor, 850102568$compositionally biased region:Poly-Asp, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
chromosome 19 open reading frame 47,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 19 open reading frame 47,UP_SEQ_FEATURE[850073519$chain:Uncharacterized protein C19orf47, 850102581$compositionally biased region:Poly-Ser, 850106258$modified residue, 850118574$splice variant]
chromosome 19 open reading frame 71,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
chromosome 19 open reading frame 71,UP_SEQ_FEATURE[850073534$chain:Uncharacterized protein C19orf71, 850117295$sequence variant]
chromosome 2 open reading frame 14; Uncharacterized protein C2orf14-like 2; Uncharacterized protein C2orf14-like 1,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 2 open reading frame 14; Uncharacterized protein C2orf14-like 2; Uncharacterized protein C2orf14-like 1,UP_SEQ_FEATURE[850073927$chain:Uncharacterized protein C2orf14, 850073928$chain:Uncharacterized protein C2orf14-like 1, 850073929$chain:Uncharacterized protein C2orf14-like 2]
chromosome 7 open reading frame 49,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001212$polymorphism]
chromosome 7 open reading frame 49,UP_SEQ_FEATURE[850032329$chain:Modulator of retrovirus infection homolog, 850117295$sequence variant, 850118574$splice variant]
chromosome 8 open reading frame 83,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
chromosome 8 open reading frame 83,UP_SEQ_FEATURE[850097920$chain:UPF0599 protein C8orf83, 850118623$transmembrane region]
chromosome 9 open reading frame 24,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
chromosome 9 open reading frame 24,UP_SEQ_FEATURE[850074539$chain:Uncharacterized protein C9orf24, 850117295$sequence variant, 850118574$splice variant]
citron (rho-interacting, serine/threonine kinase 21),COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
citron (rho-interacting, serine/threonine kinase 21),INTERPRO[450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001035$IPR001180:Citron-like, 450001635$IPR001849:Pleckstrin homology, 450001967$IPR002219:Protein kinase C, phorbol ester/diacylglycerol binding, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450004935$IPR005479:Carbamoyl phosphate synthetase, large subunit, ATP-binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450010818$IPR011993:Pleckstrin homology-type, 450015732$IPR017405:Citron Rho-interacting kinase, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
citron (rho-interacting, serine/threonine kinase 21),PIR_SUPERFAMILY[630029748$PIRSF038145:citron Rho-interacting kinase, 630029749$PIRSF038145:Citron_Rho-interacting_kinase]
citron (rho-interacting, serine/threonine kinase 21),SMART[760000028$SM00036:CNH, 760000096$SM00109:C1, 760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000205$SM00233:PH]
citron (rho-interacting, serine/threonine kinase 21),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000825$kinase, 790000937$metal-binding, 790000973$mitosis, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001399$sh3-binding, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
citron (rho-interacting, serine/threonine kinase 21),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850011548$chain:Citron Rho-interacting kinase, 850103028$domain:AGC-kinase C-terminal, 850103376$domain:CNH, 850104979$domain:PH, 850105086$domain:Protein kinase, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850112777$region of interest:Interaction with Rho/Rac, 850117294$sequence conflict, 850117295$sequence variant, 850117711$short sequence motif:SH3-binding, 850118574$splice variant, 850118892$zinc finger region:Phorbol-ester/DAG-type]
clathrin, light chain (Lcb),INTERPRO[450000867$IPR000996:Clathrin light chain]
clathrin, light chain (Lcb),KEGG_PATHWAY[470038840$hsa04142:Lysosome, 470038841$hsa04144:Endocytosis, 470038894$hsa05016:Huntington's disease]
clathrin, light chain (Lcb),PIR_SUPERFAMILY[630002413$PIRSF002289:clathrin light chain]
clathrin, light chain (Lcb),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000334$coated pit, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000447$disulfide bond, 790000919$membrane, 790001162$phosphoprotein]
clathrin, light chain (Lcb),UP_SEQ_FEATURE[850011634$chain:Clathrin light chain B, 850102883$disulfide bond, 850106258$modified residue, 850113150$region of interest:Involved in binding clathrin heavy chain, 850117294$sequence conflict, 850118574$splice variant]
coagulation factor II (thrombin) receptor,BIOCARTA[30000018$h_amiPathway:Acute Myocardial Infarction, 30000109$h_extrinsicPathway:Extrinsic Prothrombin Activation Pathway, 30000113$h_fibrinolysisPathway:Fibrinolysis Pathway, 30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
coagulation factor II (thrombin) receptor,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000816$IPR000935:Thrombin receptor, 450003437$IPR003912:Protease-activated receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
coagulation factor II (thrombin) receptor,KEGG_PATHWAY[470038829$hsa04020:Calcium signaling pathway, 470038833$hsa04080:Neuroactive ligand-receptor interaction, 470038841$hsa04144:Endocytosis, 470038859$hsa04610:Complement and coagulation cascades, 470038881$hsa04810:Regulation of actin cytoskeleton]
coagulation factor II (thrombin) receptor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000192$blood coagulation, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
coagulation factor II (thrombin) receptor,UP_SEQ_FEATURE[850048651$chain:Proteinase-activated receptor 1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850109698$propeptide:Removed for receptor activation, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118124$site:Cleavage; by thrombin, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
coiled-coil domain containing 38,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
coiled-coil domain containing 38,UP_SEQ_FEATURE[850012007$chain:Coiled-coil domain-containing protein 38, 850117294$sequence conflict, 850117295$sequence variant]
coiled-coil domain containing 41,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 41,UP_SEQ_FEATURE[850012010$chain:Coiled-coil domain-containing protein 41, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
coiled-coil domain containing 82,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
coiled-coil domain containing 82,UP_SEQ_FEATURE[850012059$chain:Coiled-coil domain-containing protein 82, 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,INTERPRO[450001635$IPR001849:Pleckstrin homology, 450002572$IPR002913:Lipid-binding START, 450010818$IPR011993:Pleckstrin homology-type]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,SMART[760000205$SM00233:PH, 760000206$SM00234:START]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000875$lipid transport, 790001162$phosphoprotein, 790001212$polymorphism, 790001558$transport]
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein,UP_SEQ_FEATURE[850012222$chain:Collagen type IV alpha-3-binding protein, 850104979$domain:PH, 850105403$domain:START, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant, 850117459$short sequence motif:FFAT, 850118574$splice variant, 850118575$strand]
collectin sub-family member 11,INTERPRO[450001149$IPR001304:C-type lectin, 450007490$IPR008160:Collagen triple helix repeat, 450014523$IPR016186:C-type lectin-like, 450016659$IPR018378:C-type lectin, conserved site]
collectin sub-family member 11,SMART[760000026$SM00034:CLECT]
collectin sub-family member 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000344$coiled coil, 790000345$collagen, 790000356$complete proteome, 790000447$disulfide bond, 790000848$Lectin, 790000907$mannose-binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
collectin sub-family member 11,UP_SEQ_FEATURE[850012246$chain:Collectin-11, 850102883$disulfide bond, 850103184$domain:C-type lectin, 850103389$domain:Collagen-like, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),INTERPRO[450003099$IPR003532:Short hematopoietin receptor, family 2, conserved site, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),OMIM_DISEASE[520001195$Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia, 520002838$Leukemia, acute myeloid, M2 type, 520004183$Pulmonary alveolar proteinosis]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SMART[760000051$SM00060:FN3]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000616$glycoprotein, 790000634$growth factor receptor, 790000919$membrane, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage),UP_SEQ_FEATURE[850022370$chain:Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117329$short sequence motif:Box 1 motif, 850117767$short sequence motif:WSXWS motif, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
complement component 1, s subcomponent,BIOCARTA[30000066$h_classicPathway:Classical Complement Pathway, 30000067$h_compPathway:Complement Pathway]
complement component 1, s subcomponent,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000373$IPR000436:Sushi/SCR/CCP, 450000750$IPR000859:CUB, 450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450011699$IPR013032:EGF-like region, conserved site, 450014444$IPR016060:Complement control module, 450016397$IPR018097:EGF-like calcium-binding, conserved site, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
complement component 1, s subcomponent,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades, 470038916$hsa05322:Systemic lupus erythematosus]
complement component 1, s subcomponent,OMIM_DISEASE[520000719$C1r/C1s deficiency, combined, 520000720$C1s deficiency, isolated]
complement component 1, s subcomponent,PIR_SUPERFAMILY[630001305$PIRSF001155:complement-activating serine proteases C1r/C1s/MASP]
complement component 1, s subcomponent,SMART[760000013$SM00020:Tryp_SPc, 760000024$SM00032:CCP, 760000034$SM00042:CUB, 760000153$SM00179:EGF_CA]
complement component 1, s subcomponent,SP_PIR_KEYWORDS[790000002$3d-structure, 790000022$acute phase, 790000176$beta-hydroxyasparagine, 790000211$calcium, 790000212$calcium binding, 790000355$complement pathway, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000481$egf-like domain, 790000616$glycoprotein, 790000701$homodimer, 790000743$hydrolase, 790000745$hydroxylation, 790000763$immune response, 790000777$innate immunity, 790000937$metal-binding, 790001191$plasma, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001383$Serine protease, 790001386$serine proteinase, 790001405$signal, 790001471$sushi]
complement component 1, s subcomponent,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850012330$chain:Complement C1s subcomponent, 850012331$chain:Complement C1s subcomponent heavy chain, 850012332$chain:Complement C1s subcomponent light chain, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103444$domain:CUB 2, 850103705$domain:EGF-like; calcium-binding, 850104964$domain:Peptidase S1, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
congenital dyserythropoietic anemia, type I,OMIM_DISEASE[520000060$A Genome-Wide Association Study Identifies Protein Quantitative Trait Loci (pQTLs), 520000305$Anemia, congenital dyserythropoietic, type I]
congenital dyserythropoietic anemia, type I,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000360$congenital dyserythropoietic anemia, 790000446$disease mutation, 790000672$hereditary hemolytic anemia, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
congenital dyserythropoietic anemia, type I,UP_SEQ_FEATURE[850011884$chain:Codanin-1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
connector enhancer of kinase suppressor of Ras 2,INTERPRO[450001316$IPR001478:PDZ/DHR/GLGF, 450001470$IPR001660:Sterile alpha motif SAM, 450001635$IPR001849:Pleckstrin homology, 450009649$IPR010599:Connector enhancer of kinase suppressor of ras 2, 450010818$IPR011993:Pleckstrin homology-type, 450012380$IPR013761:Sterile alpha motif-type, 450016193$IPR017874:CRIC domain, 450017792$IPR019555:CRIC domain, Chordata]
connector enhancer of kinase suppressor of Ras 2,SMART[760000200$SM00228:PDZ, 760000205$SM00233:PH, 760000399$SM00454:SAM]
connector enhancer of kinase suppressor of Ras 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism]
connector enhancer of kinase suppressor of Ras 2,UP_SEQ_FEATURE[850012467$chain:Connector enhancer of kinase suppressor of ras 2, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850103412$domain:CRIC, 850103552$domain:DUF1170, 850104918$domain:PDZ, 850104979$domain:PH, 850105249$domain:SAM, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
coronin, actin binding protein, 2B,INTERPRO[450001490$IPR001680:WD40 repeat, 450013497$IPR015048:Region of unknown function DUF1899, 450013498$IPR015049:Region of unknown function DUF1900, 450013946$IPR015505:Coronin, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site, 450018016$IPR019781:WD40 repeat, subgroup, 450018017$IPR019782:WD40 repeat 2]
coronin, actin binding protein, 2B,SMART[760000289$SM00320:WD40]
coronin, actin binding protein, 2B,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790001212$polymorphism, 790001304$repeat, 790001638$wd repeat]
coronin, actin binding protein, 2B,UP_SEQ_FEATURE[850012629$chain:Coronin-2B, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cubilin (intrinsic factor-cobalamin receptor),INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450000750$IPR000859:CUB, 450001663$IPR001881:EGF-like calcium-binding, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
cubilin (intrinsic factor-cobalamin receptor),OMIM_DISEASE[520003120$Megaloblastic anemia-1, Finnish type]
cubilin (intrinsic factor-cobalamin receptor),PIR_SUPERFAMILY[630027753$PIRSF036316:intrinsic factor-B12 receptor cubilin]
cubilin (intrinsic factor-cobalamin receptor),SMART[760000034$SM00042:CUB, 760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
cubilin (intrinsic factor-cobalamin receptor),SP_PIR_KEYWORDS[790000211$calcium, 790000305$cholesterol metabolism, 790000329$cleavage on pair of basic residues, 790000336$Cobalamin, 790000338$cobalt, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000501$endosome, 790000616$glycoprotein, 790000873$lipid metabolism, 790000897$lysosome, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001442$steroid metabolism, 790001558$transport, 790001625$vitamin B12 uptake]
cubilin (intrinsic factor-cobalamin receptor),UP_SEQ_FEATURE[850012808$chain:Cubilin, 850102883$disulfide bond, 850103433$domain:CUB 1, 850103434$domain:CUB 10, 850103435$domain:CUB 11, 850103436$domain:CUB 12, 850103437$domain:CUB 13, 850103438$domain:CUB 14, 850103439$domain:CUB 15, 850103440$domain:CUB 16, 850103441$domain:CUB 17, 850103442$domain:CUB 18, 850103443$domain:CUB 19, 850103444$domain:CUB 2, 850103445$domain:CUB 20, 850103446$domain:CUB 21, 850103447$domain:CUB 22, 850103448$domain:CUB 23, 850103449$domain:CUB 24, 850103450$domain:CUB 25, 850103451$domain:CUB 26, 850103452$domain:CUB 27, 850103453$domain:CUB 3, 850103454$domain:CUB 4, 850103455$domain:CUB 5, 850103456$domain:CUB 6, 850103457$domain:CUB 7, 850103458$domain:CUB 8, 850103459$domain:CUB 9, 850103597$domain:EGF-like 1, 850103644$domain:EGF-like 2; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103687$domain:EGF-like 4; calcium-binding, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103699$domain:EGF-like 7; calcium-binding, 850105770$glycosylation site:N-linked (GlcNAc...), 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118052$site:Cleavage; by furin]
cyclin D-type binding-protein 1,BIOCARTA[30000019$h_anthraxPathway:Anthrax Toxin Mechanism of Action]
cyclin D-type binding-protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000258$cell cycle, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein]
cyclin D-type binding-protein 1,UP_SEQ_FEATURE[850013054$chain:Cyclin-D1-binding protein 1, 850112793$region of interest:Interaction with RPLP0, 850112909$region of interest:Interaction with TCF3, 850114328$region of interest:Required for interaction with CCND1, 850117294$sequence conflict, 850118574$splice variant]
cyclin-dependent kinase 5,BBID[10000052$26.cyclin-CDK_complexes]
cyclin-dependent kinase 5,BIOCARTA[30000039$h_biopeptidesPathway:Bioactive Peptide Induced Signaling Pathway, 30000056$h_cdk5Pathway:Phosphorylation of MEK1 by cdk5/p35 down regulates the MAP kinase pathway, 30000065$h_ck1Pathway:Regulation of ck1/cdk5 by type 1 glutamate receptors, 30000116$h_fosbPathway:FOSB gene expression and drug abuse, 30000173$h_Lis1Pathway:Lissencephaly gene (LIS1) in neuronal migration and development, 30000214$h_p35alzheimersPathway:Deregulation of CDK5 in Alzheimers Disease, 30000246$h_rac1Pathway:Rac 1 cell motility signaling pathway, 30000258$h_reelinPathway:Reelin Signaling Pathway]
cyclin-dependent kinase 5,INTERPRO[450000618$IPR000719:Protein kinase, core, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
cyclin-dependent kinase 5,KEGG_PATHWAY[470038851$hsa04360:Axon guidance, 470038891$hsa05010:Alzheimer's disease]
cyclin-dependent kinase 5,PIR_SUPERFAMILY[630000671$PIRSF000564:kinase-related transforming protein]
cyclin-dependent kinase 5,SMART[760000193$SM00220:S_TKc]
cyclin-dependent kinase 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000134$ATP, 790000138$atp-binding, 790000258$cell cycle, 790000260$cell division, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase]
cyclin-dependent kinase 5,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850010445$chain:Cell division protein kinase 5, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),BBID[10000001$1.RBphosphoE2F, 10000052$26.cyclin-CDK_complexes, 10000115$94.E2F_transcriptional_activity_cell_cycle]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),BIOCARTA[30000024$h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis, 30000059$h_cellcyclePathway:Cyclins and Cell Cycle Regulation, 30000074$h_ctcfPathway:CTCF: First Multivalent Nuclear Factor, 30000119$h_g1Pathway:Cell Cycle: G1/S Check Point ]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),INTERPRO[450001870$IPR002110:Ankyrin, 450009899$IPR010868:Cyclin-dependent kinase inhibitor 2a p19Arf, N-terminal]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),KEGG_PATHWAY[470038834$hsa04110:Cell cycle, 470038836$hsa04115:p53 signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038902$hsa05212:Pancreatic cancer, 470038904$hsa05214:Glioma, 470038908$hsa05218:Melanoma, 470038909$hsa05219:Bladder cancer, 470038910$hsa05220:Chronic myeloid leukemia, 470038913$hsa05223:Non-small cell lung cancer]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),OMIM_DISEASE[520000046$A common variant on chromosome 9p21 affects the risk of myocardial infarction, 520000069$A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants, 520001994$Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520002893$Li Fraumeni syndrome, 520003125$Melanoma and neural system tumor syndrome, 520003128$Melanoma, cutaneous malignant, 2, 520003247$Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes, 520003790$Orolaryngeal cancer, multiple, 520003890$Pancreatic cancer/melanoma syndrome, 520004728$Susceptibility loci for intracranial aneurysm in European and Japanese populations]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),PIR_SUPERFAMILY[630027780$PIRSF036346:cyclin-dependent kinase inhibitor p19]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),SMART[760000220$SM00248:ANK]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000086$ank repeat, 790000109$Apoptosis, 790000258$cell cycle, 790000259$cell cycle control, 790000356$complete proteome, 790000389$cyclin, 790000407$cytoplasm, 790000446$disease mutation, 790000466$dna-binding, 790000825$kinase, 790000858$Li-Fraumeni syndrome, 790001065$nucleus, 790001212$polymorphism, 790001260$protein kinase inhibitor, 790001304$repeat, 790001345$rrna processing, 790001539$Transcription, 790001543$transcription regulation, 790001580$tumor suppressor]
cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4),UP_SEQ_FEATURE[850013103$chain:Cyclin-dependent kinase inhibitor 2A, isoform 4, 850013105$chain:Cyclin-dependent kinase inhibitor 2A, isoforms 1/2/3, 850105852$helix, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
cytochrome P450, family 4, subfamily A, polypeptide 11,BIOCARTA[30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity]
cytochrome P450, family 4, subfamily A, polypeptide 11,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 4, subfamily A, polypeptide 11,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 4, subfamily A, polypeptide 11,KEGG_PATHWAY[470038734$hsa00071:Fatty acid metabolism, 470038780$hsa00590:Arachidonic acid metabolism, 470038801$hsa00830:Retinol metabolism, 470038821$hsa03320:PPAR signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction]
cytochrome P450, family 4, subfamily A, polypeptide 11,PIR_SUPERFAMILY[630000063$PIRSF000050:cytochrome P450 CYP4B1]
cytochrome P450, family 4, subfamily A, polypeptide 11,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000314$chromoprotein, 790000356$complete proteome, 790000445$direct protein sequencing, 790000488$electron transfer, 790000499$endoplasmic reticulum, 790000544$fatty acid oxidation, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000943$metalloprotein, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001556$transmembrane protein]
cytochrome P450, family 4, subfamily A, polypeptide 11,UP_SEQ_FEATURE[850000392$binding site:Heme (covalent; via 1 link), 850013783$chain:Cytochrome P450 4A11, 850102576$compositionally biased region:Poly-Leu, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
cytochrome P450, family 4, subfamily Z, polypeptide 1,COG_ONTOLOGY[90000104$Secondary metabolites biosynthesis, transport, and catabolism]
cytochrome P450, family 4, subfamily Z, polypeptide 1,INTERPRO[450000989$IPR001128:Cytochrome P450, 450002134$IPR002401:Cytochrome P450, E-class, group I, 450016280$IPR017972:Cytochrome P450, conserved site, 450016281$IPR017973:Cytochrome P450, C-terminal region]
cytochrome P450, family 4, subfamily Z, polypeptide 1,PIR_SUPERFAMILY[630000063$PIRSF000050:cytochrome P450 CYP4B1]
cytochrome P450, family 4, subfamily Z, polypeptide 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000499$endoplasmic reticulum, 790000652$heme, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790000959$microsome, 790000984$Monooxygenase, 790001092$oxidoreductase, 790001212$polymorphism, 790001409$Signal-anchor, 790001555$transmembrane]
cytochrome P450, family 4, subfamily Z, polypeptide 1,UP_SEQ_FEATURE[850013817$chain:Cytochrome P450 4Z1, 850106026$metal ion-binding site:Iron (heme axial ligand), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
cytochrome b, ascorbate dependent 3,INTERPRO[450004351$IPR004877:Cytochrome b561, eukaryote, 450006013$IPR006593:Cytochrome b561/ferric reductase transmembrane]
cytochrome b, ascorbate dependent 3,PIR_SUPERFAMILY[630013304$PIRSF016525:cytochrome b561]
cytochrome b, ascorbate dependent 3,SMART[760000578$SM00665:B561]
cytochrome b, ascorbate dependent 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000489$electron transport, 790000501$endosome, 790000616$glycoprotein, 790000652$heme, 790000802$iron, 790000897$lysosome, 790000919$membrane, 790000937$metal-binding, 790001092$oxidoreductase, 790001555$transmembrane, 790001558$transport]
cytochrome b, ascorbate dependent 3,UP_SEQ_FEATURE[850013429$chain:Cytochrome b ascorbate-dependent protein 3, 850103473$domain:Cytochrome b561, 850105770$glycosylation site:N-linked (GlcNAc...), 850106026$metal ion-binding site:Iron (heme axial ligand), 850117294$sequence conflict, 850118623$transmembrane region]
cytoskeleton associated protein 5,INTERPRO[450000307$IPR000357:HEAT, 450010814$IPR011989:Armadillo-like helical]
cytoskeleton associated protein 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000260$cell division, 790000356$complete proteome, 790000973$mitosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
cytoskeleton associated protein 5,UP_SEQ_FEATURE[850014069$chain:Cytoskeleton-associated protein 5, 850106258$modified residue, 850116140$repeat:HEAT 1, 850116141$repeat:HEAT 10, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850116168$repeat:HEAT 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dachsous 1 (Drosophila),INTERPRO[450001884$IPR002126:Cadherin]
dachsous 1 (Drosophila),SMART[760000099$SM00112:CA]
dachsous 1 (Drosophila),SP_PIR_KEYWORDS[790000211$calcium, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
dachsous 1 (Drosophila),UP_SEQ_FEATURE[850048752$chain:Protocadherin-16, 850103211$domain:Cadherin 1, 850103212$domain:Cadherin 10, 850103213$domain:Cadherin 11, 850103214$domain:Cadherin 12, 850103215$domain:Cadherin 13, 850103216$domain:Cadherin 14, 850103217$domain:Cadherin 15, 850103218$domain:Cadherin 16, 850103219$domain:Cadherin 17, 850103220$domain:Cadherin 18, 850103221$domain:Cadherin 19, 850103222$domain:Cadherin 2, 850103223$domain:Cadherin 20, 850103224$domain:Cadherin 21, 850103225$domain:Cadherin 22, 850103226$domain:Cadherin 23, 850103227$domain:Cadherin 24, 850103228$domain:Cadherin 25, 850103229$domain:Cadherin 26, 850103230$domain:Cadherin 27, 850103233$domain:Cadherin 3, 850103239$domain:Cadherin 4, 850103240$domain:Cadherin 5, 850103241$domain:Cadherin 6, 850103242$domain:Cadherin 7, 850103243$domain:Cadherin 8, 850103244$domain:Cadherin 9, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
death effector domain containing 2,INTERPRO[450001658$IPR001875:Death effector]
death effector domain containing 2,SMART[760000023$SM00031:DED]
death effector domain containing 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation]
death effector domain containing 2,UP_SEQ_FEATURE[850015883$chain:DNA-binding death effector domain- containing protein 2, 850103511$domain:DED, 850117294$sequence conflict, 850117325$short sequence motif:Bipartite nuclear localization signal, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
decorin,COG_ONTOLOGY[90000070$Function unknown]
decorin,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450014674$IPR016352:Small leucine-rich proteoglycan, class I, decorin/asporin/byglycan]
decorin,KEGG_PATHWAY[470038850$hsa04350:TGF-beta signaling pathway]
decorin,OMIM_DISEASE[520001209$Corneal dystrophy, congenital stromal]
decorin,PIR_SUPERFAMILY[630002608$PIRSF002490:class I small leucine-rich proteoglycan, decorin/asporin/byglycan types, 630002609$PIRSF002490:SLRP_I]
decorin,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
decorin,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000308$chondroitin sulfate proteoglycan, 790000346$collagen binding, 790000356$complete proteome, 790000424$dermatan sulfate, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001212$polymorphism, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat]
decorin,UP_SEQ_FEATURE[850014440$chain:Decorin, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
diablo homolog (Drosophila),BBID[10000023$126.Apoptosis-Bcl-2, 10000024$127.Mito-stress, 10000103$81.Structure_of_Caps_and_SMACs]
diablo homolog (Drosophila),BIOCARTA[30000188$h_mitochondriaPathway:Role of Mitochondria in Apoptotic Signaling]
diablo homolog (Drosophila),INTERPRO[450013589$IPR015142:Second mitochondria-derived activator of caspase/Direct IAP-binding protein with low PI]
diablo homolog (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000969$mitochondrion, 790001550$transit peptide]
diablo homolog (Drosophila),UP_SEQ_FEATURE[850014989$chain:Diablo homolog, mitochondrial, 850105852$helix, 850117294$sequence conflict, 850117494$short sequence motif:IAP-binding, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion]
diencephalon/mesencephalon homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450003200$IPR003654:Paired-like homeodomain protein, OAR, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
diencephalon/mesencephalon homeobox 1,SMART[760000341$SM00389:HOX]
diencephalon/mesencephalon homeobox 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
diencephalon/mesencephalon homeobox 1,UP_SEQ_FEATURE[850015048$chain:Diencephalon/mesencephalon homeobox protein 1, 850102927$DNA-binding region:Homeobox, 850113100$region of interest:Interacts with OXT2 and is required for repressor activity, 850117294$sequence conflict, 850117295$sequence variant, 850117629$short sequence motif:OAR, 850118574$splice variant]
dihydroorotate dehydrogenase,COG_ONTOLOGY[90000090$Nucleotide transport and metabolism]
dihydroorotate dehydrogenase,INTERPRO[450001140$IPR001295:Dihydroorotate dehydrogenase, conserved site, 450005173$IPR005719:Dihydroorotate dehydrogenase, class 2, 450010918$IPR012135:Dihydroorotate dehydrogenase, classes 1 and 2, 450012397$IPR013785:Aldolase-type TIM barrel]
dihydroorotate dehydrogenase,KEGG_PATHWAY[470038744$hsa00240:Pyrimidine metabolism]
dihydroorotate dehydrogenase,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
dihydroorotate dehydrogenase,PIR_SUPERFAMILY[630000197$PIRSF000164:DHO_oxidase, 630000198$PIRSF000164:dihydroorotate oxidase]
dihydroorotate dehydrogenase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000537$FAD, 790000559$Flavoprotein, 790000562$fmn, 790000919$membrane, 790000966$mitochondrial inner membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001092$oxidoreductase, 790001212$polymorphism, 790001285$pyrimidine biosynthesis, 790001287$pyrimidine nucleotide biosynthesis, 790001550$transit peptide, 790001555$transmembrane]
dihydroorotate dehydrogenase,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850015129$chain:Dihydroorotate dehydrogenase, mitochondrial, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118623$transmembrane region, 850118624$turn]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation, 30000015$h_alkPathway:ALK in cardiac myocytes, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000137$h_hesPathway:Segmentation Clock, 30000227$h_pitx2Pathway:Multi-step Regulation of Transcription by Pitx2, 30000240$h_ps1Pathway:Presenilin action in Notch and Wnt signaling, 30000313$h_wntPathway:WNT Signaling Pathway]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,INTERPRO[450000504$IPR000591:Pleckstrin/G-protein, interacting region, 450001015$IPR001158:DIX, 450001316$IPR001478:PDZ/DHR/GLGF, 450002925$IPR003351:Dishevelled protein, 450007617$IPR008339:Dishevelled region, 450007618$IPR008340:Dishevelled-1 protein, 450010816$IPR011991:Winged helix repressor DNA-binding, 450013947$IPR015506:Dishevelled related protein]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway, 470038848$hsa04330:Notch signaling pathway, 470038885$hsa04916:Melanogenesis, 470038899$hsa05200:Pathways in cancer, 470038900$hsa05210:Colorectal cancer, 470038907$hsa05217:Basal cell carcinoma]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,SMART[760000014$SM00021:DAX, 760000041$SM00049:DEP, 760000200$SM00228:PDZ]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790001162$phosphoprotein, 790001592$ubl conjugation, 790001642$wnt signaling pathway]
dishevelled, dsh homolog 1 (Drosophila); dishevelled, dsh homolog 1 (Drosophila)-like 1,UP_SEQ_FEATURE[850059217$chain:Segment polarity protein dishevelled homolog DVL-1, 850059218$chain:Segment polarity protein dishevelled homolog DVL-1-like, 850102566$compositionally biased region:Poly-Arg, 850103515$domain:DEP, 850103527$domain:DIX, 850104918$domain:PDZ, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),INTERPRO[450016755$IPR018481:Glycosyl transferase, family 4, conserved region]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),KEGG_PATHWAY[470038766$hsa00510:N-Glycan biosynthesis]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),OMIM_DISEASE[520001181$Congenital disorder of glycosylation, type Ij]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),PIR_SUPERFAMILY[630006312$PIRSF006375:UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000359$congenital disorder of glycosylation, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001547$transferase, 790001555$transmembrane]
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase),UP_SEQ_FEATURE[850068279$chain:UDP-N-acetylglucosamine--dolichyl- phosphate N- acetylglucosaminephosphotransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117422$short sequence motif:Dolichol recognition, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
downstream neighbor of SON,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790001065$nucleus, 790001162$phosphoprotein]
downstream neighbor of SON,UP_SEQ_FEATURE[850045640$chain:Protein downstream neighbor of Son, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
dynactin 5 (p25),INTERPRO[450001293$IPR001451:Bacterial transferase hexapeptide repeat]
dynactin 5 (p25),OMIM_DISEASE[520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls]
dynactin 5 (p25),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
dynactin 5 (p25),UP_SEQ_FEATURE[850016482$chain:Dynactin subunit 5]
dynamin 1-like,COG_ONTOLOGY[90000073$General function prediction only]
dynamin 1-like,INTERPRO[450000320$IPR000375:Dynamin central region, 450001246$IPR001401:Dynamin, GTPase region, 450002754$IPR003130:Dynamin GTPase effector, 450017997$IPR019762:Dynamin, GTPase region, conserved site]
dynamin 1-like,KEGG_PATHWAY[470038841$hsa04144:Endocytosis, 470038872$hsa04666:Fc gamma R-mediated phagocytosis]
dynamin 1-like,OMIM_DISEASE[520001679$Encephalopahty, lethal, due to defective mitochondrial peroxisomal fission]
dynamin 1-like,PIR_SUPERFAMILY[630005064$PIRSF005108:dynamin-related, VPS1]
dynamin 1-like,SMART[760000045$SM00053:DYNc, 760000272$SM00302:GED]
dynamin 1-like,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000637$GTP binding, 790000639$gtp-binding, 790000743$hydrolase, 790000919$membrane, 790001063$nucleotide-binding, 790001097$P-loop, 790001162$phosphoprotein, 790001212$polymorphism, 790001278$purine nucleotide binding]
dynamin 1-like,UP_SEQ_FEATURE[850016487$chain:Dynamin-1-like protein, 850104046$domain:GED, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850111134$region of interest:C-terminal dimerization domain, 850112379$region of interest:Interaction with GSK3B, 850113522$region of interest:N-terminal dimerization domain, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dystonin,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning, 90000057$DNA replication, recombination, and repair]
dystonin,INTERPRO[450000887$IPR001014:Ribosomal protein L23/L25, conserved site, 450000964$IPR001101:Plectin repeat, 450001411$IPR001589:Actinin-type, actin-binding, conserved site, 450001520$IPR001715:Calponin-like actin-binding, 450001788$IPR002017:Spectrin repeat, 450001814$IPR002048:Calcium-binding EF-hand, 450002732$IPR003108:Growth-arrest-specific protein 2, 450010817$IPR011992:EF-Hand type, 450016451$IPR018159:Spectrin/alpha-actinin, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
dystonin,PIR_SUPERFAMILY[630002765$PIRSF002662:plectin]
dystonin,SMART[760000025$SM00033:CH, 760000046$SM00054:EFh, 760000132$SM00150:SPEC, 760000215$SM00243:GAS2, 760000222$SM00250:PLEC]
dystonin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000171$basement membrane, 790000211$calcium, 790000256$cell adhesion, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000530$extracellular matrix, 790000616$glycoprotein, 790000811$isopeptide bond, 790000924$membrane protein, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001592$ubl conjugation]
dystonin,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850008525$chain:Bullous pemphigoid antigen 1, isoform 7, 850008527$chain:Bullous pemphigoid antigen 1, isoforms 1/2/3/4/5/8, 850008529$chain:Bullous pemphigoid antigen 1, isoforms 6/9/10, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850103007$domain:Actin-binding, 850103318$domain:CH 1, 850103319$domain:CH 2, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850105350$domain:SH3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850111230$region of interest:Central fibrous rod domain, 850111755$region of interest:Globular 1, 850111756$region of interest:Globular 2, 850116729$repeat:Plectin 1, 850116730$repeat:Plectin 10, 850116731$repeat:Plectin 11, 850116740$repeat:Plectin 2, 850116751$repeat:Plectin 3, 850116762$repeat:Plectin 4, 850116773$repeat:Plectin 5, 850116784$repeat:Plectin 6, 850116795$repeat:Plectin 7, 850116803$repeat:Plectin 8, 850116804$repeat:Plectin 9, 850117015$repeat:Spectrin 1, 850117016$repeat:Spectrin 10, 850117017$repeat:Spectrin 11, 850117018$repeat:Spectrin 12, 850117019$repeat:Spectrin 13, 850117020$repeat:Spectrin 14, 850117021$repeat:Spectrin 15, 850117022$repeat:Spectrin 16, 850117023$repeat:Spectrin 17, 850117024$repeat:Spectrin 18, 850117025$repeat:Spectrin 19, 850117026$repeat:Spectrin 2, 850117027$repeat:Spectrin 20, 850117028$repeat:Spectrin 21, 850117029$repeat:Spectrin 22, 850117030$repeat:Spectrin 23, 850117031$repeat:Spectrin 24, 850117032$repeat:Spectrin 25, 850117033$repeat:Spectrin 26, 850117034$repeat:Spectrin 27, 850117035$repeat:Spectrin 28, 850117036$repeat:Spectrin 29, 850117037$repeat:Spectrin 3, 850117046$repeat:Spectrin 4, 850117047$repeat:Spectrin 5, 850117048$repeat:Spectrin 6, 850117049$repeat:Spectrin 7, 850117050$repeat:Spectrin 8, 850117051$repeat:Spectrin 9, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
dystrobrevin, alpha,INTERPRO[450000371$IPR000433:Zinc finger, ZZ-type, 450010817$IPR011992:EF-Hand type, 450013600$IPR015153:EF-hand, region 1, 450013601$IPR015154:EF-hand, region 2, 450015760$IPR017432:Distrobrevin]
dystrobrevin, alpha,OMIM_DISEASE[520002801$Left ventricular noncompaction with congenital heart defects, 520002802$Left ventricular noncompaction, familial isolated, 1]
dystrobrevin, alpha,PIR_SUPERFAMILY[630029818$PIRSF038204:Distrobrevin]
dystrobrevin, alpha,SMART[760000262$SM00291:ZnF_ZZ]
dystrobrevin, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000263$cell junction, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000937$metal-binding, 790001162$phosphoprotein, 790001475$synapse, 790001648$zinc, 790001651$zinc-finger]
dystrobrevin, alpha,UP_SEQ_FEATURE[850016560$chain:Dystrobrevin alpha, 850105852$helix, 850106258$modified residue, 850114839$region of interest:Syntrophin-binding region, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118951$zinc finger region:ZZ-type]
dystroglycan 1 (dystrophin-associated glycoprotein 1),BBID[10000002$10.Dysdap, 10000084$63.LAT_couples_T-cell_receptor, 10000104$82.TCR_and_Cap_or_SMAC]
dystroglycan 1 (dystrophin-associated glycoprotein 1),BIOCARTA[30000008$h_agrPathway:Agrin in Postsynaptic Differentiation]
dystroglycan 1 (dystrophin-associated glycoprotein 1),INTERPRO[450006062$IPR006644:Dystroglycan-type cadherin-like, 450007739$IPR008465:Dystroglycan, 450012396$IPR013783:Immunoglobulin-like fold]
dystroglycan 1 (dystrophin-associated glycoprotein 1),KEGG_PATHWAY[470038854$hsa04512:ECM-receptor interaction, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM), 470038921$hsa05412:Arrhythmogenic right ventricular cardiomyopathy (ARVC), 470038922$hsa05414:Dilated cardiomyopathy, 470038923$hsa05416:Viral myocarditis]
dystroglycan 1 (dystrophin-associated glycoprotein 1),SMART[760000642$SM00736:CADG]
dystroglycan 1 (dystrophin-associated glycoprotein 1),SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
dystroglycan 1 (dystrophin-associated glycoprotein 1),UP_SEQ_FEATURE[850004758$chain:Alpha-dystroglycan, 850007674$chain:Beta-dystroglycan, 850102883$disulfide bond, 850104974$domain:Peptidase S72, 850105770$glycosylation site:N-linked (GlcNAc...), 850105846$glycosylation site:O-linked (Xyl...) (glycosaminoglycan), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
electron-transfer-flavoprotein, alpha polypeptide,COG_ONTOLOGY[90000064$Energy production and conversion]
electron-transfer-flavoprotein, alpha polypeptide,INTERPRO[450001152$IPR001308:Electron transfer flavoprotein, alpha subunit, 450013180$IPR014729:Rossmann-like alpha/beta/alpha sandwich fold, 450013181$IPR014730:Electron transfer flavoprotein, alpha/beta-subunit, N-terminal, 450013182$IPR014731:Electron transfer flavoprotein, alpha subunit, C-terminal, 450016493$IPR018206:Electron transfer flavoprotein, alpha subunit, C-terminal, conserved site]
electron-transfer-flavoprotein, alpha polypeptide,OMIM_DISEASE[520002133$Glutaricaciduria, type IIA]
electron-transfer-flavoprotein, alpha polypeptide,PIR_SUPERFAMILY[630000101$PIRSF000089:Electra_flavoP_a, 630000102$PIRSF000089:electron transfer flavoprotein, alpha subunit]
electron-transfer-flavoprotein, alpha polypeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000489$electron transport, 790000537$FAD, 790000559$Flavoprotein, 790000601$Glutaricaciduria, 790000969$mitochondrion, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide, 790001558$transport]
electron-transfer-flavoprotein, alpha polypeptide,UP_SEQ_FEATURE[850017044$chain:Electron transfer flavoprotein subunit alpha, mitochondrial, 850105852$helix, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
epithelial splicing regulatory protein 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
epithelial splicing regulatory protein 1,SMART[760000328$SM00360:RRM]
epithelial splicing regulatory protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
epithelial splicing regulatory protein 1,UP_SEQ_FEATURE[850017707$chain:Epithelial splicing regulatory protein 1, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
etoposide induced 2.4 mRNA,INTERPRO[450008976$IPR009890:Etoposide-induced 2.4]
etoposide induced 2.4 mRNA,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
etoposide induced 2.4 mRNA,PIR_SUPERFAMILY[630029664$PIRSF038080:etoposide-induced protein 2.4]
etoposide induced 2.4 mRNA,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
etoposide induced 2.4 mRNA,UP_SEQ_FEATURE[850018033$chain:Etoposide-induced protein 2.4 homolog, 850102566$compositionally biased region:Poly-Arg, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
eukaryotic translation initiation factor 1A domain containing,INTERPRO[450001105$IPR001253:Translation initiation factor 1A (eIF-1A), 450005623$IPR006196:S1, IF1 type, 450011038$IPR012340:Nucleic acid-binding, OB-fold]
eukaryotic translation initiation factor 1A domain containing,SMART[760000567$SM00652:eIF1a]
eukaryotic translation initiation factor 1A domain containing,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001339$rna-binding]
eukaryotic translation initiation factor 1A domain containing,UP_SEQ_FEATURE[850043652$chain:Probable RNA-binding protein EIF1AD, 850102572$compositionally biased region:Poly-Glu, 850105242$domain:S1-like, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand]
eukaryotic translation initiation factor 2-alpha kinase 2,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000131$h_gsk3Pathway:Inactivation of Gsk3 by AKT causes accumulation of b-catenin in Alveolar Macrophages, 30000250$h_ranklPathway:Bone Remodelling, 30000262$h_rnaPathway:Double Stranded RNA Induced Gene Expression, 30000300$h_tollPathway:Toll-Like Receptor Pathway]
eukaryotic translation initiation factor 2-alpha kinase 2,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001016$IPR001159:Double-stranded RNA binding, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450013172$IPR014720:Double-stranded RNA-binding-like, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
eukaryotic translation initiation factor 2-alpha kinase 2,SMART[760000326$SM00358:DSRM]
eukaryotic translation initiation factor 2-alpha kinase 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000104$Antiviral defense, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001388$serine/threonine-protein kinase, 790001547$transferase]
eukaryotic translation initiation factor 2-alpha kinase 2,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850026469$chain:Interferon-induced, double-stranded RNA- activated protein kinase, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850109967$region of interest:2 X 13 AA approximate repeats, 850115074$repeat:1, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
eukaryotic translation initiation factor 4 gamma, 2,INTERPRO[450002885$IPR003307:eIF4-gamma/eIF5/eIF2-epsilon, 450003415$IPR003890:MIF4G-like, type 3, 450003416$IPR003891:Initiation factor eIF-4 gamma, MA3, 450014420$IPR016021:MIF4-like, type 1/2/3]
eukaryotic translation initiation factor 4 gamma, 2,KEGG_PATHWAY[470038923$hsa05416:Viral myocarditis]
eukaryotic translation initiation factor 4 gamma, 2,SMART[760000457$SM00515:eIF5C, 760000483$SM00543:MIF4G, 760000484$SM00544:MA3]
eukaryotic translation initiation factor 4 gamma, 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000776$Initiation factor, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001307$repressor, 790001551$translation regulation]
eukaryotic translation initiation factor 4 gamma, 2,UP_SEQ_FEATURE[850018126$chain:Eukaryotic translation initiation factor 4 gamma 2, 850104771$domain:MI, 850104778$domain:MIF4G, 850105686$domain:W2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
eukaryotic translation initiation factor 5,BIOCARTA[30000094$h_eif2Pathway:Regulation of eIF2, 30000096$h_eifPathway:Eukaryotic protein translation]
eukaryotic translation initiation factor 5,INTERPRO[450002426$IPR002735:Translation initiation factor IF2/IF5, 450002885$IPR003307:eIF4-gamma/eIF5/eIF2-epsilon]
eukaryotic translation initiation factor 5,SMART[760000457$SM00515:eIF5C, 760000568$SM00653:eIF2B_5]
eukaryotic translation initiation factor 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000639$gtp-binding, 790000776$Initiation factor, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis]
eukaryotic translation initiation factor 5,UP_SEQ_FEATURE[850018150$chain:Eukaryotic translation initiation factor 5, 850102459$compositionally biased region:Asp-rich (acidic), 850102468$compositionally biased region:Asp/Glu-rich (highly acidic), 850105686$domain:W2, 850105852$helix, 850106258$modified residue, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
exocyst complex component 6,INTERPRO[450006595$IPR007225:Exocyst complex subunit Sec15-like]
exocyst complex component 6,PIR_SUPERFAMILY[630019487$PIRSF025007:exocyst complex, component Sec15, 630019488$PIRSF025007:Sec15]
exocyst complex component 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000522$exocytosis, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
exocyst complex component 6,UP_SEQ_FEATURE[850018194$chain:Exocyst complex component 6, 850117294$sequence conflict, 850117295$sequence variant]
exonuclease 3'-5' domain containing 2,INTERPRO[450002278$IPR002562:3'-5' exonuclease]
exonuclease 3'-5' domain containing 2,SMART[760000419$SM00474:35EXOc]
exonuclease 3'-5' domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000523$exonuclease, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism]
exonuclease 3'-5' domain containing 2,UP_SEQ_FEATURE[850018235$chain:Exonuclease 3'-5' domain-containing protein 2, 850102974$domain:3'-5' exonuclease, 850117294$sequence conflict, 850117295$sequence variant]
exophilin 5,INTERPRO[450009940$IPR010911:Rab-binding domain]
exophilin 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
exophilin 5,UP_SEQ_FEATURE[850018239$chain:Exophilin-5, 850105137$domain:RabBD, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
eyes absent homolog 3 (Drosophila),INTERPRO[450005281$IPR005834:Haloacid dehalogenase-like hydrolase, 450005968$IPR006545:EYA]
eyes absent homolog 3 (Drosophila),PIR_SUPERFAMILY[630029716$PIRSF038125:eyes absent protein, 630030896$PIRSF500736:eyes absent protein homolog 3]
eyes absent homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000053$alternative splicing, 790000311$chromatin regulator, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000452$DNA damage, 790000459$dna repair, 790000743$hydrolase, 790000899$magnesium, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001261$protein phosphatase, 790001539$Transcription, 790001543$transcription regulation]
eyes absent homolog 3 (Drosophila),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850000131$active site:Proton donor, 850018454$chain:Eyes absent homolog 3, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
family with sequence similarity 116, member A,INTERPRO[450011538$IPR012860:Protein of unknown function DUF1630]
family with sequence similarity 116, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 116, member A,UP_SEQ_FEATURE[850045838$chain:Protein FAM116A, 850106258$modified residue, 850117294$sequence conflict]
family with sequence similarity 131, member C,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 131, member C,UP_SEQ_FEATURE[850045864$chain:Protein FAM131C, 850102586$compositionally biased region:Pro-rich, 850117294$sequence conflict, 850117295$sequence variant]
family with sequence similarity 133, member B pseudogene; similar to FAM133B protein; family with sequence similarity 133, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
family with sequence similarity 133, member B pseudogene; similar to FAM133B protein; family with sequence similarity 133, member B,UP_SEQ_FEATURE[850045869$chain:Protein FAM133B, 850102554$compositionally biased region:Lys-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850118574$splice variant]
family with sequence similarity 134, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001020$neuropathy, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 134, member B,UP_SEQ_FEATURE[850045871$chain:Protein FAM134B, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 155, member A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 155, member A,UP_SEQ_FEATURE[850066307$chain:Transmembrane protein FAM155A, 850102570$compositionally biased region:Poly-Gln, 850102573$compositionally biased region:Poly-Gly, 850105770$glycosylation site:N-linked (GlcNAc...), 850118623$transmembrane region]
family with sequence similarity 160, member B1,INTERPRO[450017622$IPR019384:Retinoic acid induced 16-like protein]
family with sequence similarity 160, member B1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 160, member B1,UP_SEQ_FEATURE[850097667$chain:UPF0518 protein FAM160B1, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 176, member B,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
family with sequence similarity 176, member B,UP_SEQ_FEATURE[850045905$chain:Protein FAM176B, 850106258$modified residue, 850118623$transmembrane region]
family with sequence similarity 177, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 177, member B,UP_SEQ_FEATURE[850045907$chain:Protein FAM177B, 850102572$compositionally biased region:Poly-Glu, 850117295$sequence variant, 850118574$splice variant]
family with sequence similarity 22, member D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 22, member D,UP_SEQ_FEATURE[850045952$chain:Protein FAM22D, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 24, member B,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
family with sequence similarity 24, member B,UP_SEQ_FEATURE[850045959$chain:Protein FAM24B, 850117295$sequence variant, 850117814$signal peptide]
family with sequence similarity 26, member D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
family with sequence similarity 26, member D,UP_SEQ_FEATURE[850045961$chain:Protein FAM26D, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 46, member B,INTERPRO[450011613$IPR012937:Protein of unknown function DUF1693]
family with sequence similarity 46, member B,PIR_SUPERFAMILY[630011340$PIRSF013835:Caenorhabditis elegans hypothetical protein F55A12.9]
family with sequence similarity 46, member B,SP_PIR_KEYWORDS[790000356$complete proteome]
family with sequence similarity 46, member B,UP_SEQ_FEATURE[850045989$chain:Protein FAM46B]
family with sequence similarity 54, member A,INTERPRO[450007315$IPR007972:Protein of unknown function DUF729]
family with sequence similarity 54, member A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
family with sequence similarity 54, member A,UP_SEQ_FEATURE[850046007$chain:Protein FAM54A, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant]
family with sequence similarity 55, member B,OMIM_DISEASE[520000048$A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study]
family with sequence similarity 55, member B,PIR_SUPERFAMILY[630010122$PIRSF011875:pirsf011875]
family with sequence similarity 55, member B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
family with sequence similarity 55, member B,UP_SEQ_FEATURE[850046012$chain:Protein FAM55B, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
family with sequence similarity 71, member F2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001212$polymorphism]
family with sequence similarity 71, member F2,UP_SEQ_FEATURE[850046040$chain:Protein FAM71F2, 850117295$sequence variant, 850118574$splice variant]
fatty acid synthase,INTERPRO[450000688$IPR000794:Beta-ketoacyl synthase, 450000904$IPR001031:Thioesterase, 450001079$IPR001227:Acyl transferase region, 450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450005594$IPR006162:Phosphopantetheine attachment site, 450005595$IPR006163:Phosphopantetheine-binding, 450008211$IPR009081:Acyl carrier protein-like, 450011786$IPR013149:Alcohol dehydrogenase, zinc-binding, 450011854$IPR013217:Methyltransferase type 12, 450012624$IPR014030:Beta-ketoacyl synthase, N-terminal, 450012625$IPR014031:Beta-ketoacyl synthase, C-terminal, 450012635$IPR014043:Acyl transferase, 450014425$IPR016038:Thiolase-like, subgroup, 450014426$IPR016040:NAD(P)-binding domain, 450016488$IPR018201:Beta-ketoacyl synthase, active site]
fatty acid synthase,KEGG_PATHWAY[470038732$hsa00061:Fatty acid biosynthesis, 470038882$hsa04910:Insulin signaling pathway]
fatty acid synthase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000542$Fatty acid biosynthesis, 790000743$hydrolase, 790000874$lipid synthesis, 790000891$lyase, 790000993$multifunctional enzyme, 790001006$nad, 790001008$nadp, 790001092$oxidoreductase, 790001161$Phosphopantetheine, 790001162$phosphoprotein, 790001212$polymorphism, 790001283$pyridoxal phosphate, 790001547$transferase]
fatty acid synthase,UP_SEQ_FEATURE[850000033$active site:For beta-hydroxyacyl dehydratase activity, 850000040$active site:For beta-ketoacyl synthase activity, 850000054$active site:For malonyltransferase activity, 850000083$active site:For thioesterase activity, 850019051$chain:Fatty acid synthase, 850103010$domain:Acyl carrier, 850105852$helix, 850106258$modified residue, 850106308$nucleotide phosphate-binding region:NADP (ER), 850106309$nucleotide phosphate-binding region:NADP (KR), 850110865$region of interest:Acyl and malonyl transferases, 850111013$region of interest:Beta-ketoacyl reductase, 850111016$region of interest:Beta-ketoacyl synthase, 850111587$region of interest:Enoyl reductase, 850114875$region of interest:Thioesterase, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
fibroblast growth factor 14,INTERPRO[450001959$IPR002209:Heparin-binding growth factor/Fibroblast growth factor, 450002089$IPR002348:Interleukin 1/heparin-binding growth factor]
fibroblast growth factor 14,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038899$hsa05200:Pathways in cancer, 470038908$hsa05218:Melanoma]
fibroblast growth factor 14,OMIM_DISEASE[520004635$Spinocerebellar ataxia-27]
fibroblast growth factor 14,SMART[760000388$SM00442:FGF]
fibroblast growth factor 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000632$growth factor, 790001015$neurodegeneration, 790001065$nucleus, 790001212$polymorphism, 790001431$spinocerebellar ataxia]
fibroblast growth factor 14,UP_SEQ_FEATURE[850019388$chain:Fibroblast growth factor 14, 850117295$sequence variant, 850118574$splice variant]
flavin containing monooxygenase 2 (non-functional),INTERPRO[450000835$IPR000960:Flavin-containing monooxygenase FMO, 450002000$IPR002254:Flavin-containing monooxygenase (FMO) 2, 450010924$IPR012143:Dimethylaniline monooxygenase, N-oxide-forming]
flavin containing monooxygenase 2 (non-functional),KEGG_PATHWAY[470038809$hsa00982:Drug metabolism]
flavin containing monooxygenase 2 (non-functional),PIR_SUPERFAMILY[630000386$PIRSF000332:dimethylaniline monooxygenase (N-oxide-forming), 630000387$PIRSF000332:FMO]
flavin containing monooxygenase 2 (non-functional),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000899$magnesium, 790000919$membrane, 790000959$microsome, 790000984$Monooxygenase, 790001008$nadp, 790001092$oxidoreductase, 790001212$polymorphism, 790001555$transmembrane]
flavin containing monooxygenase 2 (non-functional),UP_SEQ_FEATURE[850015179$chain:Dimethylaniline monooxygenase [N-oxide- forming] 2, 850106258$modified residue, 850106285$nucleotide phosphate-binding region:FAD, 850106307$nucleotide phosphate-binding region:NADP, 850117294$sequence conflict, 850117295$sequence variant]
fms-related tyrosine kinase 3 ligand,INTERPRO[450003721$IPR004213:Flt3 ligand, 450011046$IPR012351:Four-helical cytokine, core]
fms-related tyrosine kinase 3 ligand,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038867$hsa04640:Hematopoietic cell lineage, 470038899$hsa05200:Pathways in cancer]
fms-related tyrosine kinase 3 ligand,PIR_SUPERFAMILY[630012510$PIRSF015744:Fms-related tyrosine kinase 3 ligand/SL cytokine]
fms-related tyrosine kinase 3 ligand,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
fms-related tyrosine kinase 3 ligand,UP_SEQ_FEATURE[850060940$chain:SL cytokine, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
forkhead box J2,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box J2,SMART[760000307$SM00339:FH]
forkhead box J2,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
forkhead box J2,UP_SEQ_FEATURE[850019877$chain:Forkhead box protein J2, 850102570$compositionally biased region:Poly-Gln, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850102914$DNA-binding region:Fork-head, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
forkhead box P3,INTERPRO[450001565$IPR001766:Transcription factor, fork head, 450006475$IPR007087:Zinc finger, C2H2-type, 450010816$IPR011991:Winged helix repressor DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016421$IPR018122:Transcription factor, fork head, conserved site]
forkhead box P3,OMIM_DISEASE[520001516$Diabetes mellitus, type I, susceptibility to, 520002620$Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked]
forkhead box P3,SMART[760000307$SM00339:FH, 760000323$SM00355:ZnF_C2H2]
forkhead box P3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000430$diabetes mellitus, 790000446$disease mutation, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
forkhead box P3,UP_SEQ_FEATURE[850019897$chain:Forkhead box protein P3, 850102914$DNA-binding region:Fork-head, 850104712$domain:Leucine-zipper, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118655$zinc finger region:C2H2-type]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),INTERPRO[450001336$IPR001503:Glycosyl transferase, family 10]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),KEGG_PATHWAY[470038784$hsa00601:Glycosphingolipid biosynthesis]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000619$glycosyltransferase, 790000624$golgi apparatus, 790000691$hexosyltransferase, 790000919$membrane, 790001212$polymorphism, 790001409$Signal-anchor, 790001547$transferase, 790001555$transmembrane]
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific),UP_SEQ_FEATURE[850004581$chain:Alpha-(1,3)-fucosyltransferase, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
gamma-glutamyl cyclotransferase,INTERPRO[450008399$IPR009288:AIG2-like, 450016251$IPR017939:Gamma-glutamylcyclotransferase]
gamma-glutamyl cyclotransferase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
gamma-glutamyl cyclotransferase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000025$Acyltransferase, 790000053$alternative splicing, 790000356$complete proteome, 790001547$transferase]
gamma-glutamyl cyclotransferase,UP_SEQ_FEATURE[850020541$chain:Gamma-glutamylcyclotransferase, 850105852$helix, 850106259$mutagenesis site, 850118574$splice variant, 850118575$strand, 850118624$turn]
gastrulation brain homeobox 1,INTERPRO[450001200$IPR001356:Homeobox, 450010997$IPR012287:Homeodomain-related, 450016278$IPR017970:Homeobox, conserved site]
gastrulation brain homeobox 1,SMART[760000341$SM00389:HOX]
gastrulation brain homeobox 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation]
gastrulation brain homeobox 1,UP_SEQ_FEATURE[850024460$chain:Homeobox protein GBX-1, 850102378$compositionally biased region:Ala-rich, 850102517$compositionally biased region:Gly-rich, 850102586$compositionally biased region:Pro-rich, 850102927$DNA-binding region:Homeobox, 850117295$sequence variant]
general transcription factor IIH, polypeptide 1, 62kDa,INTERPRO[450005056$IPR005607:BSD, 450010818$IPR011993:Pleckstrin homology-type, 450012473$IPR013876:TFIIH p62 subunit, N-terminal]
general transcription factor IIH, polypeptide 1, 62kDa,KEGG_PATHWAY[470038816$hsa03022:Basal transcription factors, 470038823$hsa03420:Nucleotide excision repair]
general transcription factor IIH, polypeptide 1, 62kDa,SMART[760000657$SM00751:BSD]
general transcription factor IIH, polypeptide 1, 62kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
general transcription factor IIH, polypeptide 1, 62kDa,UP_SEQ_FEATURE[850021051$chain:General transcription factor IIH subunit 1, 850103175$domain:BSD 1, 850103176$domain:BSD 2, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
germ cell associated 1,INTERPRO[450011158$IPR012478:GSG1-like]
germ cell associated 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
germ cell associated 1,UP_SEQ_FEATURE[850021091$chain:Germ cell-specific gene 1 protein, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
ghrelin/obestatin prepropeptide,BIOCARTA[30000126$h_ghrelinPathway:Ghrelin: Regulation of Food Intake and Energy Homeostasis]
ghrelin/obestatin prepropeptide,INTERPRO[450004900$IPR005441:Preproghrelin peptide, 450006144$IPR006737:Motilin/ghrelin-associated peptide, 450006145$IPR006738:Motilin/ghrelin]
ghrelin/obestatin prepropeptide,OMIM_DISEASE[520003721$Obesity, susceptibility to]
ghrelin/obestatin prepropeptide,PIR_SUPERFAMILY[630001985$PIRSF001846:motilin]
ghrelin/obestatin prepropeptide,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000060$amidation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000708$hormone, 790000881$lipoprotein, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001447$stomach]
ghrelin/obestatin prepropeptide,UP_SEQ_FEATURE[850105852$helix, 850105876$lipid moiety-binding region:O-decanoyl serine; alternate, 850105879$lipid moiety-binding region:O-octanoyl serine; alternate, 850106258$modified residue, 850107719$peptide:Ghrelin-27, 850107720$peptide:Ghrelin-28, 850108513$peptide:Obestatin, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand]
glucocorticoid modulatory element binding protein 1,INTERPRO[450000665$IPR000770:SAND, 450009947$IPR010919:SAND-like]
glucocorticoid modulatory element binding protein 1,SMART[760000230$SM00258:SAND]
glucocorticoid modulatory element binding protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc]
glucocorticoid modulatory element binding protein 1,UP_SEQ_FEATURE[850000333$binding site:DNA, 850021368$chain:Glucocorticoid modulatory element-binding protein 1, 850105253$domain:SAND, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
glutamate receptor, metabotropic 2,INTERPRO[450000138$IPR000162:GPCR, family 3, metabotropic glutamate receptor, 450000290$IPR000337:GPCR, family 3, 450001299$IPR001458:GPCR, family 3, metabotropic glutamate receptor 2, 450001618$IPR001828:Extracellular ligand-binding receptor, 450010362$IPR011500:GPCR, family 3, nine cysteines region, 450016286$IPR017978:GPCR, family 3, C-terminal, 450016287$IPR017979:GPCR, family 3, conserved site]
glutamate receptor, metabotropic 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
glutamate receptor, metabotropic 2,PIR_SUPERFAMILY[630005529$PIRSF005608:metabotropic glutamate receptors and related]
glutamate receptor, metabotropic 2,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001301$receptor, 790001405$signal, 790001546$transducer, 790001555$transmembrane]
glutamate receptor, metabotropic 2,UP_SEQ_FEATURE[850031237$chain:Metabotropic glutamate receptor 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
glutathione S-transferase mu 2 (muscle),COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
glutathione S-transferase mu 2 (muscle),INTERPRO[450002707$IPR003081:Glutathione S-transferase, Mu class, 450003562$IPR004045:Glutathione S-transferase, N-terminal, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450009996$IPR010987:Glutathione S-transferase, C-terminal-like, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
glutathione S-transferase mu 2 (muscle),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism, 470038808$hsa00980:Metabolism of xenobiotics by cytochrome P450, 470038809$hsa00982:Drug metabolism]
glutathione S-transferase mu 2 (muscle),PIR_SUPERFAMILY[630000598$PIRSF000503:glutathione transferase]
glutathione S-transferase mu 2 (muscle),SP_PIR_KEYWORDS[790000002$3d-structure, 790000199$brain, 790000244$cardiac muscle, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000646$heart, 790000701$homodimer, 790001212$polymorphism, 790001415$skeletal muscle, 790001547$transferase]
glutathione S-transferase mu 2 (muscle),UP_SEQ_FEATURE[850021801$chain:Glutathione S-transferase Mu 2, 850104084$domain:GST C-terminal, 850104087$domain:GST N-terminal, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
glutathione synthetase,BIOCARTA[30000117$h_freePathway:Free Radical Induced Apoptosis]
glutathione synthetase,INTERPRO[450004360$IPR004887:Glutathione synthase, substrate-binding, eukaryotic, 450005064$IPR005615:Glutathione synthase, eukaryotic, 450012420$IPR013816:ATP-grasp fold, subdomain 2, 450012634$IPR014042:Glutathione synthase, alpha-helical, eukaryotic, 450012641$IPR014049:Glutathione synthase, N-terminal, eukaryotic]
glutathione synthetase,KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
glutathione synthetase,OMIM_DISEASE[520002136$Glutathione synthetase deficiency, 520002266$Hemolytic anemia due to glutathione synthetase deficiency]
glutathione synthetase,PIR_SUPERFAMILY[630001728$PIRSF001558:glutathione synthase, 630001729$PIRSF001558:GSHase]
glutathione synthetase,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000603$glutathione biosynthesis, 790000672$hereditary hemolytic anemia, 790000859$ligase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001212$polymorphism]
glutathione synthetase,UP_SEQ_FEATURE[850000242$binding site:ATP, 850000249$binding site:ATP; via carbonyl oxygen, 850000555$binding site:Substrate, 850021826$chain:Glutathione synthetase, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850114716$region of interest:Substrate binding, 850117295$sequence variant, 850118575$strand, 850118624$turn]
growth differentiation factor 15,INTERPRO[450001626$IPR001839:Transforming growth factor beta, 450016259$IPR017948:Transforming growth factor beta, conserved site]
growth differentiation factor 15,SMART[760000177$SM00204:TGFB]
growth differentiation factor 15,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000402$cytokine, 790000447$disulfide bond, 790000616$glycoprotein, 790000632$growth factor, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
growth differentiation factor 15,UP_SEQ_FEATURE[850022489$chain:Growth/differentiation factor 15, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
guanylate binding protein 1, interferon-inducible, 67kDa,INTERPRO[450002808$IPR003191:Guanylate-binding protein, C-terminal, 450014315$IPR015894:Guanylate-binding protein, N-terminal]
guanylate binding protein 1, interferon-inducible, 67kDa,PIR_SUPERFAMILY[630005479$PIRSF005552:guanine nucleotide-binding protein 1]
guanylate binding protein 1, interferon-inducible, 67kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000639$gtp-binding, 790000881$lipoprotein, 790000919$membrane, 790001063$nucleotide-binding, 790001212$polymorphism, 790001236$prenylation]
guanylate binding protein 1, interferon-inducible, 67kDa,UP_SEQ_FEATURE[850026453$chain:Interferon-induced guanylate-binding protein 1, 850105852$helix, 850105890$lipid moiety-binding region:S-farnesyl cysteine, 850106296$nucleotide phosphate-binding region:GTP, 850117295$sequence variant, 850118575$strand, 850118624$turn]
hect domain and RLD 2,COG_ONTOLOGY[90000026$Cell division and chromosome partitioning / Cytoskeleton]
hect domain and RLD 2,INTERPRO[450000351$IPR000408:Regulator of chromosome condensation, RCC1, 450000371$IPR000433:Zinc finger, ZZ-type, 450000485$IPR000569:HECT, 450001053$IPR001199:Cytochrome b5, 450004408$IPR004939:Anaphase-promoting complex, subunit 10, 450006043$IPR006624:Beta-propeller repeat TECPR, 450008218$IPR009091:Regulator of chromosome condensation/beta-lactamase-inhibitor protein II, 450009656$IPR010606:Mib-herc2, 450016778$IPR018506:Cytochrome b5, heme-binding site, 450018010$IPR019775:WD40 repeat, conserved site]
hect domain and RLD 2,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis]
hect domain and RLD 2,OMIM_DISEASE[520000057$A Genome-Wide Association Study Identifies Novel Alleles Associated with Hair Color and Skin Pigmentation, 520004495$Skin/hair/eye pigmentation 1, blond/brown hair, 520004496$Skin/hair/eye pigmentation 1, blue/nonblue eyes, 520004821$Three genome-wide association studies and a linkage analysis identify HERC2 as a human iris color gene]
hect domain and RLD 2,SMART[760000104$SM00119:HECTc, 760000262$SM00291:ZnF_ZZ, 760000613$SM00706:TECPR]
hect domain and RLD 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000344$coiled coil, 790000356$complete proteome, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001593$ubl conjugation pathway, 790001638$wd repeat, 790001648$zinc, 790001651$zinc-finger]
hect domain and RLD 2,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850041853$chain:Probable E3 ubiquitin-protein ligase HERC2, 850103472$domain:Cytochrome b5 heme-binding, 850103533$domain:DOC, 850104105$domain:HECT, 850104774$domain:MIB/HERC2, 850105852$helix, 850106258$modified residue, 850116898$repeat:RCC1 1, 850116899$repeat:RCC1 10, 850116900$repeat:RCC1 11, 850116901$repeat:RCC1 12, 850116902$repeat:RCC1 13, 850116903$repeat:RCC1 14, 850116904$repeat:RCC1 15, 850116905$repeat:RCC1 16, 850116906$repeat:RCC1 17, 850116907$repeat:RCC1 18, 850116908$repeat:RCC1 19, 850116909$repeat:RCC1 2, 850116910$repeat:RCC1 3, 850116911$repeat:RCC1 4, 850116912$repeat:RCC1 5, 850116913$repeat:RCC1 6, 850116914$repeat:RCC1 7, 850116915$repeat:RCC1 8, 850116916$repeat:RCC1 9, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118951$zinc finger region:ZZ-type]
helicase (DNA) B,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
helicase (DNA) B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000649$helicase, 790000743$hydrolase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism]
helicase (DNA) B,UP_SEQ_FEATURE[850015566$chain:DNA helicase B, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
heterogeneous nuclear ribonucleoprotein C (C1/C2),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450015671$IPR017347:Heterogeneous nuclear ribonucleoprotein C, Raly]
heterogeneous nuclear ribonucleoprotein C (C1/C2),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
heterogeneous nuclear ribonucleoprotein C (C1/C2),PIR_SUPERFAMILY[630029563$PIRSF037992:heterogeneous nuclear ribonucleoprotein C, Raly type, 630029564$PIRSF037992:hnRNP-C_Raly]
heterogeneous nuclear ribonucleoprotein C (C1/C2),SMART[760000328$SM00360:RRM]
heterogeneous nuclear ribonucleoprotein C (C1/C2),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000811$isopeptide bond, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001433$Spliceosome, 790001592$ubl conjugation]
heterogeneous nuclear ribonucleoprotein C (C1/C2),UP_SEQ_FEATURE[850023604$chain:Heterogeneous nuclear ribonucleoproteins C1/C2, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850105211$domain:RRM, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
hexokinase domain containing 1,COG_ONTOLOGY[90000016$Carbohydrate transport and metabolism]
hexokinase domain containing 1,INTERPRO[450001155$IPR001312:Hexokinase, 450018039$IPR019807:Hexokinase, conserved site]
hexokinase domain containing 1,PIR_SUPERFAMILY[630000626$PIRSF000527:hexokinase I]
hexokinase domain containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000615$glycolysis, 790000825$kinase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001547$transferase]
hexokinase domain containing 1,UP_SEQ_FEATURE[850000242$binding site:ATP, 850051422$chain:Putative hexokinase HKDC1, 850106263$nucleotide phosphate-binding region:ATP, 850111773$region of interest:Glucose-binding, 850117295$sequence variant, 850118574$splice variant]
hippocalcin-like 1,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
hippocalcin-like 1,INTERPRO[450000986$IPR001125:Recoverin, 450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
hippocalcin-like 1,PIR_SUPERFAMILY[630002469$PIRSF002350:calmodulin]
hippocalcin-like 1,SMART[760000046$SM00054:EFh]
hippocalcin-like 1,SP_PIR_KEYWORDS[790000189$blocked amino end, 790000211$calcium, 790000356$complete proteome, 790000480$EF hand, 790000881$lipoprotein, 790001004$myristate, 790001005$myristylation, 790001304$repeat]
hippocalcin-like 1,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850023765$chain:Hippocalcin-like protein 1, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850105869$lipid moiety-binding region:N-myristoyl glycine, 850117294$sequence conflict]
hippocampus abundant transcript 1,INTERPRO[450001735$IPR001958:Tetracycline resistance protein, TetA, 450005276$IPR005829:Sugar transporter, conserved site, 450010529$IPR011701:Major facilitator superfamily MFS-1]
hippocampus abundant transcript 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
hippocampus abundant transcript 1,UP_SEQ_FEATURE[850023767$chain:Hippocampus abundant transcript 1 protein, 850102577$compositionally biased region:Poly-Lys, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
histone cluster 2, H2bf,INTERPRO[450000478$IPR000558:Histone H2B, 450006498$IPR007125:Histone core, 450008207$IPR009072:Histone-fold]
histone cluster 2, H2bf,KEGG_PATHWAY[470038916$hsa05322:Systemic lupus erythematosus]
histone cluster 2, H2bf,PIR_SUPERFAMILY[630002184$PIRSF002050:histone H2B]
histone cluster 2, H2bf,SMART[760000373$SM00427:H2B]
histone cluster 2, H2bf,SP_PIR_KEYWORDS[790000012$acetylation, 790000315$chromosomal protein, 790000356$complete proteome, 790000466$dna-binding, 790000811$isopeptide bond, 790000953$methylation, 790001058$nucleosome core, 790001065$nucleus, 790001162$phosphoprotein, 790001592$ubl conjugation]
histone cluster 2, H2bf,UP_SEQ_FEATURE[850024035$chain:Histone H2B type 2-F, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850106258$modified residue]
hook homolog 3 (Drosophila),INTERPRO[450007894$IPR008636:HOOK]
hook homolog 3 (Drosophila),SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000960$microtubule, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
hook homolog 3 (Drosophila),UP_SEQ_FEATURE[850046431$chain:Protein Hook homolog 3, 850106258$modified residue, 850114238$region of interest:Required for association with Golgi, 850114363$region of interest:Required for interaction with MSR1, 850114780$region of interest:Sufficient for interaction with microtubules, 850117294$sequence conflict, 850117295$sequence variant]
hyaluronoglucosaminidase 1,INTERPRO[450001743$IPR001968:Glycoside hydrolase, family 56, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450012397$IPR013785:Aldolase-type TIM barrel, 450015758$IPR017430:Glycoside hydrolase, family 56, Hyaluronidase, 450016447$IPR018155:Hyaluronidase]
hyaluronoglucosaminidase 1,KEGG_PATHWAY[470038771$hsa00531:Glycosaminoglycan degradation, 470038840$hsa04142:Lysosome]
hyaluronoglucosaminidase 1,OMIM_DISEASE[520003390$Mucopolysaccharidosis type IX]
hyaluronoglucosaminidase 1,PIR_SUPERFAMILY[630029812$PIRSF038193:hyaluronidase, 630030933$PIRSF500774:hyaluronidase-1]
hyaluronoglucosaminidase 1,SMART[760000155$SM00181:EGF]
hyaluronoglucosaminidase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000617$glycosidase, 790000743$hydrolase, 790000897$lysosome, 790000992$Mucopolysaccharidosis, 790001363$Secreted, 790001405$signal]
hyaluronoglucosaminidase 1,UP_SEQ_FEATURE[850000131$active site:Proton donor, 850025133$chain:Hyaluronidase-1, 850102883$disulfide bond, 850103596$domain:EGF-like, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118624$turn]
hydrocephalus inducing homolog 2 (mouse); hydrocephalus inducing homolog (mouse),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
hydrocephalus inducing homolog 2 (mouse); hydrocephalus inducing homolog (mouse),UP_SEQ_FEATURE[850025150$chain:Hydrocephalus-inducing protein homolog, 850102572$compositionally biased region:Poly-Glu, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
hypothetical LOC100270710; MARVEL domain containing 1,INTERPRO[450007548$IPR008253:Marvel]
hypothetical LOC100270710; MARVEL domain containing 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001555$transmembrane]
hypothetical LOC100270710; MARVEL domain containing 1,UP_SEQ_FEATURE[850051894$chain:Putative MARVEL domain-containing protein 1, 850102580$compositionally biased region:Poly-Pro, 850104755$domain:MARVEL, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
hypothetical protein FLJ20674,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
hypothetical protein FLJ20674,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
hypothetical protein FLJ20674,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
hypothetical protein FLJ20674,UP_SEQ_FEATURE[850025528$chain:Ig-like domain-containing protein FLJ20674, 850102507$compositionally biased region:Glu-rich, 850102576$compositionally biased region:Poly-Leu, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
hypothetical protein LOC728621,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
hypothetical protein LOC728621,UP_SEQ_FEATURE[850012002$chain:Coiled-coil domain-containing protein 30, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
hypoxia up-regulated 1,INTERPRO[450000896$IPR001023:Heat shock protein Hsp70, 450011768$IPR013126:Heat shock protein 70, 450016471$IPR018181:Heat shock protein 70, conserved site]
hypoxia up-regulated 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000288$Chaperone, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790001063$nucleotide-binding, 790001405$signal, 790001450$stress response]
hypoxia up-regulated 1,UP_SEQ_FEATURE[850025306$chain:Hypoxia up-regulated protein 1, 850102572$compositionally biased region:Poly-Glu, 850102580$compositionally biased region:Poly-Pro, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide]
importin 7,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
importin 7,INTERPRO[450001329$IPR001494:Importin-beta, N-terminal, 450002642$IPR003006:Immunoglobulin/major histocompatibility complex, conserved site, 450010814$IPR011989:Armadillo-like helical]
importin 7,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
importin 7,UP_SEQ_FEATURE[850025668$chain:Importin-7, 850102458$compositionally biased region:Asp-rich, 850104418$domain:Importin N-terminal, 850106258$modified residue, 850106259$mutagenesis site, 850117295$sequence variant]
inositol hexakisphosphate kinase 2,INTERPRO[450004977$IPR005522:Inositol polyphosphate kinase]
inositol hexakisphosphate kinase 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001065$nucleus, 790001547$transferase]
inositol hexakisphosphate kinase 2,UP_SEQ_FEATURE[850026033$chain:Inositol hexakisphosphate kinase 2, 850114716$region of interest:Substrate binding, 850117294$sequence conflict, 850118574$splice variant]
inositol polyphosphate-4-phosphatase, type II, 105kDa,KEGG_PATHWAY[470038776$hsa00562:Inositol phosphate metabolism, 470038832$hsa04070:Phosphatidylinositol signaling system]
inositol polyphosphate-4-phosphatase, type II, 105kDa,PIR_SUPERFAMILY[630016131$PIRSF019532:inositol-3,4-bisphosphate 4-phosphatase type I/II]
inositol polyphosphate-4-phosphatase, type II, 105kDa,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism]
inositol polyphosphate-4-phosphatase, type II, 105kDa,UP_SEQ_FEATURE[850067392$chain:Type II inositol-3,4-bisphosphate 4- phosphatase, 850103199$domain:C2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant]
integrator complex subunit 3,INTERPRO[450017571$IPR019333:Integrator complex, subunit 3]
integrator complex subunit 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000452$DNA damage, 790000459$dna repair, 790001065$nucleus, 790001162$phosphoprotein]
integrator complex subunit 3,UP_SEQ_FEATURE[850026239$chain:Integrator complex subunit 3, 850102390$compositionally biased region:Ala/Gly-rich, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),INTERPRO[450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450012387$IPR013768:Intercellular adhesion molecule, N-terminal, 450012396$IPR013783:Immunoglobulin-like fold]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),OMIM_DISEASE[520000606$Blood group, Landsteiner-Wiener]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000194$blood group antigen, 790000256$cell adhesion, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
intercellular adhesion molecule 4 (Landsteiner-Wiener blood group),UP_SEQ_FEATURE[850026354$chain:Intercellular adhesion molecule 4, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interferon regulatory factor 6,INTERPRO[450001188$IPR001346:Interferon regulatory factor, 450010816$IPR011991:Winged helix repressor DNA-binding, 450016174$IPR017855:SMAD domain-like, 450017709$IPR019471:Interferon regulatory factor-3, 450018048$IPR019817:Interferon regulatory factor, conserved site]
interferon regulatory factor 6,OMIM_DISEASE[520003784$Orofacial cleft 6, 520004058$Popliteal pterygium syndrome, 520005011$van der Woude syndrome]
interferon regulatory factor 6,PIR_SUPERFAMILY[630005637$PIRSF005710:interferon regulatory factor 3-9]
interferon regulatory factor 6,SMART[760000316$SM00348:IRF]
interferon regulatory factor 6,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000434$differentiation, 790000446$disease mutation, 790000466$dna-binding, 790001065$nucleus, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation]
interferon regulatory factor 6,UP_SEQ_FEATURE[850026412$chain:Interferon regulatory factor 6, 850102968$DNA-binding region:Tryptophan pentad repeat, 850117295$sequence variant]
interferon-related developmental regulator 1,INTERPRO[450006320$IPR006921:Interferon-related developmental regulator, C-terminal, 450007056$IPR007701:Interferon-related developmental regulator, N-terminal]
interferon-related developmental regulator 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001162$phosphoprotein]
interferon-related developmental regulator 1,UP_SEQ_FEATURE[850026478$chain:Interferon-related developmental regulator 1, 850102565$compositionally biased region:Poly-Ala, 850102573$compositionally biased region:Poly-Gly, 850106258$modified residue, 850117294$sequence conflict]
interleukin 17 receptor E,INTERPRO[450012192$IPR013568:SEFIR]
interleukin 17 receptor E,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
interleukin 17 receptor E,UP_SEQ_FEATURE[850026539$chain:Interleukin-17 receptor E, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 2 receptor, alpha,BBID[10000087$67.Ikaros_and_signaling_inhibitors]
interleukin 2 receptor, alpha,BIOCARTA[30000155$h_il2Pathway:IL 2 signaling pathway, 30000156$h_il2rbPathway:IL-2 Receptor Beta Chain in T cell Activation, 30000294$h_th1th2Pathway:Th1/Th2 Differentiation, 30000299$h_tob1Pathway:Role of Tob in T-cell activation]
interleukin 2 receptor, alpha,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450013927$IPR015486:Interleukin-2 receptor alpha chain, 450014444$IPR016060:Complement control module]
interleukin 2 receptor, alpha,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038841$hsa04144:Endocytosis, 470038866$hsa04630:Jak-STAT signaling pathway, 470038867$hsa04640:Hematopoietic cell lineage]
interleukin 2 receptor, alpha,OMIM_DISEASE[520001490$Diabetes mellitus, insulin-dependent, susceptibility to, 520001491$Diabetes mellitus, insulin-dependent, susceptibility to, 10, 520001519$Diabetes, mellitus, insulin-dependent, susceptibility to, 10, 520001520$Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 520002662$Interleukin-2 receptor, alpha chain, deficiency of, 520003249$Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci, 520004352$Risk alleles for multiple sclerosis identified by a genomewide study]
interleukin 2 receptor, alpha,PIR_SUPERFAMILY[630002091$PIRSF001954:interleukin-2 receptor, alpha chain]
interleukin 2 receptor, alpha,SMART[760000024$SM00032:CCP]
interleukin 2 receptor, alpha,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000403$cytokine receptor, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000679$heterodimer, 790000687$heterotrimer, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001463$sulfoprotein, 790001471$sushi, 790001480$T-cell proliferation, 790001555$transmembrane, 790001556$transmembrane protein]
interleukin 2 receptor, alpha,UP_SEQ_FEATURE[850026553$chain:Interleukin-2 receptor subunit alpha, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin 23 receptor,INTERPRO[450003484$IPR003961:Fibronectin, type III]
interleukin 23 receptor,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038866$hsa04630:Jak-STAT signaling pathway]
interleukin 23 receptor,OMIM_DISEASE[520000055$A genome-wide association study identifies IL23R as an inflammatory bowel disease gene, 520001278$Crohn disease, ileal, protection against, 520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease, 520002011$Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci, 520002014$Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis, 520002016$Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls, 520002931$Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease, 520003688$Novel Crohn disease locus identified by genome-wide association maps to a gene desert on 5p13.1 and modulates expression of PTGER4, 520004173$Psoriasis, protection against]
interleukin 23 receptor,SMART[760000051$SM00060:FN3]
interleukin 23 receptor,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000763$immune response, 790000775$inflammatory response, 790000777$innate immunity, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
interleukin 23 receptor,UP_SEQ_FEATURE[850026564$chain:Interleukin-23 receptor, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
interleukin enhancer binding factor 3, 90kDa,INTERPRO[450001016$IPR001159:Double-stranded RNA binding, 450005981$IPR006561:DZF]
interleukin enhancer binding factor 3, 90kDa,SMART[760000326$SM00358:DSRM, 760000509$SM00572:DZF]
interleukin enhancer binding factor 3, 90kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000466$dna-binding, 790000953$methylation, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001539$Transcription, 790001541$transcription factor, 790001543$transcription regulation]
interleukin enhancer binding factor 3, 90kDa,UP_SEQ_FEATURE[850026487$chain:Interleukin enhancer-binding factor 3, 850102424$compositionally biased region:Arg/Gly-rich, 850102573$compositionally biased region:Poly-Gly, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850103546$domain:DRBM 1, 850103547$domain:DRBM 2, 850103567$domain:DZF, 850106258$modified residue, 850112712$region of interest:Interaction with PRMT1, 850117294$sequence conflict, 850117295$sequence variant, 850117325$short sequence motif:Bipartite nuclear localization signal, 850118574$splice variant]
islet cell autoantigen 1,69kDa-like,INTERPRO[450006131$IPR006723:Islet cell autoantigen ICA69 homologue, 450009558$IPR010504:Arfaptin-like]
islet cell autoantigen 1,69kDa-like,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
islet cell autoantigen 1,69kDa-like,UP_SEQ_FEATURE[850026834$chain:Islet cell autoantigen 1-like protein, 850103030$domain:AH, 850117294$sequence conflict, 850118574$splice variant]
kallikrein-related peptidase 8,INTERPRO[450001106$IPR001254:Peptidase S1 and S6, chymotrypsin/Hap, 450001157$IPR001314:Peptidase S1A, chymotrypsin, 450016414$IPR018114:Peptidase S1/S6, chymotrypsin/Hap, active site]
kallikrein-related peptidase 8,SMART[760000013$SM00020:Tryp_SPc]
kallikrein-related peptidase 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001252$Protease, 790001363$Secreted, 790001383$Serine protease, 790001405$signal, 790001652$zymogen]
kallikrein-related peptidase 8,UP_SEQ_FEATURE[850000011$active site:Charge relay system, 850027042$chain:Kallikrein-8, 850102883$disulfide bond, 850104964$domain:Peptidase S1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
karyopherin (importin) beta 1,BIOCARTA[30000208$h_npcPathway:Mechanism of Protein Import into the Nucleus, 30000251$h_ranMSpathway:Role of Ran in mitotic spindle regulation]
karyopherin (importin) beta 1,COG_ONTOLOGY[90000079$Intracellular trafficking and secretion]
karyopherin (importin) beta 1,INTERPRO[450000194$IPR000225:Armadillo, 450000307$IPR000357:HEAT, 450001329$IPR001494:Importin-beta, N-terminal, 450010814$IPR011989:Armadillo-like helical]
karyopherin (importin) beta 1,SMART[760000159$SM00185:ARM]
karyopherin (importin) beta 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000811$isopeptide bond, 790001065$nucleus, 790001162$phosphoprotein, 790001266$protein transport, 790001304$repeat, 790001558$transport, 790001592$ubl conjugation]
karyopherin (importin) beta 1,UP_SEQ_FEATURE[850025659$chain:Importin subunit beta-1, 850102568$compositionally biased region:Poly-Asp, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850104418$domain:Importin N-terminal, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850111945$region of interest:IAB-binding, 850114174$region of interest:Ran-GTP binding, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850116163$repeat:HEAT 4, 850116164$repeat:HEAT 5, 850116165$repeat:HEAT 6, 850116166$repeat:HEAT 7, 850116167$repeat:HEAT 8, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
kelch-like 17 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006066$IPR006651:Kelch, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014332$IPR015915:Kelch-type beta propeller, 450015416$IPR017096:Kelch-like protein, gigaxonin]
kelch-like 17 (Drosophila),PIR_SUPERFAMILY[630028539$PIRSF037037:Kelch-like_protein_gigaxonin]
kelch-like 17 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 17 (Drosophila),SP_PIR_KEYWORDS[790000019$actin-binding, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000819$kelch repeat, 790000919$membrane, 790001223$postsynaptic cell membrane, 790001304$repeat, 790001475$synapse]
kelch-like 17 (Drosophila),UP_SEQ_FEATURE[850027132$chain:Kelch-like protein 17, 850102586$compositionally biased region:Pro-rich, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6]
kelch-like 21 (Drosophila),INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006067$IPR006652:Kelch repeat type 1, 450010229$IPR011333:BTB/POZ fold, 450010533$IPR011705:BTB/Kelch-associated, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related]
kelch-like 21 (Drosophila),SMART[760000197$SM00225:BTB, 760000541$SM00612:Kelch]
kelch-like 21 (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000819$kelch repeat, 790001304$repeat, 790001593$ubl conjugation pathway]
kelch-like 21 (Drosophila),UP_SEQ_FEATURE[850027136$chain:Kelch-like protein 21, 850103083$domain:BACK, 850103177$domain:BTB, 850116239$repeat:Kelch 1, 850116250$repeat:Kelch 2, 850116251$repeat:Kelch 3, 850116252$repeat:Kelch 4, 850116253$repeat:Kelch 5, 850116254$repeat:Kelch 6, 850117294$sequence conflict, 850118574$splice variant]
keratin 4,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 4,OMIM_DISEASE[520005089$White sponge nevus]
keratin 4,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 4,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 4,UP_SEQ_FEATURE[850027207$chain:Keratin, type II cytoskeletal 4, 850102517$compositionally biased region:Gly-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant, 850118563$site:Stutter]
keratin 76,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450002681$IPR003054:Type II keratin, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
keratin 76,PIR_SUPERFAMILY[630002406$PIRSF002282:cytoskeletal keratin]
keratin 76,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790000821$keratin, 790001162$phosphoprotein, 790001212$polymorphism]
keratin 76,UP_SEQ_FEATURE[850027205$chain:Keratin, type II cytoskeletal 2 oral, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111276$region of interest:Coil 2, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant]
keratin associated protein 3-1,INTERPRO[450007017$IPR007659:Keratin, high-sulphur matrix protein]
keratin associated protein 3-1,PIR_SUPERFAMILY[630002380$PIRSF002249:keratin high-sulfur matrix protein IIIB]
keratin associated protein 3-1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000821$keratin, 790001304$repeat]
keratin associated protein 3-1,UP_SEQ_FEATURE[850027291$chain:Keratin-associated protein 3-1, 850110395$region of interest:4 X 5 AA repeats of C-C-X(3), 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4]
keratocan,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat]
keratocan,OMIM_DISEASE[520001205$Cornea plana congenita, recessive]
keratocan,PIR_SUPERFAMILY[630005362$PIRSF005438:class II small leucine-rich proteoglycan, 630030690$PIRSF500476:keratokan]
keratocan,SMART[760000007$SM00013:LRRNT]
keratocan,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001269$proteoglycan, 790001304$repeat, 790001363$Secreted, 790001377$sensory transduction, 790001405$signal, 790001622$vision]
keratocan,UP_SEQ_FEATURE[850027335$chain:Keratocan, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105784$glycosylation site:N-linked (GlcNAc...) (keratan sulfate), 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117295$sequence variant, 850117814$signal peptide]
kininogen 1,BIOCARTA[30000165$h_intrinsicPathway:Intrinsic Prothrombin Activation Pathway]
kininogen 1,INTERPRO[450000008$IPR000010:Proteinase inhibitor I25, cystatin, 450002128$IPR002395:HMW kininogen, 450016374$IPR018073:Proteinase inhibitor I25, cystatin, conserved site]
kininogen 1,KEGG_PATHWAY[470038859$hsa04610:Complement and coagulation cascades]
kininogen 1,OMIM_DISEASE[520001913$Fitzgerald factor deficiency, 520002334$High molecular weight kininogen deficiency, 520002335$High-molecular-weight kininogen deficiency, 520002744$Kininogen deficiency]
kininogen 1,SMART[760000035$SM00043:CY]
kininogen 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000192$blood coagulation, 790000198$bradykinin, 790000356$complete proteome, 790000398$cysteine proteinase inhibitor, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000473$duplication, 790000616$glycoprotein, 790000745$hydroxylation, 790000747$hydroxyproline, 790000775$inflammatory response, 790001162$phosphoprotein, 790001191$plasma, 790001212$polymorphism, 790001253$protease inhibitor, 790001289$pyroglutamic acid, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001484$tandem repeat, 790001510$thiol protease inhibitor, 790001606$vasoactive, 790001608$vasodilator]
kininogen 1,UP_SEQ_FEATURE[850027560$chain:Kininogen-1, 850027561$chain:Kininogen-1 heavy chain, 850027562$chain:Kininogen-1 light chain, 850102540$compositionally biased region:His-rich, 850102883$disulfide bond, 850103469$domain:Cystatin 1, 850103470$domain:Cystatin 2, 850103471$domain:Cystatin 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850105822$glycosylation site:O-linked (GalNAc...), 850106258$modified residue, 850106774$peptide:Bradykinin, 850108110$peptide:Low molecular weight growth-promoting factor, 850108134$peptide:Lysyl-bradykinin, 850109303$peptide:T-kinin, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118073$site:Cleavage; by kallikrein, 850118450$site:Not glycosylated, 850118574$splice variant]
late cornified envelope 2A,INTERPRO[450002847$IPR003267:Small proline-rich]
late cornified envelope 2A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000822$keratinization, 790001212$polymorphism]
late cornified envelope 2A,UP_SEQ_FEATURE[850028026$chain:Late cornified envelope protein 2A, 850102480$compositionally biased region:Cys-rich, 850117295$sequence variant]
latent transforming growth factor beta binding protein 2,INTERPRO[450000128$IPR000152:EGF-type aspartate/asparagine hydroxylation conserved site, 450000637$IPR000742:EGF-like, type 3, 450001663$IPR001881:EGF-like calcium-binding, 450001962$IPR002212:Matrix fibril-associated, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450011699$IPR013032:EGF-like region, conserved site, 450011735$IPR013091:EGF calcium-binding, 450011755$IPR013111:EGF, extracellular, 450016196$IPR017878:TGF-beta binding, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
latent transforming growth factor beta binding protein 2,PIR_SUPERFAMILY[630029159$PIRSF037569:latent transforming growth factor beta-binding protein]
latent transforming growth factor beta binding protein 2,SMART[760000153$SM00179:EGF_CA, 760000155$SM00181:EGF]
latent transforming growth factor beta binding protein 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000633$Growth factor binding, 790000745$hydroxylation, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
latent transforming growth factor beta binding protein 2,UP_SEQ_FEATURE[850028084$chain:Latent-transforming growth factor beta- binding protein 2, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103600$domain:EGF-like 10; calcium-binding, 850103602$domain:EGF-like 11; calcium-binding, 850103604$domain:EGF-like 12; calcium-binding, 850103606$domain:EGF-like 13; calcium-binding, 850103608$domain:EGF-like 14; calcium-binding, 850103610$domain:EGF-like 15; calcium-binding, 850103612$domain:EGF-like 16; calcium-binding, 850103614$domain:EGF-like 17; calcium-binding, 850103616$domain:EGF-like 18; calcium-binding, 850103618$domain:EGF-like 19; calcium-binding, 850103623$domain:EGF-like 2, 850103625$domain:EGF-like 20; calcium-binding, 850103667$domain:EGF-like 3; calcium-binding, 850103668$domain:EGF-like 4, 850103693$domain:EGF-like 5; calcium-binding, 850103696$domain:EGF-like 6; calcium-binding, 850103699$domain:EGF-like 7; calcium-binding, 850103701$domain:EGF-like 8; calcium-binding, 850103703$domain:EGF-like 9; calcium-binding, 850105465$domain:TB 1, 850105466$domain:TB 2, 850105467$domain:TB 3, 850105468$domain:TB 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide]
lectin, galactoside-binding, soluble, 14,INTERPRO[450000945$IPR001079:Galectin, carbohydrate recognition domain, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup]
lectin, galactoside-binding, soluble, 14,SMART[760000247$SM00276:GLECT]
lectin, galactoside-binding, soluble, 14,SP_PIR_KEYWORDS[790000356$complete proteome, 790000848$Lectin, 790001065$nucleus, 790001212$polymorphism]
lectin, galactoside-binding, soluble, 14,UP_SEQ_FEATURE[850039417$chain:Placental protein 13-like, 850104037$domain:Galectin, 850117294$sequence conflict, 850117295$sequence variant]
lectin, galactoside-binding, soluble, 9B,INTERPRO[450000945$IPR001079:Galectin, carbohydrate recognition domain, 450011956$IPR013320:Concanavalin A-like lectin/glucanase, subgroup]
lectin, galactoside-binding, soluble, 9B,SMART[760000247$SM00276:GLECT]
lectin, galactoside-binding, soluble, 9B,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000848$Lectin, 790001304$repeat]
lectin, galactoside-binding, soluble, 9B,UP_SEQ_FEATURE[850020449$chain:Galectin-9B, 850104038$domain:Galectin 1, 850104039$domain:Galectin 2, 850111010$region of interest:Beta-galactoside binding 1, 850111011$region of interest:Beta-galactoside binding 2, 850117294$sequence conflict, 850118574$splice variant]
leucine rich repeat and Ig domain containing 1,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype, 450003159$IPR003598:Immunoglobulin subtype 2, 450006486$IPR007110:Immunoglobulin-like, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold]
leucine rich repeat and Ig domain containing 1,SMART[760000007$SM00013:LRRNT, 760000071$SM00082:LRRCT, 760000333$SM00369:LRR_TYP, 760000356$SM00408:IGc2]
leucine rich repeat and Ig domain containing 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000853$leucine-rich repeat, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
leucine rich repeat and Ig domain containing 1,UP_SEQ_FEATURE[850028321$chain:Leucine-rich repeat and immunoglobulin- like domain-containing nogo receptor- interacting protein 1, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116312$repeat:LRR 13, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
leucine zipper, putative tumor suppressor 2,INTERPRO[450008731$IPR009638:Fez1]
leucine zipper, putative tumor suppressor 2,SP_PIR_KEYWORDS[790000258$cell cycle, 790000260$cell division, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000960$microtubule, 790000973$mitosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001642$wnt signaling pathway]
leucine zipper, putative tumor suppressor 2,UP_SEQ_FEATURE[850028294$chain:Leucine zipper putative tumor suppressor 2, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850106259$mutagenesis site, 850114270$region of interest:Required for centrosomal localization, 850114751$region of interest:Sufficient for interaction with CTNNB1, 850114772$region of interest:Sufficient for interaction with KATNB1 and for inhibition of katanin-mediated microtubule severing, 850117294$sequence conflict, 850117295$sequence variant, 850117605$short sequence motif:Nuclear export signal]
low density lipoprotein receptor-related protein 5,INTERPRO[450000026$IPR000033:Low-density lipoprotein receptor, YWTD repeat, 450001927$IPR002172:Low density lipoprotein-receptor, class A, cysteine-rich, 450005635$IPR006209:EGF, 450005636$IPR006210:EGF-like, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450015369$IPR017049:Low density lipoprotein receptor-related protein, 5/6, 450016397$IPR018097:EGF-like calcium-binding, conserved site]
low density lipoprotein receptor-related protein 5,KEGG_PATHWAY[470038846$hsa04310:Wnt signaling pathway]
low density lipoprotein receptor-related protein 5,OMIM_DISEASE[520000647$Bone mineral density variability 1, 520000650$Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study, 520001836$Exudative vitreoretinopathy 4, 520002450$Hyperostosis, endosteal, 520003818$Osteopetrosis, AD type I, 520003831$Osteoporosis, 520003837$Osteoporosis-pseudoglioma syndrome, 520003840$Osteosclerosis, 520005010$van Buchem disease, type 2]
low density lipoprotein receptor-related protein 5,PIR_SUPERFAMILY[630027750$PIRSF036314:LDL_recpt-rel_p5/6, 630027751$PIRSF036314:low density lipoprotein receptor-related protein, 5/6 types, 630030929$PIRSF500770:low-density lipoprotein receptor-related protein 5]
low density lipoprotein receptor-related protein 5,SMART[760000117$SM00135:LY, 760000155$SM00181:EGF, 760000166$SM00192:LDLa]
low density lipoprotein receptor-related protein 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000446$disease mutation, 790000447$disulfide bond, 790000481$egf-like domain, 790000496$Endocytosis, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001084$osteopetrosis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001642$wnt signaling pathway]
low density lipoprotein receptor-related protein 5,UP_SEQ_FEATURE[850029132$chain:Low-density lipoprotein receptor-related protein 5, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850104665$domain:LDL-receptor class A 1, 850104678$domain:LDL-receptor class A 2, 850104691$domain:LDL-receptor class A 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850116264$repeat:LDL-receptor class B 1, 850116265$repeat:LDL-receptor class B 10, 850116266$repeat:LDL-receptor class B 11, 850116267$repeat:LDL-receptor class B 12, 850116268$repeat:LDL-receptor class B 13, 850116269$repeat:LDL-receptor class B 14, 850116270$repeat:LDL-receptor class B 15, 850116271$repeat:LDL-receptor class B 16, 850116272$repeat:LDL-receptor class B 17, 850116273$repeat:LDL-receptor class B 18, 850116274$repeat:LDL-receptor class B 19, 850116275$repeat:LDL-receptor class B 2, 850116276$repeat:LDL-receptor class B 20, 850116286$repeat:LDL-receptor class B 3, 850116295$repeat:LDL-receptor class B 4, 850116296$repeat:LDL-receptor class B 5, 850116297$repeat:LDL-receptor class B 6, 850116298$repeat:LDL-receptor class B 7, 850116299$repeat:LDL-receptor class B 8, 850116300$repeat:LDL-receptor class B 9, 850117267$repeat:YWTD 1, 850117268$repeat:YWTD 10, 850117269$repeat:YWTD 11, 850117270$repeat:YWTD 2, 850117271$repeat:YWTD 3, 850117272$repeat:YWTD 4, 850117273$repeat:YWTD 5, 850117274$repeat:YWTD 6, 850117275$repeat:YWTD 7, 850117276$repeat:YWTD 8, 850117277$repeat:YWTD 9, 850117294$sequence conflict, 850117295$sequence variant, 850117651$short sequence motif:PPPSP motif, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
lumican,INTERPRO[450000318$IPR000372:Leucine-rich repeat, cysteine-rich flanking region, N-terminal, 450001429$IPR001611:Leucine-rich repeat, 450003153$IPR003591:Leucine-rich repeat, typical subtype]
lumican,PIR_SUPERFAMILY[630005362$PIRSF005438:class II small leucine-rich proteoglycan, 630030687$PIRSF500473:lumican]
lumican,SMART[760000007$SM00013:LRRNT, 760000333$SM00369:LRR_TYP]
lumican,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000853$leucine-rich repeat, 790001269$proteoglycan, 790001291$Pyrrolidone carboxylic acid, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001461$sulfation]
lumican,UP_SEQ_FEATURE[850029183$chain:Lumican, 850102480$compositionally biased region:Cys-rich, 850102883$disulfide bond, 850105784$glycosylation site:N-linked (GlcNAc...) (keratan sulfate), 850106258$modified residue, 850116308$repeat:LRR 1, 850116309$repeat:LRR 10, 850116310$repeat:LRR 11, 850116311$repeat:LRR 12, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850116340$repeat:LRR 4, 850116341$repeat:LRR 5, 850116342$repeat:LRR 6, 850116343$repeat:LRR 7, 850116344$repeat:LRR 8, 850116346$repeat:LRR 9, 850117294$sequence conflict, 850117814$signal peptide]
macrophage expressed 1,INTERPRO[450001647$IPR001862:Membrane attack complex component/perforin/complement C9]
macrophage expressed 1,SMART[760000402$SM00457:MACPF]
macrophage expressed 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
macrophage expressed 1,UP_SEQ_FEATURE[850029494$chain:Macrophage-expressed gene 1 protein, 850104738$domain:MACPF, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
matrix metallopeptidase 1 (interstitial collagenase),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 1 (interstitial collagenase),KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038909$hsa05219:Bladder cancer]
matrix metallopeptidase 1 (interstitial collagenase),OMIM_DISEASE[520001203$COPD, rate of decline of lung function in, 520001708$Epidermolysis bullosa dystrophica, autosomal recessive, modifier of]
matrix metallopeptidase 1 (interstitial collagenase),PIR_SUPERFAMILY[630001331$PIRSF001191:matrix metalloproteinase, stromelysin type, 630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 1 (interstitial collagenase),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 1 (interstitial collagenase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000144$autocatalytic cleavage, 790000211$calcium, 790000345$collagen, 790000347$collagen degradation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000550$fibroblast, 790000616$glycoprotein, 790000733$host-virus interaction, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000944$metalloproteinase, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 1 (interstitial collagenase),UP_SEQ_FEATURE[850001196$chain:22 kDa interstitial collagenase, 850001292$chain:27 kDa interstitial collagenase, 850026638$chain:Interstitial collagenase, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105925$metal ion-binding site:Calcium 3, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850105930$metal ion-binding site:Calcium 4; via carbonyl oxygen, 850106219$metal ion-binding site:Zinc 1, 850106227$metal ion-binding site:Zinc 2; catalytic, 850106228$metal ion-binding site:Zinc 2; in inhibited form, 850109636$propeptide:Activation peptide, 850113432$region of interest:Metalloprotease, 850117294$sequence conflict, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118006$site:Cleavage; by autolysis, 850118575$strand, 850118624$turn]
matrix metallopeptidase 13 (collagenase 3),INTERPRO[450000498$IPR000585:Hemopexin/matrixin, 450001611$IPR001818:Peptidase M10A and M12B, matrixin and adamalysin, 450002196$IPR002477:Peptidoglycan binding-like, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450005466$IPR006026:Peptidase, metallopeptidases, 450014617$IPR016293:Peptidase M10A, matrix metallopeotidase, 450016760$IPR018486:Hemopexin/matrixin, conserved site, 450016761$IPR018487:Hemopexin/matrixin, repeat]
matrix metallopeptidase 13 (collagenase 3),OMIM_DISEASE[520004657$Spondyloepimetaphyseal dysplasia, Missouri type]
matrix metallopeptidase 13 (collagenase 3),PIR_SUPERFAMILY[630001331$PIRSF001191:matrix metalloproteinase, stromelysin type, 630001332$PIRSF001191:Peptidase_M10A_matrix]
matrix metallopeptidase 13 (collagenase 3),SMART[760000105$SM00120:HX, 760000207$SM00235:ZnMc]
matrix metallopeptidase 13 (collagenase 3),SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000345$collagen, 790000347$collagen degradation, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000944$metalloproteinase, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001648$zinc, 790001652$zymogen]
matrix metallopeptidase 13 (collagenase 3),UP_SEQ_FEATURE[850012235$chain:Collagenase 3, 850102883$disulfide bond, 850104116$domain:Hemopexin-like 1, 850104117$domain:Hemopexin-like 2, 850104118$domain:Hemopexin-like 3, 850104119$domain:Hemopexin-like 4, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850105910$metal ion-binding site:Calcium 1, 850105915$metal ion-binding site:Calcium 1; via carbonyl oxygen, 850105918$metal ion-binding site:Calcium 2, 850105922$metal ion-binding site:Calcium 2; via carbonyl oxygen, 850105927$metal ion-binding site:Calcium 3; via carbonyl oxygen, 850105930$metal ion-binding site:Calcium 4; via carbonyl oxygen, 850106219$metal ion-binding site:Zinc 1, 850106227$metal ion-binding site:Zinc 2; catalytic, 850106228$metal ion-binding site:Zinc 2; in inhibited form, 850109636$propeptide:Activation peptide, 850117295$sequence variant, 850117368$short sequence motif:Cysteine switch, 850117814$signal peptide, 850118575$strand, 850118624$turn]
meiotic nuclear divisions 1 homolog (S. cerevisiae),COG_ONTOLOGY[90000027$Cell division and chromosome partitioning / General function prediction only]
meiotic nuclear divisions 1 homolog (S. cerevisiae),INTERPRO[450005095$IPR005647:Meiotic nuclear division protein 1]
meiotic nuclear divisions 1 homolog (S. cerevisiae),PIR_SUPERFAMILY[630020595$PIRSF026991:meiotic nuclear division protein 1, 630020596$PIRSF026991:Mnd1]
meiotic nuclear divisions 1 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000458$dna recombination, 790000466$dna-binding, 790000915$meiosis, 790001065$nucleus]
meiotic nuclear divisions 1 homolog (S. cerevisiae),UP_SEQ_FEATURE[850030843$chain:Meiotic nuclear division protein 1 homolog]
metallothionein 3,INTERPRO[450000004$IPR000006:Metallothionein, vertebrate, 450002652$IPR003019:Metallothionein superfamily, eukaryotic, 450016366$IPR018064:Metallothionein, vertebrate, metal binding site]
metallothionein 3,PIR_SUPERFAMILY[630002679$PIRSF002564:metallothionein]
metallothionein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000057$Alzheimer's disease, 790000189$blocked amino end, 790000199$brain, 790000356$complete proteome, 790000371$copper, 790000445$direct protein sequencing, 790000937$metal-binding, 790000938$metal-thiolate cluster, 790001648$zinc]
metallothionein 3,UP_SEQ_FEATURE[850031356$chain:Metallothionein-3, 850105852$helix, 850105996$metal ion-binding site:Divalent metal cation; cluster A, 850105997$metal ion-binding site:Divalent metal cation; cluster B, 850106258$modified residue, 850110903$region of interest:Alpha, 850111001$region of interest:Beta, 850118575$strand]
microspherule protein 1,INTERPRO[450000219$IPR000253:Forkhead-associated]
microspherule protein 1,SMART[760000212$SM00240:FHA]
microspherule protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
microspherule protein 1,UP_SEQ_FEATURE[850031678$chain:Microspherule protein 1, 850102597$compositionally biased region:Ser-rich, 850103775$domain:FHA, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
microtubule associated monoxygenase, calponin and LIM domain containing 2,INTERPRO[450001520$IPR001715:Calponin-like actin-binding, 450001575$IPR001781:Zinc finger, LIM-type, 450002591$IPR002938:Monooxygenase, FAD-binding, 450002669$IPR003042:Aromatic-ring hydroxylase-like]
microtubule associated monoxygenase, calponin and LIM domain containing 2,SMART[760000025$SM00033:CH, 760000114$SM00132:LIM]
microtubule associated monoxygenase, calponin and LIM domain containing 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000537$FAD, 790000559$Flavoprotein, 790000864$LIM domain, 790000937$metal-binding, 790001212$polymorphism, 790001648$zinc]
microtubule associated monoxygenase, calponin and LIM domain containing 2,UP_SEQ_FEATURE[850046876$chain:Protein MICAL-2, 850103317$domain:CH, 850104716$domain:LIM zinc-binding, 850105852$helix, 850106285$nucleotide phosphate-binding region:FAD, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
microtubule-associated protein 1S,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000466$dna-binding, 790000960$microtubule, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
microtubule-associated protein 1S,UP_SEQ_FEATURE[850030504$chain:MAP1S heavy chain, 850030505$chain:MAP1S light chain, 850031688$chain:Microtubule-associated protein 1S, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850113567$region of interest:Necessary for association with actin, 850113568$region of interest:Necessary for association with microtubules, 850113640$region of interest:Necessary for interaction with RASSF1 isoform A and isoform C, 850113707$region of interest:Necessary for the microtubule-organizing center localization, 850113708$region of interest:Necessary for the mitochondrial aggregation and genome destruction, 850117294$sequence conflict, 850117295$sequence variant]
microtubule-associated protein 6,INTERPRO[450007230$IPR007882:STOP]
microtubule-associated protein 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000218$calmodulin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000624$golgi apparatus, 790000881$lipoprotein, 790000960$microtubule, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism]
microtubule-associated protein 6,UP_SEQ_FEATURE[850031691$chain:Microtubule-associated protein 6, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850111164$region of interest:Calmodulin-binding, 850113457$region of interest:Mn 1, 850113458$region of interest:Mn 2, 850113459$region of interest:Mn 3, 850117295$sequence variant, 850118574$splice variant]
mitochondrial carrier homolog 2 (C. elegans),INTERPRO[450016408$IPR018108:Mitochondrial substrate/solute carrier]
mitochondrial carrier homolog 2 (C. elegans),OMIM_DISEASE[520004491$Six new loci associated with body mass index highlight a neuronal influence on body weight regulation]
mitochondrial carrier homolog 2 (C. elegans),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
mitochondrial carrier homolog 2 (C. elegans),UP_SEQ_FEATURE[850031844$chain:Mitochondrial carrier homolog 2, 850106258$modified residue, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117295$sequence variant, 850118623$transmembrane region]
mitofusin 2,INTERPRO[450001246$IPR001401:Dynamin, GTPase region, 450006284$IPR006884:Fzo-like conserved region]
mitofusin 2,OMIM_DISEASE[520000951$Charcot-Marie-Tooth disease, type 2A2, 520002297$Hereditary motor and sensory neuropathy VI]
mitofusin 2,SMART[760000045$SM00053:DYNc]
mitofusin 2,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000289$charcot-marie-tooth disease, 790000344$coiled coil, 790000356$complete proteome, 790000446$disease mutation, 790000639$gtp-binding, 790000743$hydrolase, 790000919$membrane, 790000969$mitochondrion, 790000971$mitochondrion outer membrane, 790001020$neuropathy, 790001063$nucleotide-binding, 790001555$transmembrane]
mitofusin 2,UP_SEQ_FEATURE[850032062$chain:Mitofusin-2, 850106258$modified residue, 850106259$mutagenesis site, 850106296$nucleotide phosphate-binding region:GTP, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118594$topological domain:Mitochondrial intermembrane, 850118623$transmembrane region]
mitogen-activated protein kinase 8 interacting protein 1,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
mitogen-activated protein kinase 8 interacting protein 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
mitogen-activated protein kinase 8 interacting protein 1,OMIM_DISEASE[520001498$Diabetes mellitus, noninsulin-dependent]
mitogen-activated protein kinase 8 interacting protein 1,SMART[760000295$SM00326:SH3, 760000407$SM00462:PTB]
mitogen-activated protein kinase 8 interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000430$diabetes mellitus, 790000446$disease mutation, 790000825$kinase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001398$sh3 domain, 790001592$ubl conjugation]
mitogen-activated protein kinase 8 interacting protein 1,UP_SEQ_FEATURE[850008633$chain:C-jun-amino-terminal kinase-interacting protein 1, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850104993$domain:PID, 850105350$domain:SH3, 850106258$modified residue, 850106259$mutagenesis site, 850113235$region of interest:JNK-binding domain (JBD), 850113452$region of interest:Minimal inhibitory domain (MID), 850117295$sequence variant, 850117371$short sequence motif:D-box 1, 850117372$short sequence motif:D-box 2]
mucin 6, oligomeric mucus/gel-forming,INTERPRO[450001632$IPR001846:von Willebrand factor, type D, 450005633$IPR006207:Cystine knot, C-terminal, 450013302$IPR014853:Conserved-cysteine-rich domain, 450016728$IPR018453:Protease inhibitor I8, cysteine-rich trypsin inhibitor-like subgroup]
mucin 6, oligomeric mucus/gel-forming,SMART[760000033$SM00041:CT, 760000189$SM00216:VWD]
mucin 6, oligomeric mucus/gel-forming,SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001405$signal]
mucin 6, oligomeric mucus/gel-forming,UP_SEQ_FEATURE[850032662$chain:Mucin-6, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850102605$compositionally biased region:Thr-rich, 850102883$disulfide bond, 850103430$domain:CTCK, 850105503$domain:TIL, 850105673$domain:VWFD 1, 850105678$domain:VWFD 2, 850105679$domain:VWFD 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850110942$region of interest:Approximate repeats, 850115271$repeat:1; truncated, 850115273$repeat:2, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide]
multiple inositol polyphosphate histidine phosphatase, 1,INTERPRO[450000480$IPR000560:Histidine acid phosphatase, 450000773$IPR000886:Endoplasmic reticulum, targeting sequence, 450014598$IPR016274:Histidine acid phosphatase, eukaryotic]
multiple inositol polyphosphate histidine phosphatase, 1,KEGG_PATHWAY[470038776$hsa00562:Inositol phosphate metabolism]
multiple inositol polyphosphate histidine phosphatase, 1,OMIM_DISEASE[520004860$Thyroid carcinoma, follicular]
multiple inositol polyphosphate histidine phosphatase, 1,PIR_SUPERFAMILY[630001032$PIRSF000894:acid phosphatase, 630001033$PIRSF000894:Acid_phosphatase]
multiple inositol polyphosphate histidine phosphatase, 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000743$hydrolase, 790001212$polymorphism, 790001405$signal]
multiple inositol polyphosphate histidine phosphatase, 1,UP_SEQ_FEATURE[850032784$chain:Multiple inositol polyphosphate phosphatase 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant]
mutL homolog 3 (E. coli),COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
mutL homolog 3 (E. coli),INTERPRO[450001859$IPR002099:DNA mismatch repair protein, 450003155$IPR003594:ATP-binding region, ATPase-like, 450012134$IPR013507:DNA mismatch repair protein, C-terminal, 450013173$IPR014721:Ribosomal protein S5 domain 2-type fold, 450013212$IPR014762:DNA mismatch repair, conserved site, 450013240$IPR014790:MutL, C-terminal, dimerisation]
mutL homolog 3 (E. coli),KEGG_PATHWAY[470038824$hsa03430:Mismatch repair]
mutL homolog 3 (E. coli),OMIM_DISEASE[520001083$Colon cancer, hereditary nonpolypopsis, type 7, 520001101$Colorectal cancer, somatic]
mutL homolog 3 (E. coli),SMART[760000339$SM00387:HATPase_c]
mutL homolog 3 (E. coli),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000446$disease mutation, 790000452$DNA damage, 790000459$dna repair, 790000674$hereditary nonpolyposis colorectal cancer, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
mutL homolog 3 (E. coli),UP_SEQ_FEATURE[850015587$chain:DNA mismatch repair protein MLH3, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
myeloid-associated differentiation marker,INTERPRO[450007548$IPR008253:Marvel]
myeloid-associated differentiation marker,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001304$repeat, 790001555$transmembrane]
myeloid-associated differentiation marker,UP_SEQ_FEATURE[850032928$chain:Myeloid-associated differentiation marker, 850104756$domain:MARVEL 1, 850104757$domain:MARVEL 2, 850106258$modified residue, 850117294$sequence conflict, 850118623$transmembrane region]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),INTERPRO[450000032$IPR000038:Cell division/GTP binding protein, 450000544$IPR000637:HMG-I and HMG-Y, DNA-binding, conserved site, 450001068$IPR001214:SET, 450001324$IPR001487:Bromodomain, 450001740$IPR001965:Zinc finger, PHD-type, 450002527$IPR002857:Zinc finger, CXXC-type, 450003176$IPR003616:Post-SET zinc-binding region, 450003413$IPR003888:FY-rich, N-terminal, 450003414$IPR003889:FY-rich, C-terminal, 450007148$IPR007797:AF-4 proto-oncoprotein, 450013919$IPR015479:Transcription factor AF4, 450014157$IPR015722:MLL Transcription Factor, 450014376$IPR015967:Zinc finger C4-type, RecR, 450014891$IPR016569:Methyltransferase, trithorax, 450016267$IPR017956:AT hook, DNA-binding, conserved site, 450016532$IPR018247:EF-HAND 1, 450016788$IPR018516:FY-rich, C-terminal subgroup, 450016790$IPR018518:FY-rich, N-terminal subgroup, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),OMIM_DISEASE[520002862$Leukemia, myeloid/lymphoid or mixed-lineage]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),PIR_SUPERFAMILY[630009176$PIRSF010354:Methyltransferase_trithorax, 630009177$PIRSF010354:protein methyltransferase, trithorax protein type]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),SMART[760000221$SM00249:PHD, 760000267$SM00297:BROMO, 760000286$SM00317:SET, 760000336$SM00384:AT_hook, 760000451$SM00508:PostSET, 760000481$SM00541:FYRN, 760000482$SM00542:FYRC]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000021$acute lymphoblastic leukemia, 790000053$alternative splicing, 790000109$Apoptosis, 790000206$bromodomain, 790000311$chromatin regulator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000466$dna-binding, 790000573$fusion protein, 790000639$gtp-binding, 790000811$isopeptide bond, 790000937$metal-binding, 790000954$methyltransferase, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001348$s-adenosyl-l-methionine, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001592$ubl conjugation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila),UP_SEQ_FEATURE[850000532$binding site:S-adenosyl-L-methionine, 850024151$chain:Histone-lysine N-methyltransferase MLL, 850032210$chain:MLL cleavage product C180, 850032211$chain:MLL cleavage product N320, 850102393$compositionally biased region:Ala/Gly/Ser-rich, 850102573$compositionally biased region:Poly-Gly, 850102580$compositionally biased region:Poly-Pro, 850102720$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin), 850102885$DNA-binding region:A.T hook 1, 850102888$DNA-binding region:A.T hook 2, 850102889$DNA-binding region:A.T hook 3, 850103173$domain:Bromo; divergent, 850104016$domain:FY-rich C-terminal, 850104017$domain:FY-rich N-terminal, 850105053$domain:Post-SET, 850105340$domain:SET, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106258$modified residue, 850106259$mutagenesis site, 850114570$region of interest:S-adenosyl-L-methionine binding, 850117294$sequence conflict, 850117295$sequence variant, 850117891$site:Breakpoint for translocation to form MLL- AF3P21 and MLL-CASC5 oncogenes, 850117893$site:Breakpoint for translocation to form MLL- AFF4 fusion protein, 850117896$site:Breakpoint for translocation to form MLL- CENPK oncogene, 850117899$site:Breakpoint for translocation to form MLL- FRYL fusion protein, 850117900$site:Breakpoint for translocation to form MLL- GAS7 oncogene, 850117901$site:Breakpoint for translocation to form MLL- LPP, 850117905$site:Breakpoint for translocation to form MLL- ZFYVE19 oncogene, 850118120$site:Cleavage; by TASP1, site 1, 850118121$site:Cleavage; by TASP1, site 2, 850118293$site:Important for WDR5-recognition and binding, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118796$zinc finger region:CXXC-type, 850118878$zinc finger region:PHD-type 1, 850118880$zinc finger region:PHD-type 2, 850118883$zinc finger region:PHD-type 3]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,INTERPRO[450004502$IPR005033:YEATS]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,PIR_SUPERFAMILY[630028760$PIRSF037229:MLLT]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,SP_PIR_KEYWORDS[790000020$activator, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001271$Proto-oncogene, 790001539$Transcription, 790001543$transcription regulation]
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3,UP_SEQ_FEATURE[850045003$chain:Protein AF-9, 850102580$compositionally biased region:Poly-Pro, 850102581$compositionally biased region:Poly-Ser, 850105744$domain:YEATS, 850106258$modified residue, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850118436$site:MLL fusion point (in acute myeloid leukemia patient CO), 850118437$site:MLL fusion point (in acute myeloid leukemia patient F1)]
myosin, light chain 12B, regulatory,COG_ONTOLOGY[90000111$Signal transduction mechanisms / Cytoskeleton / Cell division and chromosome partitioning / General function prediction only]
myosin, light chain 12B, regulatory,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016533$IPR018248:EF hand, 450016534$IPR018249:EF-HAND 2]
myosin, light chain 12B, regulatory,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038857$hsa04530:Tight junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
myosin, light chain 12B, regulatory,SMART[760000046$SM00054:EFh]
myosin, light chain 12B, regulatory,SP_PIR_KEYWORDS[790000012$acetylation, 790000211$calcium, 790000356$complete proteome, 790000986$motor protein, 790000997$muscle protein, 790001002$myosin, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
myosin, light chain 12B, regulatory,UP_SEQ_FEATURE[850033011$chain:Myosin regulatory light chain 12B, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant]
nestin,INTERPRO[450001474$IPR001664:Intermediate filament protein, 450014429$IPR016044:Filament, 450016344$IPR018039:Intermediate filament protein, conserved site]
nestin,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000788$Intermediate filament, 790001162$phosphoprotein, 790001212$polymorphism]
nestin,UP_SEQ_FEATURE[850033870$chain:Nestin, 850106258$modified residue, 850111274$region of interest:Coil 1A, 850111275$region of interest:Coil 1B, 850111277$region of interest:Coil 2A, 850111278$region of interest:Coil 2B, 850111838$region of interest:Head, 850113284$region of interest:Linker 1, 850113285$region of interest:Linker 12, 850113286$region of interest:Linker 2, 850114553$region of interest:Rod, 850114844$region of interest:Tail, 850117294$sequence conflict, 850117295$sequence variant]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,COG_ONTOLOGY[90000057$DNA replication, recombination, and repair]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,INTERPRO[450009680$IPR010630:Neuroblastoma breakpoint family]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
neuroblastoma breakpoint family, member 15; neuroblastoma breakpoint family, member 14; neuroblastoma breakpoint family, member 9; neuroblastoma breakpoint family, member 11; neuroblastoma breakpoint family, member 11-like; neuroblastoma breakpoint family, member 10; neuroblastoma breakpoint family, member 12; neuroblastoma breakpoint family, member 20; neuroblastoma breakpoint family, member 1; KIAA1245; neuroblastoma breakpoint family, member 8,UP_SEQ_FEATURE[850033937$chain:Neuroblastoma breakpoint family member 1, 850033938$chain:Neuroblastoma breakpoint family member 10, 850033939$chain:Neuroblastoma breakpoint family member 11, 850033940$chain:Neuroblastoma breakpoint family member 12, 850033941$chain:Neuroblastoma breakpoint family member 14, 850033942$chain:Neuroblastoma breakpoint family member 15, 850033944$chain:Neuroblastoma breakpoint family member 20, 850033950$chain:Neuroblastoma breakpoint family member 8, 850033951$chain:Neuroblastoma breakpoint family member 9, 850102566$compositionally biased region:Poly-Arg, 850102572$compositionally biased region:Poly-Glu, 850104832$domain:NBPF 1, 850104833$domain:NBPF 10, 850104834$domain:NBPF 2, 850104835$domain:NBPF 3, 850104836$domain:NBPF 4, 850104837$domain:NBPF 5, 850104838$domain:NBPF 6, 850104839$domain:NBPF 7, 850104840$domain:NBPF 8, 850104841$domain:NBPF 9, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
neuron navigator 3; similar to neuron navigator 3,INTERPRO[450001520$IPR001715:Calponin-like actin-binding, 450003154$IPR003593:ATPase, AAA+ type, core]
neuron navigator 3; similar to neuron navigator 3,SMART[760000025$SM00033:CH, 760000335$SM00382:AAA]
neuron navigator 3; similar to neuron navigator 3,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
neuron navigator 3; similar to neuron navigator 3,UP_SEQ_FEATURE[850034015$chain:Neuron navigator 3, 850102570$compositionally biased region:Poly-Gln, 850102577$compositionally biased region:Poly-Lys, 850102597$compositionally biased region:Ser-rich, 850103317$domain:CH, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
neuropeptide W,INTERPRO[450011933$IPR013297:Neuropeptide B/W precursor, 450011935$IPR013299:Neuropeptide W precursor]
neuropeptide W,SP_PIR_KEYWORDS[790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790001021$neuropeptide, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
neuropeptide W,UP_SEQ_FEATURE[850108409$peptide:Neuropeptide W-23, 850108410$peptide:Neuropeptide W-30, 850117295$sequence variant, 850117814$signal peptide]
neurotrophic tyrosine kinase, receptor, type 1,BIOCARTA[30000006$h_actinYPathway:Y branching of actin filaments, 30000104$h_erk5Pathway:Role of Erk5 in Neuronal Survival, 30000302$h_trkaPathway:Trka Receptor Signaling Pathway]
neurotrophic tyrosine kinase, receptor, type 1,INTERPRO[450000409$IPR000483:Cysteine-rich flanking region, C-terminal, 450000618$IPR000719:Protein kinase, core, 450001096$IPR001245:Tyrosine protein kinase, 450001782$IPR002011:Receptor tyrosine kinase, class II, conserved site, 450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450007559$IPR008266:Tyrosine protein kinase, active site, 450012396$IPR013783:Immunoglobulin-like fold, 450015769$IPR017441:Protein kinase, ATP binding site]
neurotrophic tyrosine kinase, receptor, type 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway, 470038841$hsa04144:Endocytosis, 470038843$hsa04210:Apoptosis, 470038877$hsa04722:Neurotrophin signaling pathway, 470038899$hsa05200:Pathways in cancer, 470038906$hsa05216:Thyroid cancer]
neurotrophic tyrosine kinase, receptor, type 1,OMIM_DISEASE[520002647$Insensitivity to pain, congenital, with anhidrosis, 520003113$Medullary thyroid carcinoma, familial]
neurotrophic tyrosine kinase, receptor, type 1,PIR_SUPERFAMILY[630000733$PIRSF000623:tyrosine-protein kinase, BDNF/NT/NGF receptor type]
neurotrophic tyrosine kinase, receptor, type 1,SMART[760000071$SM00082:LRRCT, 760000192$SM00219:TyrKc, 760000357$SM00409:IG]
neurotrophic tyrosine kinase, receptor, type 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000134$ATP, 790000138$atp-binding, 790000149$autophosphorylation, 790000264$cell membrane, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000446$disease mutation, 790000447$disulfide bond, 790000573$fusion protein, 790000616$glycoprotein, 790000634$growth factor receptor, 790000768$Immunoglobulin domain, 790000825$kinase, 790000853$leucine-rich repeat, 790000919$membrane, 790001016$neurogenesis, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001271$Proto-oncogene, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001484$tandem repeat, 790001547$transferase, 790001549$transforming protein, 790001555$transmembrane, 790001556$transmembrane protein, 790001586$tyrosine-protein kinase, 790001588$tyrosine-specific protein kinase]
neurotrophic tyrosine kinase, receptor, type 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850023681$chain:High affinity nerve growth factor receptor, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850105086$domain:Protein kinase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106263$nucleotide phosphate-binding region:ATP, 850112862$region of interest:Interaction with SQSTM1, 850116308$repeat:LRR 1, 850116319$repeat:LRR 2, 850116330$repeat:LRR 3, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850117952$site:Breakpoint for translocation to form TRK and TRK-T3, 850117953$site:Breakpoint for translocation to form TRK- T1, 850118323$site:Interaction with PLC-gamma-1, 850118331$site:Interaction with SHC1, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
non imprinted in Prader-Willi/Angelman syndrome 1,INTERPRO[450001055$IPR001202:WW/Rsp5/WWP, 450007794$IPR008521:Protein of unknown function DUF803]
non imprinted in Prader-Willi/Angelman syndrome 1,OMIM_DISEASE[520004569$Spastic paraplegia-6]
non imprinted in Prader-Willi/Angelman syndrome 1,SMART[760000401$SM00456:WW]
non imprinted in Prader-Willi/Angelman syndrome 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000501$endosome, 790000675$hereditary spastic paraplegia, 790000798$ion transport, 790000899$magnesium, 790000919$membrane, 790001015$neurodegeneration, 790001555$transmembrane, 790001558$transport]
non imprinted in Prader-Willi/Angelman syndrome 1,UP_SEQ_FEATURE[850030007$chain:Magnesium transporter NIPA1, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase),INTERPRO[450001390$IPR001564:Nucleoside diphosphate kinase, core, 450006022$IPR006602:Region of unknown function DM10, 450010278$IPR011410:Nucleoside diphosphate kinase, NDK7]
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism]
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase),PIR_SUPERFAMILY[630027960$PIRSF036503:NDK7, 630027961$PIRSF036503:nucleoside diphosphate kinase, NDK7 type]
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase),SMART[760000501$SM00562:NDK, 760000588$SM00676:DM10]
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase),SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001062$nucleotide metabolism, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001547$transferase]
non-metastatic cells 7, protein expressed in (nucleoside-diphosphate kinase),UP_SEQ_FEATURE[850000110$active site:Pros-phosphohistidine intermediate, 850000242$binding site:ATP, 850035282$chain:Nucleoside diphosphate kinase 7, 850103528$domain:DM10]
nuclear autoantigenic sperm protein (histone-binding),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017781$IPR019544:Tetratricopeptide, SHNi-TPR domain, 450017972$IPR019734:Tetratricopeptide repeat]
nuclear autoantigenic sperm protein (histone-binding),SMART[760000020$SM00028:TPR]
nuclear autoantigenic sperm protein (histone-binding),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000258$cell cycle, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000460$dna replication, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001537$tpr repeat, 790001558$transport]
nuclear autoantigenic sperm protein (histone-binding),UP_SEQ_FEATURE[850034809$chain:Nuclear autoantigenic sperm protein, 850102508$compositionally biased region:Glu-rich (acidic), 850106258$modified residue, 850111897$region of interest:Histone-binding, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant]
nuclear factor I/A,INTERPRO[450000554$IPR000647:CTF transcription factor/nuclear factor 1, 450003179$IPR003619:MAD homology 1, Dwarfin-type, 450017785$IPR019548:CTF transcription factor/nuclear factor 1, N-terminal, 450017977$IPR019739:CTF transcription factor/nuclear factor 1, conserved site]
nuclear factor I/A,PIR_SUPERFAMILY[630015091$PIRSF018476:nuclear factor 1]
nuclear factor I/A,SMART[760000463$SM00523:DWA]
nuclear factor I/A,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000460$dna replication, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001539$Transcription, 790001543$transcription regulation]
nuclear factor I/A,UP_SEQ_FEATURE[850034840$chain:Nuclear factor 1 A-type, 850102905$DNA-binding region:CTF/NF-I, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
nuclear import 7 homolog (S. cerevisiae),INTERPRO[450002197$IPR002478:PUA, 450015007$IPR016686:Ribosome biogenesis factor, NIP7]
nuclear import 7 homolog (S. cerevisiae),PIR_SUPERFAMILY[630013954$PIRSF017190:60S ribosome subunit biogenesis protein NIP7, 630013955$PIRSF017190:Rbsml_synth_fac_NIP7]
nuclear import 7 homolog (S. cerevisiae),SMART[760000327$SM00359:PUA]
nuclear import 7 homolog (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001331$ribosome biogenesis, 790001339$rna-binding]
nuclear import 7 homolog (S. cerevisiae),UP_SEQ_FEATURE[850002846$chain:60S ribosome subunit biogenesis protein NIP7 homolog, 850105121$domain:PUA, 850105852$helix, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
nuclear mitotic apparatus protein 1,BIOCARTA[30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000251$h_ranMSpathway:Role of Ran in mitotic spindle regulation]
nuclear mitotic apparatus protein 1,OMIM_DISEASE[520002848$Leukemia, acute promyelocytic, NUMA/RARA type]
nuclear mitotic apparatus protein 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000973$mitosis, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism]
nuclear mitotic apparatus protein 1,UP_SEQ_FEATURE[850034986$chain:Nuclear mitotic apparatus protein 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nuclear receptor co-repressor 2,BIOCARTA[30000046$h_carm-erPathway:CARM1 and Regulation of the Estrogen Receptor, 30000092$h_egfr_smrtePathway:Map Kinase Inactivation of SMRT Corepressor, 30000108$h_etsPathway:METS affect on Macrophage Differentiation, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha), 30000254$h_rarrxrPathway:Nuclear receptors coordinate the activities of chromatin remodeling complexes and coactivators to facilitate initiation of transcription in carcinoma cells]
nuclear receptor co-repressor 2,INTERPRO[450000876$IPR001005:SANT, DNA-binding, 450010997$IPR012287:Homeodomain-related, 450013228$IPR014778:Myb, DNA-binding, 450016201$IPR017884:SANT, eukarya]
nuclear receptor co-repressor 2,KEGG_PATHWAY[470038848$hsa04330:Notch signaling pathway]
nuclear receptor co-repressor 2,SMART[760000623$SM00717:SANT]
nuclear receptor co-repressor 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
nuclear receptor co-repressor 2,UP_SEQ_FEATURE[850035037$chain:Nuclear receptor corepressor 2, 850102570$compositionally biased region:Poly-Gln, 850102573$compositionally biased region:Poly-Gly, 850102577$compositionally biased region:Poly-Lys, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850105255$domain:SANT 1, 850105256$domain:SANT 2, 850105852$helix, 850106258$modified residue, 850112828$region of interest:Interaction with SIN3A/B, 850117294$sequence conflict, 850117295$sequence variant, 850117349$short sequence motif:CORNR box of ID1, 850117350$short sequence motif:CORNR box of ID2, 850118574$splice variant, 850118575$strand, 850118624$turn]
nuclear receptor coactivator 7,INTERPRO[450002201$IPR002482:Peptidoglycan-binding Lysin subgroup, 450003692$IPR004182:GRAM, 450005991$IPR006571:TLDc, 450016672$IPR018392:Peptidoglycan-binding lysin domain]
nuclear receptor coactivator 7,SMART[760000229$SM00257:LysM, 760000505$SM00568:GRAM, 760000520$SM00584:TLDc]
nuclear receptor coactivator 7,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation]
nuclear receptor coactivator 7,UP_SEQ_FEATURE[850035035$chain:Nuclear receptor coactivator 7, 850105532$domain:TLD, 850106258$modified residue, 850106259$mutagenesis site, 850116349$repeat:LysM, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
nuclear receptor interacting protein 3,INTERPRO[450017359$IPR019103:Peptidase aspartic, eukaryotic predicted]
nuclear receptor interacting protein 3,SP_PIR_KEYWORDS[790000356$complete proteome]
nuclear receptor interacting protein 3,UP_SEQ_FEATURE[850035069$chain:Nuclear receptor-interacting protein 3]
nuclear receptor subfamily 1, group H, member 3,BIOCARTA[30000118$h_fxrPathway:FXR and LXR Regulation of Cholesterol Metabolism, 30000211$h_nuclearRsPathway:Nuclear Receptors in Lipid Metabolism and Toxicity, 30000235$h_pparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha)]
nuclear receptor subfamily 1, group H, member 3,INTERPRO[450000459$IPR000536:Nuclear hormone receptor, ligand-binding, core, 450000806$IPR000923:Blue (type 1) copper domain, 450001442$IPR001628:Zinc finger, nuclear hormone receptor-type, 450001527$IPR001723:Steroid hormone receptor, 450001531$IPR001728:Thyroid hormone receptor, 450006475$IPR007087:Zinc finger, C2H2-type, 450008168$IPR008946:Nuclear hormone receptor, ligand-binding, 450011732$IPR013088:Zinc finger, NHR/GATA-type]
nuclear receptor subfamily 1, group H, member 3,KEGG_PATHWAY[470038821$hsa03320:PPAR signaling pathway]
nuclear receptor subfamily 1, group H, member 3,OMIM_DISEASE[520001995$Genome-wide association analysis of metabolic traits in a birth cohort from a founder population]
nuclear receptor subfamily 1, group H, member 3,SMART[760000350$SM00399:ZnF_C4, 760000376$SM00430:HOLI]
nuclear receptor subfamily 1, group H, member 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
nuclear receptor subfamily 1, group H, member 3,UP_SEQ_FEATURE[850036544$chain:Oxysterols receptor LXR-alpha, 850102946$DNA-binding region:Nuclear receptor, 850105852$helix, 850113269$region of interest:Ligand-binding, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118866$zinc finger region:NR C4-type]
nucleoporin 98kDa,INTERPRO[450006599$IPR007230:Peptidase S59, nucleoporin]
nucleoporin 98kDa,OMIM_DISEASE[520002859$Leukemia, lymphycytic, acute T-cell]
nucleoporin 98kDa,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000356$complete proteome, 790000445$direct protein sequencing, 790000733$host-virus interaction, 790000919$membrane, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001554$translocation, 790001558$transport]
nucleoporin 98kDa,UP_SEQ_FEATURE[850035011$chain:Nuclear pore complex protein Nup96, 850035012$chain:Nuclear pore complex protein Nup98, 850102537$compositionally biased region:Gly/Thr-rich, 850102572$compositionally biased region:Poly-Glu, 850104971$domain:Peptidase S59, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117920$site:Breakpoint for translocation to form NUP98-PHF23 oncogene, 850118574$splice variant, 850118575$strand, 850118624$turn]
nucleoporin like 2,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type]
nucleoporin like 2,SMART[760000324$SM00356:ZnF_C3H1]
nucleoporin like 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790000937$metal-binding, 790000990$mRNA transport, 790001048$nuclear pore complex, 790001065$nucleus, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001554$translocation, 790001558$transport, 790001648$zinc, 790001651$zinc-finger]
nucleoporin like 2,UP_SEQ_FEATURE[850035267$chain:Nucleoporin-like protein 2, 850102597$compositionally biased region:Ser-rich, 850112365$region of interest:Interaction with GLE1, 850112408$region of interest:Interaction with HIV-1 Vpr, 850115899$repeat:FG 1, 850115900$repeat:FG 10, 850115901$repeat:FG 11, 850115902$repeat:FG 12, 850115910$repeat:FG 2, 850115911$repeat:FG 3, 850115912$repeat:FG 4, 850115913$repeat:FG 5, 850115914$repeat:FG 6, 850115915$repeat:FG 7, 850115916$repeat:FG 8, 850115917$repeat:FG 9, 850117295$sequence variant, 850118574$splice variant, 850118751$zinc finger region:C3H1-type]
nucleosome assembly protein 1-like 4,INTERPRO[450001919$IPR002164:Nucleosome assembly protein (NAP)]
nucleosome assembly protein 1-like 4,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001065$nucleus, 790001162$phosphoprotein]
nucleosome assembly protein 1-like 4,UP_SEQ_FEATURE[850035326$chain:Nucleosome assembly protein 1-like 4, 850102464$compositionally biased region:Asp/Glu-rich (acidic), 850102572$compositionally biased region:Poly-Glu, 850106258$modified residue, 850117610$short sequence motif:Nuclear localization signal]
nurim (nuclear envelope membrane protein),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001555$transmembrane]
nurim (nuclear envelope membrane protein),UP_SEQ_FEATURE[850035377$chain:Nurim, 850102552$compositionally biased region:Leu-rich, 850102576$compositionally biased region:Poly-Leu, 850118574$splice variant, 850118623$transmembrane region]
odz, odd Oz/ten-m homolog 4 (Drosophila),COG_ONTOLOGY[90000032$Cell envelope biogenesis, outer membrane]
odz, odd Oz/ten-m homolog 4 (Drosophila),INTERPRO[450000637$IPR000742:EGF-like, type 3, 450001109$IPR001258:NHL repeat, 450005636$IPR006210:EGF-like, 450005953$IPR006530:YD repeat, 450008574$IPR009471:Teneurin intracellular, N-terminal, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular]
odz, odd Oz/ten-m homolog 4 (Drosophila),SMART[760000155$SM00181:EGF]
odz, odd Oz/ten-m homolog 4 (Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001409$Signal-anchor, 790001555$transmembrane]
odz, odd Oz/ten-m homolog 4 (Drosophila),UP_SEQ_FEATURE[850063832$chain:Teneurin-4, 850102580$compositionally biased region:Poly-Pro, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850105475$domain:Teneurin N-terminal, 850105770$glycosylation site:N-linked (GlcNAc...), 850116579$repeat:NHL 1, 850116580$repeat:NHL 2, 850116581$repeat:NHL 3, 850116582$repeat:NHL 4, 850116583$repeat:NHL 5, 850117244$repeat:YD 1, 850117245$repeat:YD 10, 850117246$repeat:YD 11, 850117247$repeat:YD 12, 850117248$repeat:YD 13, 850117249$repeat:YD 14, 850117250$repeat:YD 15, 850117251$repeat:YD 16, 850117252$repeat:YD 17, 850117253$repeat:YD 18, 850117254$repeat:YD 19, 850117255$repeat:YD 2, 850117256$repeat:YD 20, 850117257$repeat:YD 21, 850117258$repeat:YD 22, 850117259$repeat:YD 23, 850117260$repeat:YD 3, 850117261$repeat:YD 4, 850117262$repeat:YD 5, 850117263$repeat:YD 6, 850117264$repeat:YD 7, 850117265$repeat:YD 8, 850117266$repeat:YD 9, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 10, subfamily K, member 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 10, subfamily K, member 1,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 10, subfamily K, member 1,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 10, subfamily K, member 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 10, subfamily K, member 1,UP_SEQ_FEATURE[850035544$chain:Olfactory receptor 10K1, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 13, subfamily J, member 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 13, subfamily J, member 1,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 13, subfamily J, member 1,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 13, subfamily J, member 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 13, subfamily J, member 1,UP_SEQ_FEATURE[850035584$chain:Olfactory receptor 13J1, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 2, subfamily M, member 3,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 2, subfamily M, member 3,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 2, subfamily M, member 3,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 2, subfamily M, member 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 2, subfamily M, member 3,UP_SEQ_FEATURE[850035689$chain:Olfactory receptor 2M3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 4, subfamily D, member 11,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 4, subfamily D, member 11,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 4, subfamily D, member 11,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 4, subfamily D, member 11,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 4, subfamily D, member 11,UP_SEQ_FEATURE[850035760$chain:Olfactory receptor 4D11, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 52, subfamily N, member 4,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 52, subfamily N, member 4,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 52, subfamily N, member 4,PIR_SUPERFAMILY[630030153$PIRSF038651:G protein-coupled olfactory receptor, class I, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 52, subfamily N, member 4,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 52, subfamily N, member 4,UP_SEQ_FEATURE[850035843$chain:Olfactory receptor 52N4, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
olfactory receptor, family 8, subfamily K, member 5,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000624$IPR000725:Olfactory receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
olfactory receptor, family 8, subfamily K, member 5,KEGG_PATHWAY[470038879$hsa04740:Olfactory transduction]
olfactory receptor, family 8, subfamily K, member 5,PIR_SUPERFAMILY[630003245$PIRSF003152:G protein-coupled olfactory receptor, class II, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
olfactory receptor, family 8, subfamily K, member 5,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001069$olfaction, 790001212$polymorphism, 790001301$receptor, 790001377$sensory transduction, 790001546$transducer, 790001555$transmembrane]
olfactory receptor, family 8, subfamily K, member 5,UP_SEQ_FEATURE[850035970$chain:Olfactory receptor 8K5, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
opsin 1 (cone pigments), medium-wave-sensitive 2; opsin 1 (cone pigments), medium-wave-sensitive,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000323$IPR000378:Opsin, red/green sensitive, 450001559$IPR001760:Opsin, 450011699$IPR013032:EGF-like region, conserved site, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
opsin 1 (cone pigments), medium-wave-sensitive 2; opsin 1 (cone pigments), medium-wave-sensitive,OMIM_DISEASE[520000633$Blue-cone monochromacy, 520001088$Colorblindness, deutan]
opsin 1 (cone pigments), medium-wave-sensitive 2; opsin 1 (cone pigments), medium-wave-sensitive,PIR_SUPERFAMILY[630030050$PIRSF038544:animal opsin, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
opsin 1 (cone pigments), medium-wave-sensitive 2; opsin 1 (cone pigments), medium-wave-sensitive,SP_PIR_KEYWORDS[790000002$3d-structure, 790000312$chromophore, 790000314$chromoprotein, 790000348$color vision, 790000356$complete proteome, 790000446$disease mutation, 790000447$disulfide bond, 790000573$fusion protein, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001171$photoreceptor, 790001172$photoreceptor protein, 790001301$receptor, 790001314$retinal, 790001315$retinal protein, 790001377$sensory transduction, 790001394$sex-linked inheritance, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein, 790001622$vision]
opsin 1 (cone pigments), medium-wave-sensitive 2; opsin 1 (cone pigments), medium-wave-sensitive,UP_SEQ_FEATURE[850022400$chain:Green-sensitive opsin, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
paired immunoglobin-like type 2 receptor alpha,INTERPRO[450003160$IPR003599:Immunoglobulin subtype, 450006486$IPR007110:Immunoglobulin-like, 450011750$IPR013106:Immunoglobulin V-set, 450012396$IPR013783:Immunoglobulin-like fold]
paired immunoglobin-like type 2 receptor alpha,SMART[760000357$SM00409:IG]
paired immunoglobin-like type 2 receptor alpha,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001363$Secreted, 790001405$signal, 790001555$transmembrane]
paired immunoglobin-like type 2 receptor alpha,UP_SEQ_FEATURE[850036728$chain:Paired immunoglobulin-like type 2 receptor alpha, 850104407$domain:Ig-like V-type, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117520$short sequence motif:ITIM motif 1, 850117521$short sequence motif:ITIM motif 2, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pappalysin 2,INTERPRO[450000373$IPR000436:Sushi/SCR/CCP, 450000694$IPR000800:Notch region, 450003484$IPR003961:Fibronectin, type III, 450005465$IPR006025:Peptidase M, neutral zinc metallopeptidases, zinc-binding site, 450008006$IPR008754:Peptidase M43B, pregnancy-associated plasma-A, 450010761$IPR011936:Myxococcus cysteine-rich repeat, 450014444$IPR016060:Complement control module]
pappalysin 2,SMART[760000003$SM00004:NL, 760000024$SM00032:CCP, 760000051$SM00060:FN3]
pappalysin 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790001212$polymorphism, 790001252$Protease, 790001304$repeat, 790001363$Secreted, 790001405$signal, 790001471$sushi, 790001648$zinc, 790001652$zymogen]
pappalysin 2,UP_SEQ_FEATURE[850036812$chain:Pappalysin-2, 850102580$compositionally biased region:Poly-Pro, 850102582$compositionally biased region:Poly-Thr, 850102883$disulfide bond, 850105416$domain:Sushi 1, 850105429$domain:Sushi 2, 850105440$domain:Sushi 3, 850105446$domain:Sushi 4, 850105447$domain:Sushi 5, 850105770$glycosylation site:N-linked (GlcNAc...), 850106244$metal ion-binding site:Zinc; catalytic, 850106259$mutagenesis site, 850113432$region of interest:Metalloprotease, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
peptidoglycan recognition protein 3,INTERPRO[450002222$IPR002502:N-acetylmuramoyl-L-alanine amidase, family 2, 450006038$IPR006619:Peptidoglycan recognition protein, metazoa/bacteria, 450013950$IPR015510:Peptidoglycan recognition protein]
peptidoglycan recognition protein 3,SMART[760000559$SM00644:Ami_2, 760000608$SM00701:PGRP]
peptidoglycan recognition protein 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000092$antibiotic, 790000100$Antimicrobial, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000763$immune response, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
peptidoglycan recognition protein 3,UP_SEQ_FEATURE[850000451$binding site:Murein, 850037597$chain:Peptidoglycan recognition protein 3, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850112570$region of interest:Interaction with murein, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118624$turn]
peptidylprolyl isomerase E (cyclophilin E),INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450001888$IPR002130:Peptidyl-prolyl cis-trans isomerase, cyclophilin-type, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014628$IPR016304:Peptidyl-prolyl cis-trans isomerase E]
peptidylprolyl isomerase E (cyclophilin E),KEGG_PATHWAY[470038818$hsa03040:Spliceosome]
peptidylprolyl isomerase E (cyclophilin E),PIR_SUPERFAMILY[630001638$PIRSF001475:peptidyl-prolyl cis-trans isomerase E, 630001639$PIRSF001475:PPI_cyclophilin_E]
peptidylprolyl isomerase E (cyclophilin E),SMART[760000328$SM00360:RRM]
peptidylprolyl isomerase E (cyclophilin E),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000810$Isomerase, 790000988$mrna processing, 790000989$mrna splicing, 790001065$nucleus, 790001339$rna-binding, 790001343$Rotamase, 790001433$Spliceosome]
peptidylprolyl isomerase E (cyclophilin E),UP_SEQ_FEATURE[850037664$chain:Peptidyl-prolyl cis-trans isomerase E, 850102565$compositionally biased region:Poly-Ala, 850105057$domain:PPIase cyclophilin-type, 850105211$domain:RRM, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn]
peroxiredoxin 2,INTERPRO[450000755$IPR000866:Alkyl hydroperoxide reductase/ Thiol specific antioxidant/ Mal allergen, 450011036$IPR012335:Thioredoxin fold, 450016249$IPR017936:Thioredoxin-like, 450017717$IPR019479:Peroxiredoxin, C-terminal]
peroxiredoxin 2,PIR_SUPERFAMILY[630000283$PIRSF000239:alkyl hydroperoxide reductase C22 protein]
peroxiredoxin 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000101$antioxidant, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000652$heme, 790001092$oxidoreductase, 790001127$peroxidase, 790001212$polymorphism, 790001302$Redox-active center]
peroxiredoxin 2,UP_SEQ_FEATURE[850000021$active site:Cysteine sulfenic acid (-SOH) intermediate, 850037897$chain:Peroxiredoxin-2, 850102883$disulfide bond, 850105478$domain:Thioredoxin, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
peroxisomal biogenesis factor 16,INTERPRO[450012514$IPR013919:Peroxisome membrane protein, Pex16]
peroxisomal biogenesis factor 16,OMIM_DISEASE[520005136$Zellweger syndrome, complementation group 9]
peroxisomal biogenesis factor 16,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000919$membrane, 790001128$peroxisome, 790001129$peroxisome biogenesis, 790001130$peroxisome biogenesis disorder, 790001212$polymorphism, 790001555$transmembrane, 790001647$zellweger syndrome]
peroxisomal biogenesis factor 16,UP_SEQ_FEATURE[850037961$chain:Peroxisomal membrane protein PEX16, 850112668$region of interest:Interaction with PEX19, 850114450$region of interest:Required for peroxisomal location, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118601$topological domain:Peroxisomal, 850118623$transmembrane region]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,SMART[760000328$SM00360:RRM]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790001065$nucleus, 790001212$polymorphism, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation]
peroxisome proliferator-activated receptor gamma, coactivator-related 1,UP_SEQ_FEATURE[850038006$chain:Peroxisome proliferator-activated receptor gamma coactivator-related protein 1, 850102404$compositionally biased region:Arg-rich, 850102586$compositionally biased region:Pro-rich, 850102597$compositionally biased region:Ser-rich, 850105211$domain:RRM, 850113602$region of interest:Necessary for interaction with CREB1 and NRF1, 850113603$region of interest:Necessary for interaction with CREB1 and NRF1 and for transcriptional coactivation, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
phenazine biosynthesis-like protein domain containing,INTERPRO[450003262$IPR003719:Phenazine biosynthesis PhzC/PhzF protein]
phenazine biosynthesis-like protein domain containing,PIR_SUPERFAMILY[630012960$PIRSF016184:PhzC_PhzF]
phenazine biosynthesis-like protein domain containing,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000810$Isomerase, 790001212$polymorphism]
phenazine biosynthesis-like protein domain containing,UP_SEQ_FEATURE[850038162$chain:Phenazine biosynthesis-like domain- containing protein, 850117294$sequence conflict, 850117295$sequence variant]
phosphatase and actin regulator 4,INTERPRO[450003537$IPR004018:RPEL repeat]
phosphatase and actin regulator 4,SMART[760000614$SM00707:RPEL]
phosphatase and actin regulator 4,SP_PIR_KEYWORDS[790000019$actin-binding, 790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001262$protein phosphatase inhibitor, 790001304$repeat]
phosphatase and actin regulator 4,UP_SEQ_FEATURE[850038305$chain:Phosphatase and actin regulator 4, 850102572$compositionally biased region:Poly-Glu, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850116934$repeat:RPEL 1, 850116935$repeat:RPEL 2, 850116936$repeat:RPEL 3, 850117294$sequence conflict, 850118574$splice variant]
phosphatidylinositol transfer protein, membrane-associated 1,INTERPRO[450001476$IPR001666:Phosphatidylinositol transfer protein, 450003687$IPR004177:DDHD, 450011846$IPR013209:LNS2, Lipin/Ned1/Smp2]
phosphatidylinositol transfer protein, membrane-associated 1,SMART[760000680$SM00775:LNS2]
phosphatidylinositol transfer protein, membrane-associated 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000871$lipid droplet, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001266$protein transport, 790001558$transport]
phosphatidylinositol transfer protein, membrane-associated 1,UP_SEQ_FEATURE[850031134$chain:Membrane-associated phosphatidylinositol transfer protein 1, 850102581$compositionally biased region:Poly-Ser, 850103504$domain:DDHD, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118574$splice variant]
phosphatidylinositol transfer protein, membrane-associated 2,INTERPRO[450001476$IPR001666:Phosphatidylinositol transfer protein, 450003687$IPR004177:DDHD, 450011846$IPR013209:LNS2, Lipin/Ned1/Smp2]
phosphatidylinositol transfer protein, membrane-associated 2,SMART[760000680$SM00775:LNS2]
phosphatidylinositol transfer protein, membrane-associated 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000876$lipid-binding, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism]
phosphatidylinositol transfer protein, membrane-associated 2,UP_SEQ_FEATURE[850031135$chain:Membrane-associated phosphatidylinositol transfer protein 2, 850102517$compositionally biased region:Gly-rich, 850103504$domain:DDHD, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
phosphatidylserine synthase 2,INTERPRO[450003786$IPR004277:Phosphatidyl serine synthase]
phosphatidylserine synthase 2,KEGG_PATHWAY[470038778$hsa00564:Glycerophospholipid metabolism]
phosphatidylserine synthase 2,PIR_SUPERFAMILY[630021735$PIRSF028874:phosphatidylserine synthase 1, eukaryotic type]
phosphatidylserine synthase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001156$phospholipid biosynthesis, 790001162$phosphoprotein, 790001547$transferase, 790001555$transmembrane]
phosphatidylserine synthase 2,UP_SEQ_FEATURE[850038498$chain:Phosphatidylserine synthase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
phosphofructokinase, platelet,INTERPRO[450000018$IPR000023:Phosphofructokinase, 450008280$IPR009161:6-phosphofructokinase, eukaryotic type, 450014330$IPR015912:Phosphofructokinase, conserved site]
phosphofructokinase, platelet,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038727$hsa00030:Pentose phosphate pathway, 470038729$hsa00051:Fructose and mannose metabolism, 470038730$hsa00052:Galactose metabolism]
phosphofructokinase, platelet,PIR_SUPERFAMILY[630000632$PIRSF000533:ATP-dependent phosphofructokinase, eukaryotic type, 630000633$PIRSF000533:ATP_PFK_euk]
phosphofructokinase, platelet,SP_PIR_KEYWORDS[790000012$acetylation, 790000045$allosteric enzyme, 790000046$allosteric regulation, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000473$duplication, 790000615$glycolysis, 790000825$kinase, 790000899$magnesium, 790000937$metal-binding, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001304$repeat, 790001498$tetramer, 790001547$transferase]
phosphofructokinase, platelet,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000555$binding site:Substrate, 850002514$chain:6-phosphofructokinase type C, 850106170$metal ion-binding site:Magnesium; via carbonyl oxygen, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict]
pitrilysin metallopeptidase 1,COG_ONTOLOGY[90000073$General function prediction only]
pitrilysin metallopeptidase 1,INTERPRO[450001273$IPR001431:Peptidase M16, zinc-binding site, 450007211$IPR007863:Peptidase M16, C-terminal, 450010145$IPR011237:Peptidase M16, core, 450012202$IPR013578:Peptidase M16C associated]
pitrilysin metallopeptidase 1,OMIM_DISEASE[520001144$Conduct disorder and ADHD: Evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study]
pitrilysin metallopeptidase 1,PIR_SUPERFAMILY[630012981$PIRSF016207:PIRSF016207]
pitrilysin metallopeptidase 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000743$hydrolase, 790000937$metal-binding, 790000941$metalloprotease, 790000969$mitochondrion, 790001212$polymorphism, 790001252$Protease, 790001550$transit peptide, 790001648$zinc]
pitrilysin metallopeptidase 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850040575$chain:Presequence protease, mitochondrial, 850102883$disulfide bond, 850106244$metal ion-binding site:Zinc; catalytic, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
platelet endothelial aggregation receptor 1,INTERPRO[450000637$IPR000742:EGF-like, type 3, 450001815$IPR002049:EGF-like, laminin, 450005636$IPR006210:EGF-like, 450010351$IPR011489:EMI domain, 450011699$IPR013032:EGF-like region, conserved site, 450011755$IPR013111:EGF, extracellular]
platelet endothelial aggregation receptor 1,SMART[760000154$SM00180:EGF_Lam, 760000155$SM00181:EGF]
platelet endothelial aggregation receptor 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000481$egf-like domain, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
platelet endothelial aggregation receptor 1,UP_SEQ_FEATURE[850039511$chain:Platelet endothelial aggregation receptor 1, 850102586$compositionally biased region:Pro-rich, 850102883$disulfide bond, 850103597$domain:EGF-like 1, 850103623$domain:EGF-like 2, 850103646$domain:EGF-like 3, 850103668$domain:EGF-like 4, 850103689$domain:EGF-like 5, 850103695$domain:EGF-like 6, 850103698$domain:EGF-like 7, 850103700$domain:EGF-like 8, 850103702$domain:EGF-like 9, 850103714$domain:EMI, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118623$transmembrane region]
platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa),INTERPRO[450000952$IPR001087:Lipase, GDSL, 450007558$IPR008265:Lipase, GDSL, active site, 450012434$IPR013831:Esterase, SGNH hydrolase-type, subgroup]
platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa),KEGG_PATHWAY[470038779$hsa00565:Ether lipid metabolism]
platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa),PIR_SUPERFAMILY[630013398$PIRSF016613:platelet-activating factor acetylhydrolase IB, beta/gamma subunits]
platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa),SP_PIR_KEYWORDS[790000241$carboxylic ester hydrolase, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790000869$lipid degradation, 790001205$platelet, 790001212$polymorphism]
platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa),UP_SEQ_FEATURE[850039535$chain:Platelet-activating factor acetylhydrolase IB subunit gamma, 850117295$sequence variant]
pleckstrin homology domain containing, family N member 1,INTERPRO[450001635$IPR001849:Pleckstrin homology]
pleckstrin homology domain containing, family N member 1,SMART[760000205$SM00233:PH]
pleckstrin homology domain containing, family N member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
pleckstrin homology domain containing, family N member 1,UP_SEQ_FEATURE[850039574$chain:Pleckstrin homology domain-containing family N member 1, 850104980$domain:PH 1, 850104981$domain:PH 2, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
poly (ADP-ribose) polymerase 1,BBID[10000063$39.Deg_of_Chromosomal_DNA]
poly (ADP-ribose) polymerase 1,BIOCARTA[30000010$h_aifPathway:Opposing roles of AIF in Apoptosis and Cell Survival, 30000048$h_caspasePathway:Caspase Cascade in Apoptosis, 30000062$h_chemicalPathway:Apoptotic Signaling in Response to DNA Damage, 30000079$h_d4gdiPathway:D4-GDI Signaling Pathway, 30000110$h_fasPathway:FAS signaling pathway ( CD95 ), 30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF, 30000297$h_tnfr1Pathway:TNFR1 Signaling Pathway]
poly (ADP-ribose) polymerase 1,INTERPRO[450001201$IPR001357:BRCT, 450001343$IPR001510:Zinc finger, PARP-type, 450003617$IPR004102:Poly(ADP-ribose) polymerase, regulatory region, 450007575$IPR008288:NAD+ ADP-ribosyltransferase, 450008134$IPR008893:WGR, 450011020$IPR012317:Poly(ADP-ribose) polymerase, catalytic region, 450011658$IPR012982:PADR1]
poly (ADP-ribose) polymerase 1,KEGG_PATHWAY[470038822$hsa03410:Base excision repair]
poly (ADP-ribose) polymerase 1,PIR_SUPERFAMILY[630000578$PIRSF000489:NAD_ADPRT]
poly (ADP-ribose) polymerase 1,SMART[760000263$SM00292:BRCT, 760000678$SM00773:WGR]
poly (ADP-ribose) polymerase 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000028$ADP-ribosylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000452$DNA damage, 790000459$dna repair, 790000466$dna-binding, 790000619$glycosyltransferase, 790000937$metal-binding, 790001006$nad, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
poly (ADP-ribose) polymerase 1,UP_SEQ_FEATURE[850039708$chain:Poly [ADP-ribose] polymerase 1, 850103153$domain:BRCT, 850104894$domain:PARP alpha-helical, 850104895$domain:PARP catalytic, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850110974$region of interest:Automodification domain, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118575$strand, 850118624$turn, 850118871$zinc finger region:PARP-type 1, 850118872$zinc finger region:PARP-type 2]
poly (ADP-ribose) polymerase family, member 11,INTERPRO[450003680$IPR004170:WWE domain, 450011020$IPR012317:Poly(ADP-ribose) polymerase, catalytic region]
poly (ADP-ribose) polymerase family, member 11,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000619$glycosyltransferase, 790001006$nad, 790001547$transferase]
poly (ADP-ribose) polymerase family, member 11,UP_SEQ_FEATURE[850039710$chain:Poly [ADP-ribose] polymerase 11, 850104895$domain:PARP catalytic, 850105736$domain:WWE, 850105852$helix, 850118574$splice variant, 850118575$strand, 850118624$turn]
poly (ADP-ribose) polymerase family, member 4,INTERPRO[450001201$IPR001357:BRCT, 450001802$IPR002035:von Willebrand factor, type A, 450003617$IPR004102:Poly(ADP-ribose) polymerase, regulatory region, 450006007$IPR006587:Vault protein inter-alpha-trypsin, metazoa, 450011020$IPR012317:Poly(ADP-ribose) polymerase, catalytic region, 450012315$IPR013694:Vault protein inter-alpha-trypsin]
poly (ADP-ribose) polymerase family, member 4,KEGG_PATHWAY[470038822$hsa03410:Base excision repair]
poly (ADP-ribose) polymerase family, member 4,SMART[760000263$SM00292:BRCT, 760000296$SM00327:VWA, 760000539$SM00609:VIT]
poly (ADP-ribose) polymerase family, member 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000619$glycosyltransferase, 790001006$nad, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001325$ribonucleoprotein, 790001547$transferase]
poly (ADP-ribose) polymerase family, member 4,UP_SEQ_FEATURE[850039719$chain:Poly [ADP-ribose] polymerase 4, 850103153$domain:BRCT, 850104894$domain:PARP alpha-helical, 850104895$domain:PARP catalytic, 850105620$domain:VIT, 850105627$domain:VWFA, 850106258$modified residue, 850112929$region of interest:Interaction with the major vault protein, 850117294$sequence conflict, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal]
polycomb group ring finger 5,COG_ONTOLOGY[90000073$General function prediction only]
polycomb group ring finger 5,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
polycomb group ring finger 5,SMART[760000158$SM00184:RING]
polycomb group ring finger 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
polycomb group ring finger 5,UP_SEQ_FEATURE[850039824$chain:Polycomb group RING finger protein 5, 850118574$splice variant, 850118911$zinc finger region:RING-type]
polymerase (RNA) II (DNA directed) polypeptide F,INTERPRO[450005543$IPR006110:RNA polymerase Rpb6, 450005544$IPR006111:DNA-directed RNA polymerase, 14 to 18 kDa subunit, 450011003$IPR012293:RNA polymerase subunit, RPB6/omega]
polymerase (RNA) II (DNA directed) polypeptide F,KEGG_PATHWAY[470038742$hsa00230:Purine metabolism, 470038744$hsa00240:Pyrimidine metabolism, 470038815$hsa03020:RNA polymerase, 470038894$hsa05016:Huntington's disease]
polymerase (RNA) II (DNA directed) polypeptide F,PIR_SUPERFAMILY[630000900$PIRSF000778:DNA-directed RNA polymerase, subunit K/RPB6 subunit, 630030417$PIRSF500154:DNA-directed RNA polymerase, RPB6 type]
polymerase (RNA) II (DNA directed) polypeptide F,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000468$dna-directed rna polymerase, 790001064$nucleotidyltransferase, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription]
polymerase (RNA) II (DNA directed) polypeptide F,UP_SEQ_FEATURE[850016115$chain:DNA-directed RNA polymerases I, II, and III subunit RPABC2, 850105852$helix, 850106258$modified residue, 850117295$sequence variant, 850118575$strand, 850118624$turn]
post-GPI attachment to proteins 2,INTERPRO[450017640$IPR019402:Frag1/DRAM/Sfk1]
post-GPI attachment to proteins 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000499$endoplasmic reticulum, 790000624$golgi apparatus, 790000629$gpi-anchor biosynthesis, 790000919$membrane, 790001555$transmembrane]
post-GPI attachment to proteins 2,UP_SEQ_FEATURE[850040025$chain:Post-GPI attachment to proteins factor 2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
potassium inwardly-rectifying channel, subfamily J, member 2,INTERPRO[450001625$IPR001838:Potassium channel, inwardly rectifying, Kir-like, 450002851$IPR003271:Potassium channel, inwardly rectifying, Kir2.1, 450012143$IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic, 450012146$IPR013521:Potassium channel, inwardly rectifying, Kir, conserved region 2, 450012294$IPR013673:Potassium channel, inwardly rectifying, Kir, N-terminal, 450014771$IPR016449:Potassium channel, inwardly rectifying, Kir]
potassium inwardly-rectifying channel, subfamily J, member 2,OMIM_DISEASE[520002947$Long QT syndrome-7, 520004466$Short QT syndrome-3]
potassium inwardly-rectifying channel, subfamily J, member 2,PIR_SUPERFAMILY[630005389$PIRSF005465:G protein-activated inward rectifier potassium channel, 630005390$PIRSF005465:GIRK_kir]
potassium inwardly-rectifying channel, subfamily J, member 2,SP_PIR_KEYWORDS[790000244$cardiac muscle, 790000356$complete proteome, 790000446$disease mutation, 790000646$heart, 790000798$ion transport, 790000799$ionic channel, 790000886$long qt syndrome, 790000919$membrane, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001401$Short QT syndrome, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport, 790001631$voltage-gated channel]
potassium inwardly-rectifying channel, subfamily J, member 2,UP_SEQ_FEATURE[850026723$chain:Inward rectifier potassium channel 2, 850106258$modified residue, 850111830$region of interest:H5 (pore-forming helix), 850117294$sequence conflict, 850117295$sequence variant, 850117634$short sequence motif:PDZ-binding, 850117700$short sequence motif:Selectivity filter, 850118552$site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
potassium inwardly-rectifying channel, subfamily J, member 9,INTERPRO[450001625$IPR001838:Potassium channel, inwardly rectifying, Kir-like, 450002856$IPR003276:Potassium channel, inwardly rectifying, Kir3.3, 450012143$IPR013518:Potassium channel, inwardly rectifying, Kir, cytoplasmic, 450012146$IPR013521:Potassium channel, inwardly rectifying, Kir, conserved region 2, 450014771$IPR016449:Potassium channel, inwardly rectifying, Kir]
potassium inwardly-rectifying channel, subfamily J, member 9,PIR_SUPERFAMILY[630005389$PIRSF005465:G protein-activated inward rectifier potassium channel, 630005390$PIRSF005465:GIRK_kir]
potassium inwardly-rectifying channel, subfamily J, member 9,SP_PIR_KEYWORDS[790000356$complete proteome, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001226$potassium, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium inwardly-rectifying channel, subfamily J, member 9,UP_SEQ_FEATURE[850020247$chain:G protein-activated inward rectifier potassium channel 3, 850111830$region of interest:H5 (pore-forming helix), 850117295$sequence variant, 850117700$short sequence motif:Selectivity filter, 850118552$site:Role in the control of polyamine-mediated channel gating and in the blocking by intracellular magnesium, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,INTERPRO[450001818$IPR002052:N-6 adenine-specific DNA methylase, conserved site, 450002716$IPR003091:Voltage-dependent potassium channel, 450003454$IPR003929:Potassium channel, calcium-activated, BK, alpha subunit, 450005268$IPR005821:Ion transport, 450011743$IPR013099:Ion transport 2, 450014426$IPR016040:NAD(P)-binding domain]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,OMIM_DISEASE[520001979$Generalized epilepsy and paroxysmal dyskinesia]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,PIR_SUPERFAMILY[630012418$PIRSF015660:calcium-activated potassium channel, alpha subunit]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000446$disease mutation, 790000509$epilepsy, 790000798$ion transport, 790000799$ionic channel, 790000899$magnesium, 790000919$membrane, 790000937$metal-binding, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium large conductance calcium-activated channel, subfamily M, alpha member 1,UP_SEQ_FEATURE[850008948$chain:Calcium-activated potassium channel subunit alpha-1, 850102573$compositionally biased region:Poly-Gly, 850102581$compositionally biased region:Poly-Ser, 850105157$domain:RCK N-terminal, 850105852$helix, 850106107$metal ion-binding site:Magnesium, 850106258$modified residue, 850106259$mutagenesis site, 850111848$region of interest:Heme-binding motif, 850114086$region of interest:Pore-forming, in membrane, 850114615$region of interest:Segment S10, 850114617$region of interest:Segment S7, 850114618$region of interest:Segment S8, 850114619$region of interest:Segment S9, 850117294$sequence conflict, 850117295$sequence variant, 850117332$short sequence motif:Calcium bowl, 850117704$short sequence motif:Selectivity for potassium, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,INTERPRO[450003455$IPR003930:Potassium channel, calcium-activated, BK, beta subunit]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,PIR_SUPERFAMILY[630014757$PIRSF018113:calcium-activated potassium channel, beta subunit, 630031023$PIRSF500875:calcium-activated potassium channel, beta 4 subunit]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
potassium large conductance calcium-activated channel, subfamily M, beta member 4,UP_SEQ_FEATURE[850008952$chain:Calcium-activated potassium channel subunit beta-4, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
profilin family, member 4,INTERPRO[450001857$IPR002097:Profilin/allergen, 450004914$IPR005455:Profilin, plant]
profilin family, member 4,KEGG_PATHWAY[470038881$hsa04810:Regulation of actin cytoskeleton]
profilin family, member 4,PIR_SUPERFAMILY[630002462$PIRSF002342:profilin]
profilin family, member 4,SMART[760000344$SM00392:PROF]
profilin family, member 4,SP_PIR_KEYWORDS[790000019$actin-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
profilin family, member 4,UP_SEQ_FEATURE[850044477$chain:Profilin-4]
progestin and adipoQ receptor family member V,BIOCARTA[30000191$h_mPRPathway:How Progesterone Initiates the Oocyte Maturation]
progestin and adipoQ receptor family member V,INTERPRO[450003761$IPR004254:Hly-III related]
progestin and adipoQ receptor family member V,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000876$lipid-binding, 790000919$membrane, 790001077$oogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001443$steroid-binding, 790001555$transmembrane]
progestin and adipoQ receptor family member V,UP_SEQ_FEATURE[850031090$chain:Membrane progestin receptor gamma, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
prokineticin 1,INTERPRO[450008624$IPR009523:Prokineticin]
prokineticin 1,SP_PIR_KEYWORDS[790000081$angiogenesis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000632$growth factor, 790000972$mitogen, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
prokineticin 1,UP_SEQ_FEATURE[850044525$chain:Prokineticin-1, 850102883$disulfide bond, 850117295$sequence variant, 850117814$signal peptide]
proliferation-associated 2G4, 38kDa; proliferation-associated 2G4 pseudogene 4,INTERPRO[450000865$IPR000994:Peptidase M24, structural domain, 450004038$IPR004545:Proliferation-associated protein 1, 450016634$IPR018349:Peptidase M24A, methionine aminopeptidase, subfamily 2, binding site]
proliferation-associated 2G4, 38kDa; proliferation-associated 2G4 pseudogene 4,PIR_SUPERFAMILY[630001270$PIRSF001120:methionine aminopeptidase]
proliferation-associated 2G4, 38kDa; proliferation-associated 2G4 pseudogene 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001325$ribonucleoprotein, 790001339$rna-binding, 790001345$rrna processing, 790001539$Transcription, 790001543$transcription regulation, 790001551$translation regulation]
proliferation-associated 2G4, 38kDa; proliferation-associated 2G4 pseudogene 4,UP_SEQ_FEATURE[850044571$chain:Proliferation-associated protein 2G4, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850112784$region of interest:Interaction with RNA, 850113681$region of interest:Necessary for nucleolar localization, 850114543$region of interest:RNA-binding, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
proline-serine-threonine phosphatase interacting protein 1,INTERPRO[450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain, 450011951$IPR013315:Spectrin alpha chain, SH3 domain]
proline-serine-threonine phosphatase interacting protein 1,KEGG_PATHWAY[470038863$hsa04621:NOD-like receptor signaling pathway]
proline-serine-threonine phosphatase interacting protein 1,OMIM_DISEASE[520004198$Pyogenic sterile arthritis, pyoderma gangrenosum, and acne]
proline-serine-threonine phosphatase interacting protein 1,SMART[760000047$SM00055:FCH, 760000295$SM00326:SH3]
proline-serine-threonine phosphatase interacting protein 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000267$cell projection, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000446$disease mutation, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
proline-serine-threonine phosphatase interacting protein 1,UP_SEQ_FEATURE[850044631$chain:Proline-serine-threonine phosphatase- interacting protein 1, 850103755$domain:FCH, 850105350$domain:SH3, 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),INTERPRO[450004592$IPR005123:Oxoglutarate and iron-dependent oxygenase, 450006039$IPR006620:Prolyl 4-hydroxylase, alpha subunit, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),SMART[760000609$SM00702:P4Hc]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000437$dioxygenase, 790000499$endoplasmic reticulum, 790000616$glycoprotein, 790000802$iron, 790000919$membrane, 790000937$metal-binding, 790001092$oxidoreductase, 790001304$repeat, 790001409$Signal-anchor, 790001555$transmembrane, 790001626$vitamin c]
prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum),UP_SEQ_FEATURE[850000176$binding site:2-oxoglutarate, 850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850065973$chain:Transmembrane prolyl 4-hydroxylase, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103759$domain:Fe2OG dioxygenase, 850105770$glycosylation site:N-linked (GlcNAc...), 850106003$metal ion-binding site:Iron, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,BIOCARTA[30000234$h_pmlPathway:Regulation of transcriptional activity by PML]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016532$IPR018247:EF-HAND 1, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038899$hsa05200:Pathways in cancer, 470038911$hsa05221:Acute myeloid leukemia]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,OMIM_DISEASE[520002850$Leukemia, acute promyelocytic, PML/RARA type]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,PIR_SUPERFAMILY[630012398$PIRSF015640:PML-1 protein]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000316$chromosomal rearrangement, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000449$DNA binding, 790000466$dna-binding, 790000733$host-virus interaction, 790000811$isopeptide bond, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001271$Proto-oncogene, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001592$ubl conjugation, 790001648$zinc, 790001651$zinc-finger]
promyelocytic leukemia; similar to promyelocytic leukemia protein isoform 1,UP_SEQ_FEATURE[850044039$chain:Probable transcription factor PML, 850102586$compositionally biased region:Pro-rich, 850102714$cross-link:Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO), 850106219$metal ion-binding site:Zinc 1, 850106226$metal ion-binding site:Zinc 2, 850106258$modified residue, 850106259$mutagenesis site, 850113810$region of interest:Nuclear localization signal, 850117294$sequence conflict, 850117295$sequence variant, 850117930$site:Breakpoint for translocation to form PML- RARA oncogene in type A APL, 850117931$site:Breakpoint for translocation to form PML- RARA oncogene in type B APL, 850118574$splice variant, 850118575$strand, 850118640$zinc finger region:B box-type 1; atypical, 850118642$zinc finger region:B box-type 2, 850118911$zinc finger region:RING-type]
prostaglandin E synthase 2,INTERPRO[450001869$IPR002109:Glutaredoxin, 450003563$IPR004046:Glutathione S-transferase, C-terminal, 450010594$IPR011767:Glutaredoxin active site, 450011036$IPR012335:Thioredoxin fold, 450016246$IPR017933:Glutathione S-transferase/chloride channel, C-terminal]
prostaglandin E synthase 2,KEGG_PATHWAY[470038780$hsa00590:Arachidonic acid metabolism]
prostaglandin E synthase 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000542$Fatty acid biosynthesis, 790000624$golgi apparatus, 790000810$Isomerase, 790000874$lipid synthesis, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001249$prostaglandin biosynthesis, 790001555$transmembrane]
prostaglandin E synthase 2,UP_SEQ_FEATURE[850044708$chain:Prostaglandin E synthase 2, 850044709$chain:Prostaglandin E synthase 2 truncated form, 850104060$domain:Glutaredoxin, 850104084$domain:GST C-terminal, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117969$site:Cleavage, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
proteasome (prosome, macropain) 26S subunit, ATPase, 5,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
proteasome (prosome, macropain) 26S subunit, ATPase, 5,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site, 450005381$IPR005937:26S proteasome subunit P45]
proteasome (prosome, macropain) 26S subunit, ATPase, 5,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) 26S subunit, ATPase, 5,SMART[760000335$SM00382:AAA]
proteasome (prosome, macropain) 26S subunit, ATPase, 5,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790001063$nucleotide-binding, 790001065$nucleus, 790001212$polymorphism, 790001254$proteasome]
proteasome (prosome, macropain) 26S subunit, ATPase, 5,UP_SEQ_FEATURE[850001249$chain:26S protease regulatory subunit 8, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
proteasome (prosome, macropain) subunit, alpha type, 5,INTERPRO[450000365$IPR000426:Proteasome, alpha-subunit, conserved site, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta]
proteasome (prosome, macropain) subunit, alpha type, 5,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, alpha type, 5,PIR_SUPERFAMILY[630001352$PIRSF001212:multicatalytic endopeptidase complex chain C9]
proteasome (prosome, macropain) subunit, alpha type, 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001252$Protease, 790001254$proteasome, 790001267$proteinase, 790001516$threonine protease]
proteasome (prosome, macropain) subunit, alpha type, 5,UP_SEQ_FEATURE[850044865$chain:Proteasome subunit alpha type-5, 850106258$modified residue, 850117294$sequence conflict]
proteasome (prosome, macropain) subunit, beta type, 10,INTERPRO[450000211$IPR000243:Peptidase T1A, proteasome beta-subunit, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta, 450014435$IPR016050:Proteasome, beta-type subunit, conserved site]
proteasome (prosome, macropain) subunit, beta type, 10,KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, beta type, 10,PIR_SUPERFAMILY[630001352$PIRSF001212:multicatalytic endopeptidase complex chain C9]
proteasome (prosome, macropain) subunit, beta type, 10,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000743$hydrolase, 790000969$mitochondrion, 790001065$nucleus, 790001252$Protease, 790001254$proteasome, 790001267$proteinase, 790001516$threonine protease, 790001652$zymogen]
proteasome (prosome, macropain) subunit, beta type, 10,UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850044880$chain:Proteasome subunit beta type-10, 850109701$propeptide:Removed in mature form, 850118005$site:Cleavage; by autocatalysis]
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2),INTERPRO[450000211$IPR000243:Peptidase T1A, proteasome beta-subunit, 450001196$IPR001353:Proteasome, alpha and beta subunits, 450001197$IPR001353:Proteasome, subunit alpha/beta, 450014435$IPR016050:Proteasome, beta-type subunit, conserved site]
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2),KEGG_PATHWAY[470038819$hsa03050:Proteasome]
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2),PIR_SUPERFAMILY[630001355$PIRSF001214:multicatalytic endopeptidase complex chain C5]
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2),SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000733$host-virus interaction, 790000743$hydrolase, 790000763$immune response, 790001065$nucleus, 790001212$polymorphism, 790001252$Protease, 790001254$proteasome, 790001267$proteinase, 790001516$threonine protease, 790001652$zymogen]
proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2),UP_SEQ_FEATURE[850000090$active site:Nucleophile, 850044897$chain:Proteasome subunit beta type-9, 850106258$modified residue, 850106259$mutagenesis site, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850118005$site:Cleavage; by autocatalysis, 850118574$splice variant]
protein kinase C and casein kinase substrate in neurons 3,INTERPRO[450000929$IPR001060:Fps/Fes/Fer/CIP4 homology, 450001294$IPR001452:Src homology-3 domain]
protein kinase C and casein kinase substrate in neurons 3,SMART[760000047$SM00055:FCH, 760000295$SM00326:SH3]
protein kinase C and casein kinase substrate in neurons 3,SP_PIR_KEYWORDS[790000264$cell membrane, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000496$Endocytosis, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001398$sh3 domain]
protein kinase C and casein kinase substrate in neurons 3,UP_SEQ_FEATURE[850046574$chain:Protein kinase C and casein kinase substrate in neurons protein 3, 850103755$domain:FCH, 850105350$domain:SH3, 850106258$modified residue, 850117295$sequence variant]
protein kinase C, delta,BIOCARTA[30000139$h_HivnefPathway:HIV-I Nef: negative effector of Fas and TNF]
protein kinase C, delta,INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450001968$IPR002219:Protein kinase C-like, phorbol ester/diacylglycerol binding, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450012956$IPR014376:Protein kinase C, delta/epsilon/eta/theta types, 450014180$IPR015745:Protein kinase C, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related, 450016207$IPR017892:Protein kinase, C-terminal]
protein kinase C, delta,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038845$hsa04270:Vascular smooth muscle contraction, 470038857$hsa04530:Tight junction, 470038871$hsa04664:Fc epsilon RI signaling pathway, 470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038877$hsa04722:Neurotrophin signaling pathway, 470038883$hsa04912:GnRH signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
protein kinase C, delta,PIR_SUPERFAMILY[630000657$PIRSF000551:PKC_delta]
protein kinase C, delta,SMART[760000096$SM00109:C1, 760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000211$SM00239:C2]
protein kinase C, delta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000134$ATP, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000473$duplication, 790000825$kinase, 790000919$membrane, 790000937$metal-binding, 790001063$nucleotide-binding, 790001147$phorbol ester binding, 790001155$phospholipid binding, 790001162$phosphoprotein, 790001168$phosphotransferase, 790001212$polymorphism, 790001304$repeat, 790001388$serine/threonine-protein kinase, 790001390$serine/threonine-specific protein kinase, 790001547$transferase, 790001648$zinc, 790001651$zinc-finger]
protein kinase C, delta,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850046576$chain:Protein kinase C delta type, 850103028$domain:AGC-kinase C-terminal, 850103199$domain:C2, 850105086$domain:Protein kinase, 850105852$helix, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant, 850118321$site:Interaction with phosphotyrosine- containing peptide, 850118575$strand, 850118624$turn, 850118893$zinc finger region:Phorbol-ester/DAG-type 1, 850118894$zinc finger region:Phorbol-ester/DAG-type 2]
protein kinase, AMP-activated, beta 2 non-catalytic subunit,INTERPRO[450006232$IPR006828:5-AMP-activated protein kinase, beta subunit, complex-interacting region]
protein kinase, AMP-activated, beta 2 non-catalytic subunit,KEGG_PATHWAY[470038882$hsa04910:Insulin signaling pathway, 470038886$hsa04920:Adipocytokine signaling pathway, 470038920$hsa05410:Hypertrophic cardiomyopathy (HCM)]
protein kinase, AMP-activated, beta 2 non-catalytic subunit,PIR_SUPERFAMILY[630028511$PIRSF037011:AMP-activated protein kinase, beta-type regulatory subunits]
protein kinase, AMP-activated, beta 2 non-catalytic subunit,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000542$Fatty acid biosynthesis, 790000874$lipid synthesis, 790001162$phosphoprotein]
protein kinase, AMP-activated, beta 2 non-catalytic subunit,UP_SEQ_FEATURE[850002143$chain:5'-AMP-activated protein kinase subunit beta-2, 850105852$helix, 850106258$modified residue, 850118575$strand, 850118624$turn]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,BIOCARTA[30000051$h_CCR3Pathway:CCR3 signaling in Eosinophils, 30000164$h_integrinPathway:Integrin Signaling Pathway, 30000196$h_myosinPathway:PKC-catalyzed phosphorylation of inhibitory phosphoprotein of myosin phosphatase, 30000218$h_Par1Pathway:Thrombin signaling and protease-activated receptors, 30000246$h_rac1Pathway:Rac 1 cell motility signaling pathway, 30000261$h_rhoPathway:Rho cell motility signaling pathway]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,INTERPRO[450001870$IPR002110:Ankyrin, 450015727$IPR017401:Protein phosphatase 1, regulatory subunit 12A/B/C, eukaryote, 450015728$IPR017401:Protein phosphatase 1, regulatory subunits 12A/B/C, eukaryote]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,KEGG_PATHWAY[470038845$hsa04270:Vascular smooth muscle contraction]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,PIR_SUPERFAMILY[630029740$PIRSF038141:PP1_12ABC_vert, 630029741$PIRSF038141:protein phosphatase 1, regulatory subunits 12A/B/C, vertebrate type]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,SMART[760000220$SM00248:ANK]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,SP_PIR_KEYWORDS[790000052$alternative promoter usage, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
protein phosphatase 1, regulatory (inhibitor) subunit 12B,UP_SEQ_FEATURE[850047255$chain:Protein phosphatase 1 regulatory subunit 12B, 850102507$compositionally biased region:Glu-rich, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850115656$repeat:ANK 5, 850117295$sequence variant, 850118574$splice variant]
protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform,INTERPRO[450000191$IPR000222:Protein phosphatase 2C,  manganese/magnesium aspartate binding site, 450001711$IPR001932:Protein phosphatase 2C-related, 450011587$IPR012911:Protein serine/threonine phosphatase 2C, C-terminal, 450012637$IPR014045:Protein phosphatase 2C, N-terminal, 450014091$IPR015655:Protein phosphatase 2C]
protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform,PIR_SUPERFAMILY[630014864$PIRSF018231:human phosphoprotein phosphatase 1A]
protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform,SMART[760000300$SM00331:PP2C_SIG, 760000301$SM00332:PP2Cc]
protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000899$magnesium, 790000906$manganese, 790000937$metal-binding, 790001162$phosphoprotein, 790001261$protein phosphatase]
protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform,UP_SEQ_FEATURE[850047277$chain:Protein phosphatase 1A, 850105852$helix, 850106174$metal ion-binding site:Manganese 1, 850106176$metal ion-binding site:Manganese 1; via carbonyl oxygen, 850106177$metal ion-binding site:Manganese 2, 850106258$modified residue, 850118574$splice variant, 850118575$strand, 850118624$turn]
protein phosphatase 4, regulatory subunit 4,INTERPRO[450000307$IPR000357:HEAT, 450010814$IPR011989:Armadillo-like helical]
protein phosphatase 4, regulatory subunit 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001304$repeat]
protein phosphatase 4, regulatory subunit 4,UP_SEQ_FEATURE[850060137$chain:Serine/threonine-protein phosphatase 4 regulatory subunit 4, 850106259$mutagenesis site, 850116140$repeat:HEAT 1, 850116152$repeat:HEAT 2, 850116162$repeat:HEAT 3, 850118574$splice variant]
protein tyrosine phosphatase, mitochondrial 1,INTERPRO[450000291$IPR000340:Dual specificity phosphatase, catalytic domain, 450000292$IPR000340:Protein-tyrosine phosphatase, dual specificity, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, mitochondrial 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000743$hydrolase, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001261$protein phosphatase, 790001550$transit peptide]
protein tyrosine phosphatase, mitochondrial 1,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850048625$chain:Protein-tyrosine phosphatase mitochondrial 1, 850105593$domain:Tyrosine-protein phosphatase, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),BIOCARTA[30000110$h_fasPathway:FAS signaling pathway ( CD95 )]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000257$IPR000299:FERM domain, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450001316$IPR001478:PDZ/DHR/GLGF, 450010003$IPR011019:KIND, 450010818$IPR011993:Pleckstrin homology-type, 450010931$IPR012153:Protein-tyrosine phosphatase, non-receptor type-13, 450012944$IPR014352:FERM/acyl-CoA-binding protein, 3-helical bundle, 450014489$IPR016130:Protein-tyrosine phosphatase, active site, 450017249$IPR018979:FERM, N-terminal, 450017250$IPR018980:FERM, C-terminal PH-like domain, 450017984$IPR019747:FERM conserved site, 450017985$IPR019748:FERM central domain, 450017986$IPR019749:Band 4.1 domain, 450017987$IPR019750:Band 4.1 subgroup]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),PIR_SUPERFAMILY[630001080$PIRSF000933:non-receptor tyrosine-protein phosphatase, type 13, 630001081$PIRSF000933:Tyr-Ptase_nr13]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),SMART[760000168$SM00194:PTPc, 760000200$SM00228:PDZ, 760000266$SM00295:B41, 760000656$SM00750:KIND]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000743$hydrolase, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase),UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067649$chain:Tyrosine-protein phosphatase non-receptor type 13, 850102576$compositionally biased region:Poly-Leu, 850102581$compositionally biased region:Poly-Ser, 850103760$domain:FERM, 850104540$domain:KIND, 850104919$domain:PDZ 1, 850104924$domain:PDZ 2, 850104925$domain:PDZ 3, 850104926$domain:PDZ 4, 850104927$domain:PDZ 5, 850105593$domain:Tyrosine-protein phosphatase, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
protein tyrosine phosphatase, non-receptor type 23,COG_ONTOLOGY[90000025$Cell division and chromosome partitioning]
protein tyrosine phosphatase, non-receptor type 23,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450003837$IPR004328:BRO1, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, non-receptor type 23,SMART[760000168$SM00194:PTPc]
protein tyrosine phosphatase, non-receptor type 23,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790000743$hydrolase, 790001162$phosphoprotein, 790001212$polymorphism, 790001261$protein phosphatase, 790001304$repeat, 790001537$tpr repeat]
protein tyrosine phosphatase, non-receptor type 23,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850067656$chain:Tyrosine-protein phosphatase non-receptor type 23, 850102586$compositionally biased region:Pro-rich, 850103165$domain:BRO1, 850105593$domain:Tyrosine-protein phosphatase, 850106258$modified residue, 850110569$region of interest:6 X 2 AA approximate tandem repeats of P- Q, 850111885$region of interest:His, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117294$sequence conflict, 850117295$sequence variant]
protein tyrosine phosphatase, receptor type, B,BIOCARTA[30000276$h_spryPathway:Sprouty regulation of tyrosine kinase signals]
protein tyrosine phosphatase, receptor type, B,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450000667$IPR000772:Ricin B lectin, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, receptor type, B,KEGG_PATHWAY[470038856$hsa04520:Adherens junction]
protein tyrosine phosphatase, receptor type, B,PIR_SUPERFAMILY[630002145$PIRSF002007:protein-tyrosine-phosphatase, receptor type beta]
protein tyrosine phosphatase, receptor type, B,SMART[760000051$SM00060:FN3, 760000168$SM00194:PTPc, 760000403$SM00458:RICIN]
protein tyrosine phosphatase, receptor type, B,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000081$angiogenesis, 790000356$complete proteome, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, B,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850000555$binding site:Substrate, 850056940$chain:Receptor-type tyrosine-protein phosphatase beta, 850103800$domain:Fibronectin type-III 1, 850103801$domain:Fibronectin type-III 10, 850103812$domain:Fibronectin type-III 11, 850103823$domain:Fibronectin type-III 12, 850103835$domain:Fibronectin type-III 13, 850103843$domain:Fibronectin type-III 14, 850103844$domain:Fibronectin type-III 15, 850103845$domain:Fibronectin type-III 16, 850103846$domain:Fibronectin type-III 17, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850103905$domain:Fibronectin type-III 7, 850103917$domain:Fibronectin type-III 8, 850103930$domain:Fibronectin type-III 9, 850105593$domain:Tyrosine-protein phosphatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
protein tyrosine phosphatase, receptor type, F,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450003159$IPR003598:Immunoglobulin subtype 2, 450003484$IPR003961:Fibronectin, type III, 450003485$IPR003962:Fibronectin, type III subdomain, 450006486$IPR007110:Immunoglobulin-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450011742$IPR013098:Immunoglobulin I-set, 450012396$IPR013783:Immunoglobulin-like fold, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, receptor type, F,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038856$hsa04520:Adherens junction, 470038882$hsa04910:Insulin signaling pathway]
protein tyrosine phosphatase, receptor type, F,PIR_SUPERFAMILY[630002140$PIRSF002002:leukocyte antigen-related receptor-type tyrosine-protein phosphatases]
protein tyrosine phosphatase, receptor type, F,SMART[760000051$SM00060:FN3, 760000168$SM00194:PTPc, 760000356$SM00408:IGc2]
protein tyrosine phosphatase, receptor type, F,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000447$disulfide bond, 790000616$glycoprotein, 790000743$hydrolase, 790000768$Immunoglobulin domain, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, F,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850056944$chain:Receptor-type tyrosine-protein phosphatase F, 850102883$disulfide bond, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850103905$domain:Fibronectin type-III 7, 850103917$domain:Fibronectin type-III 8, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850105594$domain:Tyrosine-protein phosphatase 1, 850105595$domain:Tyrosine-protein phosphatase 2, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
protein tyrosine phosphatase, receptor type, J,INTERPRO[450000210$IPR000242:Protein-tyrosine phosphatase, receptor/non-receptor type, 450000330$IPR000387:Dual-specific/protein-tyrosine phosphatase, conserved region, 450000331$IPR000387:Protein-tyrosine phosphatase, 450003484$IPR003961:Fibronectin, type III, 450008173$IPR008957:Fibronectin, type III-like fold, 450014489$IPR016130:Protein-tyrosine phosphatase, active site]
protein tyrosine phosphatase, receptor type, J,KEGG_PATHWAY[470038856$hsa04520:Adherens junction]
protein tyrosine phosphatase, receptor type, J,OMIM_DISEASE[520001084$Colon cancer, somatic]
protein tyrosine phosphatase, receptor type, J,PIR_SUPERFAMILY[630002138$PIRSF001999:protein-tyrosine-phosphatase, receptor type J]
protein tyrosine phosphatase, receptor type, J,SMART[760000051$SM00060:FN3, 760000168$SM00194:PTPc]
protein tyrosine phosphatase, receptor type, J,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000743$hydrolase, 790000919$membrane, 790001162$phosphoprotein, 790001164$phosphoric monoester hydrolase, 790001212$polymorphism, 790001261$protein phosphatase, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein, 790001587$tyrosine-specific phosphatase]
protein tyrosine phosphatase, receptor type, J,UP_SEQ_FEATURE[850000106$active site:Phosphocysteine intermediate, 850056943$chain:Receptor-type tyrosine-protein phosphatase eta, 850103800$domain:Fibronectin type-III 1, 850103849$domain:Fibronectin type-III 2, 850103860$domain:Fibronectin type-III 3, 850103871$domain:Fibronectin type-III 4, 850103882$domain:Fibronectin type-III 5, 850103893$domain:Fibronectin type-III 6, 850103905$domain:Fibronectin type-III 7, 850103917$domain:Fibronectin type-III 8, 850103930$domain:Fibronectin type-III 9, 850105593$domain:Tyrosine-protein phosphatase, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region, 850118624$turn]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,INTERPRO[450001470$IPR001660:Sterile alpha motif SAM, 450010372$IPR011510:Sterile alpha motif homology 2]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,PIR_SUPERFAMILY[630018477$PIRSF022556:LAR-interacting protein]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,SMART[760000399$SM00454:SAM]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat]
protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 2,UP_SEQ_FEATURE[850028886$chain:Liprin-alpha-2, 850102507$compositionally biased region:Glu-rich, 850102568$compositionally biased region:Poly-Asp, 850105250$domain:SAM 1, 850105251$domain:SAM 2, 850105252$domain:SAM 3, 850106258$modified residue]
prune homolog (Drosophila),COG_ONTOLOGY[90000064$Energy production and conversion]
prune homolog (Drosophila),INTERPRO[450001477$IPR001667:Phosphoesterase, RecJ-like, 450003612$IPR004097:DHHA2, 450016388$IPR018087:Glycoside hydrolase, family 5, conserved site]
prune homolog (Drosophila),KEGG_PATHWAY[470038742$hsa00230:Purine metabolism]
prune homolog (Drosophila),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000263$cell junction, 790000356$complete proteome, 790000407$cytoplasm, 790000743$hydrolase, 790000906$manganese, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism]
prune homolog (Drosophila),UP_SEQ_FEATURE[850047395$chain:Protein prune homolog, 850106174$metal ion-binding site:Manganese 1, 850106177$metal ion-binding site:Manganese 2, 850106259$mutagenesis site, 850111619$region of interest:Essential for homodimerization, 850117294$sequence conflict, 850117295$sequence variant, 850117414$short sequence motif:DHH motif, 850118574$splice variant]
pumilio homolog 1 (Drosophila),INTERPRO[450001156$IPR001313:Pumilio RNA-binding region, 450010814$IPR011989:Armadillo-like helical]
pumilio homolog 1 (Drosophila),SMART[760000017$SM00025:Pumilio]
pumilio homolog 1 (Drosophila),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001339$rna-binding, 790001551$translation regulation]
pumilio homolog 1 (Drosophila),UP_SEQ_FEATURE[850048937$chain:Pumilio homolog 1, 850102378$compositionally biased region:Ala-rich, 850102485$compositionally biased region:Gln-rich, 850102597$compositionally biased region:Ser-rich, 850105124$domain:PUM-HD, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850116868$repeat:Pumilio 1, 850116869$repeat:Pumilio 2, 850116870$repeat:Pumilio 3, 850116871$repeat:Pumilio 4, 850116872$repeat:Pumilio 5, 850116873$repeat:Pumilio 6, 850116874$repeat:Pumilio 7, 850116875$repeat:Pumilio 8, 850117294$sequence conflict, 850118574$splice variant, 850118624$turn]
purinergic receptor P2Y, G-protein coupled, 2,BIOCARTA[30000166$h_ionPathway:Ion Channel and Phorbal Esters Signaling Pathway]
purinergic receptor P2Y, G-protein coupled, 2,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000306$IPR000356:P2U purinoceptor, 450002032$IPR002286:P2 purinoceptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
purinergic receptor P2Y, G-protein coupled, 2,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
purinergic receptor P2Y, G-protein coupled, 2,PIR_SUPERFAMILY[630005369$PIRSF005445:P2Y purinoceptors 1/2/3/4/6, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
purinergic receptor P2Y, G-protein coupled, 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000447$disulfide bond, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
purinergic receptor P2Y, G-protein coupled, 2,UP_SEQ_FEATURE[850036628$chain:P2Y purinoceptor 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
pyruvate dehydrogenase (lipoamide) beta,INTERPRO[450004931$IPR005475:Transketolase, central region, 450004932$IPR005476:Transketolase, C-terminal, 450014353$IPR015941:Transketolase C-terminal-like]
pyruvate dehydrogenase (lipoamide) beta,KEGG_PATHWAY[470038725$hsa00010:Glycolysis / Gluconeogenesis, 470038726$hsa00020:Citrate cycle (TCA cycle), 470038749$hsa00290:Valine, leucine and isoleucine biosynthesis, 470038787$hsa00620:Pyruvate metabolism, 470038790$hsa00650:Butanoate metabolism]
pyruvate dehydrogenase (lipoamide) beta,OMIM_DISEASE[520004204$Pyruvate dehydrogenase E1-beta deficiency]
pyruvate dehydrogenase (lipoamide) beta,PIR_SUPERFAMILY[630000183$PIRSF000155:pyruvate dehydrogenase, E1 component, beta subunit]
pyruvate dehydrogenase (lipoamide) beta,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000445$direct protein sequencing, 790000446$disease mutation, 790000559$Flavoprotein, 790000615$glycolysis, 790000686$heterotetramer, 790000969$mitochondrion, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001212$polymorphism, 790001294$pyruvate, 790001500$thiamin pyrophosphate, 790001503$thiamine pyrophosphate, 790001550$transit peptide]
pyruvate dehydrogenase (lipoamide) beta,UP_SEQ_FEATURE[850000585$binding site:Thiamine pyrophosphate, 850056392$chain:Pyruvate dehydrogenase E1 component subunit beta, mitochondrial, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
ras responsive element binding protein 1,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
ras responsive element binding protein 1,SMART[760000323$SM00355:ZnF_C2H2]
ras responsive element binding protein 1,SP_PIR_KEYWORDS[790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
ras responsive element binding protein 1,UP_SEQ_FEATURE[850056861$chain:Ras-responsive element-binding protein 1, 850102580$compositionally biased region:Poly-Pro, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118666$zinc finger region:C2H2-type 13, 850118669$zinc finger region:C2H2-type 14, 850118671$zinc finger region:C2H2-type 15, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
remodeling and spacing factor 1,INTERPRO[450001740$IPR001965:Zinc finger, PHD-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
remodeling and spacing factor 1,SMART[760000221$SM00249:PHD]
remodeling and spacing factor 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000311$chromatin regulator, 790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
remodeling and spacing factor 1,UP_SEQ_FEATURE[850057163$chain:Remodeling and spacing factor 1, 850102404$compositionally biased region:Arg-rich, 850102507$compositionally biased region:Glu-rich, 850102565$compositionally biased region:Poly-Ala, 850102572$compositionally biased region:Poly-Glu, 850103505$domain:DDT, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118877$zinc finger region:PHD-type]
resistance to inhibitors of cholinesterase 8 homolog A (C. elegans),INTERPRO[450007654$IPR008376:Synembryn, 450017556$IPR019318:Guanine nucleotide exchange factor, Ric8]
resistance to inhibitors of cholinesterase 8 homolog A (C. elegans),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000641$guanine-nucleotide releasing factor, 790001162$phosphoprotein]
resistance to inhibitors of cholinesterase 8 homolog A (C. elegans),UP_SEQ_FEATURE[850063240$chain:Synembryn-A, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
rhomboid domain containing 2,INTERPRO[450002317$IPR002610:Peptidase S54, rhomboid]
rhomboid domain containing 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
rhomboid domain containing 2,UP_SEQ_FEATURE[850057628$chain:Rhomboid domain-containing protein 2, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
ribonuclease P/MRP 25kDa subunit,INTERPRO[450002463$IPR002775:Alba, DNA/RNA-binding protein]
ribonuclease P/MRP 25kDa subunit,PIR_SUPERFAMILY[630028043$PIRSF036571:RNase P, p25 subunit]
ribonuclease P/MRP 25kDa subunit,SP_PIR_KEYWORDS[790000356$complete proteome, 790000743$hydrolase, 790001065$nucleus, 790001162$phosphoprotein, 790001339$rna-binding, 790001572$trna processing]
ribonuclease P/MRP 25kDa subunit,UP_SEQ_FEATURE[850057737$chain:Ribonuclease P protein subunit p25, 850106258$modified residue, 850117294$sequence conflict]
ribonuclease T2,INTERPRO[450001394$IPR001568:Ribonuclease T2, 450016476$IPR018188:Ribonuclease T2, active site]
ribonuclease T2,PIR_SUPERFAMILY[630001172$PIRSF001016:ribonuclease, T2 type]
ribonuclease T2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000447$disulfide bond, 790000498$Endonuclease, 790000616$glycoprotein, 790000743$hydrolase, 790001049$nuclease, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
ribonuclease T2,UP_SEQ_FEATURE[850057788$chain:Ribonuclease T2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
ribonuclease, RNase K,SP_PIR_KEYWORDS[790000356$complete proteome, 790000498$Endonuclease, 790000743$hydrolase, 790000919$membrane, 790001049$nuclease, 790001555$transmembrane]
ribonuclease, RNase K,UP_SEQ_FEATURE[850057719$chain:Ribonuclease kappa, 850118623$transmembrane region]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,INTERPRO[450001225$IPR001380:Ribosomal protein L13e, 450016541$IPR018256:Ribosomal protein L13e, conserved site]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,PIR_SUPERFAMILY[630002353$PIRSF002221:ribosomal protein L13]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000411$cytosol, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001325$ribonucleoprotein, 790001329$ribosomal protein, 790001330$ribosome]
ribosomal protein L13 pseudogene 12; ribosomal protein L13,UP_SEQ_FEATURE[850002608$chain:60S ribosomal protein L13, 850106258$modified residue, 850117295$sequence variant]
ribosomal protein L26-like 1,INTERPRO[450005210$IPR005756:Ribosomal protein L26, eukaryotic/archaeal, 450005271$IPR005824:KOW, 450005272$IPR005825:Ribosomal protein L24/L26, conserved site, 450013175$IPR014723:Ribosomal protein L24, SH3-like]
ribosomal protein L26-like 1,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L26-like 1,PIR_SUPERFAMILY[630002335$PIRSF002204:ribosomal protein L26]
ribosomal protein L26-like 1,SMART[760000645$SM00739:KOW]
ribosomal protein L26-like 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
ribosomal protein L26-like 1,UP_SEQ_FEATURE[850002697$chain:60S ribosomal protein L26-like 1]
ribosomal protein L27a,INTERPRO[450001051$IPR001196:Ribosomal protein L15]
ribosomal protein L27a,KEGG_PATHWAY[470038813$hsa03010:Ribosome]
ribosomal protein L27a,PIR_SUPERFAMILY[630002306$PIRSF002174:ribosomal protein, 15L type, 630030997$PIRSF500843:60S ribosomal protein L27a]
ribosomal protein L27a,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001325$ribonucleoprotein, 790001329$ribosomal protein]
ribosomal protein L27a,UP_SEQ_FEATURE[850002705$chain:60S ribosomal protein L27a, 850106258$modified residue]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,INTERPRO[450000618$IPR000719:Protein kinase, core, 450001492$IPR001683:Phox-like, 450006694$IPR007330:MIT, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,SMART[760000282$SM00312:PX, 760000651$SM00745:MIT]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000825$kinase, 790000919$membrane, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001329$ribosomal protein, 790001388$serine/threonine-protein kinase, 790001547$transferase]
ribosomal protein S6 kinase, 52kDa, polypeptide 1,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850057908$chain:Ribosomal protein S6 kinase delta-1, 850104790$domain:MIT, 850105087$domain:Protein kinase 1, 850105088$domain:Protein kinase 2, 850105129$domain:PX, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117294$sequence conflict, 850117295$sequence variant]
ring finger protein 146,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450003680$IPR004170:WWE domain, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450016422$IPR018123:WWE domain, subgroup, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 146,OMIM_DISEASE[520002020$Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33]
ring finger protein 146,SMART[760000158$SM00184:RING, 760000589$SM00678:WWE]
ring finger protein 146,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 146,UP_SEQ_FEATURE[850058187$chain:RING finger protein 146, 850105736$domain:WWE, 850105852$helix, 850117294$sequence conflict, 850118574$splice variant, 850118575$strand, 850118624$turn, 850118911$zinc finger region:RING-type]
ring finger protein 5; ring finger protein 5 pseudogene 1,INTERPRO[450001628$IPR001841:Zinc finger, RING-type, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
ring finger protein 5; ring finger protein 5 pseudogene 1,SMART[760000158$SM00184:RING]
ring finger protein 5; ring finger protein 5 pseudogene 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000859$ligase, 790000919$membrane, 790000937$metal-binding, 790001555$transmembrane, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ring finger protein 5; ring finger protein 5 pseudogene 1,UP_SEQ_FEATURE[850016727$chain:E3 ubiquitin-protein ligase RNF5, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850118623$transmembrane region, 850118911$zinc finger region:RING-type]
secretoglobin, family 2A, member 2,INTERPRO[450003185$IPR003627:Mammaglobin/Prostatein, 450005477$IPR006038:Uteroglobin-like superfamily, 450005478$IPR006039:Uteroglobin-like family, 450014487$IPR016126:Secretoglobin]
secretoglobin, family 2A, member 2,PIR_SUPERFAMILY[630002653$PIRSF002537:uteroglobin]
secretoglobin, family 2A, member 2,SMART[760000084$SM00096:UTG]
secretoglobin, family 2A, member 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790001405$signal]
secretoglobin, family 2A, member 2,UP_SEQ_FEATURE[850030348$chain:Mammaglobin-A, 850105770$glycosylation site:N-linked (GlcNAc...), 850117814$signal peptide, 850118574$splice variant]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G,INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450001920$IPR002165:Plexin, 450003160$IPR003599:Immunoglobulin subtype, 450003205$IPR003659:Plexin/semaphorin/integrin, 450006486$IPR007110:Immunoglobulin-like, 450012396$IPR013783:Immunoglobulin-like fold, 450014355$IPR015943:WD40/YVTN repeat-like]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G,PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G,SMART[760000357$SM00409:IG, 760000369$SM00423:PSI, 760000545$SM00630:Sema]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000768$Immunoglobulin domain, 790000919$membrane, 790001016$neurogenesis, 790001162$phosphoprotein, 790001405$signal, 790001555$transmembrane]
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G,UP_SEQ_FEATURE[850059305$chain:Semaphorin-4G, 850102580$compositionally biased region:Poly-Pro, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105091$domain:PSI, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D,INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450001920$IPR002165:Plexin, 450003205$IPR003659:Plexin/semaphorin/integrin, 450014355$IPR015943:WD40/YVTN repeat-like]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D,KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D,PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D,SMART[760000369$SM00423:PSI, 760000545$SM00630:Sema]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001016$neurogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001405$signal, 790001555$transmembrane]
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D,UP_SEQ_FEATURE[850059311$chain:Semaphorin-6D, 850102883$disulfide bond, 850105091$domain:PSI, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),INTERPRO[450001441$IPR001627:Semaphorin/CD100 antigen, 450001920$IPR002165:Plexin, 450003160$IPR003599:Immunoglobulin subtype, 450003205$IPR003659:Plexin/semaphorin/integrin, 450006486$IPR007110:Immunoglobulin-like, 450014355$IPR015943:WD40/YVTN repeat-like]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),KEGG_PATHWAY[470038851$hsa04360:Axon guidance]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),OMIM_DISEASE[520000602$Blood group, John-Milton-Hagen]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),PIR_SUPERFAMILY[630005453$PIRSF005526:semaphorin]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),SMART[760000357$SM00409:IG, 760000369$SM00423:PSI, 760000545$SM00630:Sema]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790000447$disulfide bond, 790000616$glycoprotein, 790000628$gpi-anchor, 790000768$Immunoglobulin domain, 790000881$lipoprotein, 790000919$membrane, 790001016$neurogenesis, 790001212$polymorphism, 790001405$signal]
semaphorin 7A, GPI membrane anchor (John Milton Hagen blood group),UP_SEQ_FEATURE[850059312$chain:Semaphorin-7A, 850102883$disulfide bond, 850104355$domain:Ig-like C2-type, 850105337$domain:Sema, 850105770$glycosylation site:N-linked (GlcNAc...), 850105855$lipid moiety-binding region:GPI-anchor amidated alanine, 850109701$propeptide:Removed in mature form, 850117295$sequence variant, 850117335$short sequence motif:Cell attachment site, 850117814$signal peptide]
serpin peptidase inhibitor, clade B (ovalbumin), member 2,BIOCARTA[30000113$h_fibrinolysisPathway:Fibrinolysis Pathway]
serpin peptidase inhibitor, clade B (ovalbumin), member 2,INTERPRO[450000186$IPR000215:Protease inhibitor I4, serpin, 450013996$IPR015556:Protease inhibitor I4, serpin, plasminogen activator inhibitor-2]
serpin peptidase inhibitor, clade B (ovalbumin), member 2,PIR_SUPERFAMILY[630001798$PIRSF001630:serpin]
serpin peptidase inhibitor, clade B (ovalbumin), member 2,SMART[760000081$SM00093:SERPIN]
serpin peptidase inhibitor, clade B (ovalbumin), member 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790001200$Plasminogen activation, 790001212$polymorphism, 790001253$protease inhibitor, 790001363$Secreted, 790001385$Serine protease inhibitor, 790001405$signal]
serpin peptidase inhibitor, clade B (ovalbumin), member 2,UP_SEQ_FEATURE[850039472$chain:Plasminogen activator inhibitor 2, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118488$site:Reactive bond, 850118575$strand, 850118624$turn]
seryl-tRNA synthetase 2, mitochondrial,INTERPRO[450002058$IPR002314:Aminoacyl-tRNA synthetase, class II (G, H, P and S), conserved region, 450002061$IPR002317:Seryl-tRNA synthetase, class IIa, 450005622$IPR006195:Aminoacyl-tRNA synthetase, class II, conserved region, 450014289$IPR015866:Seryl-tRNA synthetase, class IIa, N-terminal, 450016448$IPR018156:Seryl-tRNA synthetase, class IIa, C-terminal]
seryl-tRNA synthetase 2, mitochondrial,KEGG_PATHWAY[470038807$hsa00970:Aminoacyl-tRNA biosynthesis]
seryl-tRNA synthetase 2, mitochondrial,PIR_SUPERFAMILY[630001697$PIRSF001529:Ser-tRNA-synth_IIa, 630001698$PIRSF001529:serine-tRNA ligase]
seryl-tRNA synthetase 2, mitochondrial,SP_PIR_KEYWORDS[790000012$acetylation, 790000066$Aminoacyl-tRNA synthetase, 790000138$atp-binding, 790000356$complete proteome, 790000859$ligase, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001255$protein biosynthesis, 790001550$transit peptide]
seryl-tRNA synthetase 2, mitochondrial,UP_SEQ_FEATURE[850000250$binding site:ATP; via carbonyl oxygen and amide nitrogen, 850000548$binding site:Serine, 850060439$chain:Seryl-tRNA synthetase, mitochondrial, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850114635$region of interest:Serine binding, 850117295$sequence variant, 850118617$transit peptide:Mitochondrion]
sestrin 2,INTERPRO[450006137$IPR006730:PA26 p53-induced protein (sestrin)]
sestrin 2,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
sestrin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism]
sestrin 2,UP_SEQ_FEATURE[850060442$chain:Sestrin-2, 850117295$sequence variant]
sideroflexin 2,INTERPRO[450004176$IPR004686:Tricarboxylate/iron carrier]
sideroflexin 2,PIR_SUPERFAMILY[630008487$PIRSF009336:probable membrane protein]
sideroflexin 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000798$ion transport, 790000802$iron, 790000805$iron transport, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane, 790001558$transport]
sideroflexin 2,UP_SEQ_FEATURE[850060715$chain:Sideroflexin-2, 850117294$sequence conflict, 850118623$transmembrane region]
signal peptidase complex subunit 2 homolog (S. cerevisiae); signal peptidase complex subunit 2 homolog pseudogene,INTERPRO[450008676$IPR009582:Microsomal signal peptidase 25 kDa subunit]
signal peptidase complex subunit 2 homolog (S. cerevisiae); signal peptidase complex subunit 2 homolog pseudogene,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000445$direct protein sequencing, 790000499$endoplasmic reticulum, 790000743$hydrolase, 790000919$membrane, 790000959$microsome, 790001252$Protease, 790001555$transmembrane]
signal peptidase complex subunit 2 homolog (S. cerevisiae); signal peptidase complex subunit 2 homolog pseudogene,UP_SEQ_FEATURE[850060751$chain:Signal peptidase complex subunit 2, 850106258$modified residue, 850117294$sequence conflict, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
silver homolog (mouse),INTERPRO[450000513$IPR000601:PKD]
silver homolog (mouse),PIR_SUPERFAMILY[630012826$PIRSF016053:PIRSF016053]
silver homolog (mouse),SMART[760000077$SM00089:PKD]
silver homolog (mouse),SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000329$cleavage on pair of basic residues, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000499$endoplasmic reticulum, 790000501$endosome, 790000616$glycoprotein, 790000624$golgi apparatus, 790000916$Melanin biosynthesis, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001363$Secreted, 790001402$sialic acid, 790001405$signal, 790001555$transmembrane]
silver homolog (mouse),UP_SEQ_FEATURE[850029440$chain:M-alpha, 850029441$chain:M-beta, 850031001$chain:Melanocyte protein Pmel 17, 850105002$domain:PKD, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850109737$region of interest:10 X 13 AA approximate tandem repeats, RPT domain, 850115074$repeat:1, 850115131$repeat:10, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850115506$repeat:5, 850115534$repeat:6, 850115553$repeat:7, 850115571$repeat:8, 850115588$repeat:9, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),INTERPRO[450017580$IPR019342:NADH:ubiquinone oxidoreductase, subunit 5]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),KEGG_PATHWAY[470038741$hsa00190:Oxidative phosphorylation, 470038891$hsa05010:Alzheimer's disease, 470038892$hsa05012:Parkinson's disease, 470038894$hsa05016:Huntington's disease]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),PIR_SUPERFAMILY[630019062$PIRSF023963:NADH dehydrogenase [ubiquinone] (complex I), iron-sulfur subunit 5]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),SP_PIR_KEYWORDS[790000356$complete proteome, 790000489$electron transport, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001309$respiratory chain, 790001558$transport, 790001589$ubiquinone]
similar to NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase); NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase),UP_SEQ_FEATURE[850033549$chain:NADH dehydrogenase [ubiquinone] iron- sulfur protein 5]
similar to Putative uncharacterized protein C6orf99; chromosome 6 open reading frame 99,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
similar to Putative uncharacterized protein C6orf99; chromosome 6 open reading frame 99,UP_SEQ_FEATURE[850055318$chain:Putative uncharacterized protein C6orf99, 850118574$splice variant]
similar to solute carrier family 35, member E2,INTERPRO[450004330$IPR004853:Protein of unknown function DUF250]
similar to solute carrier family 35, member E2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
similar to solute carrier family 35, member E2,UP_SEQ_FEATURE[850061443$chain:Solute carrier family 35 member E2, 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae),INTERPRO[450002639$IPR003000:NAD-dependent histone deacetylase, silent information regulator Sir2, 450015652$IPR017328:NAD-dependent deacetylase sirtuin-2, eukaryota]
sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae),PIR_SUPERFAMILY[630029504$PIRSF037938:NAD-dependent deacetylase sirtuin-2, eukaryotic type, 630029505$PIRSF037938:SIR2_euk]
sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae),SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000743$hydrolase, 790000937$metal-binding, 790000969$mitochondrion, 790001006$nad, 790001212$polymorphism, 790001550$transit peptide, 790001648$zinc]
sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae),UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850033493$chain:NAD-dependent deacetylase sirtuin-3, mitochondrial, 850103506$domain:Deacetylase sirtuin-type, 850105852$helix, 850106218$metal ion-binding site:Zinc, 850106259$mutagenesis site, 850106301$nucleotide phosphate-binding region:NAD, 850117295$sequence variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),INTERPRO[450006867$IPR007513:Four F5 protein]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome]
small EDRK-rich factor 1A (telomeric); small EDRK-rich factor 1B (centromeric),UP_SEQ_FEATURE[850060991$chain:Small EDRK-rich factor 1, 850118574$splice variant]
small proline-rich protein 2D,INTERPRO[450002847$IPR003267:Small proline-rich]
small proline-rich protein 2D,SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790000822$keratinization, 790001212$polymorphism, 790001304$repeat]
small proline-rich protein 2D,UP_SEQ_FEATURE[850061037$chain:Small proline-rich protein 2D, 850110281$region of interest:3 X 9 AA tandem repeats of P-K-C-P-[EQ]- P-C-P-[PS], 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117294$sequence conflict, 850117295$sequence variant]
solute carrier family 22 (organic anion transporter), member 6,INTERPRO[450004237$IPR004749:Organic cation transport protein, 450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion transporter), member 6,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
solute carrier family 22 (organic anion transporter), member 6,UP_SEQ_FEATURE[850061405$chain:Solute carrier family 22 member 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118265$site:Important for interaction with cidofovir, 850118266$site:Important for interaction with cidofovir and PAH, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 22 (organic anion transporter), member 8,INTERPRO[450004237$IPR004749:Organic cation transport protein, 450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion transporter), member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000426$Detoxification, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 22 (organic anion transporter), member 8,UP_SEQ_FEATURE[850061409$chain:Solute carrier family 22 member 8, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 22 (organic anion/urate transporter), member 12,INTERPRO[450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22 (organic anion/urate transporter), member 12,OMIM_DISEASE[520002574$Hypouricemia, renal]
solute carrier family 22 (organic anion/urate transporter), member 12,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane, 790001558$transport]
solute carrier family 22 (organic anion/urate transporter), member 12,UP_SEQ_FEATURE[850061388$chain:Solute carrier family 22 member 12, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
solute carrier family 22, member 17,INTERPRO[450001257$IPR001412:Aminoacyl-tRNA synthetase, class I, conserved site, 450005276$IPR005829:Sugar transporter, conserved site, 450010529$IPR011701:Major facilitator superfamily MFS-1]
solute carrier family 22, member 17,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001555$transmembrane, 790001558$transport]
solute carrier family 22, member 17,UP_SEQ_FEATURE[850061394$chain:Solute carrier family 22 member 17, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
solute carrier family 25 (mitochondrial carrier: glutamate), member 22,BIOCARTA[30000260$h_rhodopsinPathway:Visual Signal Transduction]
solute carrier family 25 (mitochondrial carrier: glutamate), member 22,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial carrier: glutamate), member 22,OMIM_DISEASE[520001758$Epilepsy, neonatal myoclonic, with suppression-burst pattern]
solute carrier family 25 (mitochondrial carrier: glutamate), member 22,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial carrier: glutamate), member 22,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000509$epilepsy, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001304$repeat, 790001473$Symport, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial carrier: glutamate), member 22,UP_SEQ_FEATURE[850031890$chain:Mitochondrial glutamate carrier 1, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,PIR_SUPERFAMILY[630002575$PIRSF002458:ADP,ATP carrier protein]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25 (mitochondrial oxodicarboxylate carrier), member 21,UP_SEQ_FEATURE[850031828$chain:Mitochondrial 2-oxodicarboxylate carrier, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 25, member 44,INTERPRO[450001765$IPR001993:Mitochondrial substrate carrier, 450001830$IPR002067:Mitochondrial carrier protein, 450001872$IPR002113:Adenine nucleotide translocator 1, 450016408$IPR018108:Mitochondrial substrate/solute carrier]
solute carrier family 25, member 44,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001212$polymorphism, 790001304$repeat, 790001555$transmembrane, 790001558$transport]
solute carrier family 25, member 44,UP_SEQ_FEATURE[850061428$chain:Solute carrier family 25 member 44, 850117009$repeat:Solcar 1, 850117010$repeat:Solcar 2, 850117011$repeat:Solcar 3, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
solute carrier family 4, sodium bicarbonate cotransporter, member 8,INTERPRO[450002653$IPR003020:Bicarbonate transporter, eukaryotic, 450002657$IPR003024:Sodium bicarbonate cotransporter, 450010392$IPR011531:Bicarbonate transporter, C-terminal, 450012388$IPR013769:Bicarbonate transporter, cytoplasmic, 450016526$IPR018241:Anion exchange, conserved site]
solute carrier family 4, sodium bicarbonate cotransporter, member 8,PIR_SUPERFAMILY[630002584$PIRSF002468:band 3-like protein]
solute carrier family 4, sodium bicarbonate cotransporter, member 8,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000085$anion exchange, 790000102$antiport, 790000344$coiled coil, 790000356$complete proteome, 790000798$ion transport, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001555$transmembrane, 790001558$transport]
solute carrier family 4, sodium bicarbonate cotransporter, member 8,UP_SEQ_FEATURE[850017059$chain:Electroneutral sodium bicarbonate exchanger 1, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2,INTERPRO[450000148$IPR000175:Sodium:neurotransmitter symporter, 450002160$IPR002435:Sodium:neurotransmitter symporter, noradrenaline]
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2,OMIM_DISEASE[520003792$Orthostatic intolerance]
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2,PIR_SUPERFAMILY[630002561$PIRSF002444:gamma-aminobutyric acid transporter]
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2,SP_PIR_KEYWORDS[790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790001027$neurotransmitter transport, 790001212$polymorphism, 790001473$Symport, 790001555$transmembrane, 790001556$transmembrane protein, 790001558$transport]
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2,UP_SEQ_FEATURE[850061228$chain:Sodium-dependent noradrenaline transporter, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
solute carrier family 9, member 11,COG_ONTOLOGY[90000075$Inorganic ion transport and metabolism]
solute carrier family 9, member 11,INTERPRO[450000508$IPR000595:Cyclic nucleotide-binding, 450005268$IPR005821:Ion transport, 450005584$IPR006153:Cation/H+ exchanger, 450013163$IPR014710:RmlC-like jelly roll fold, 450016699$IPR018422:Cation/H+ exchanger, conserved region, 450016762$IPR018488:Cyclic nucleotide-binding, conserved site]
solute carrier family 9, member 11,SMART[760000088$SM00100:cNMP]
solute carrier family 9, member 11,SP_PIR_KEYWORDS[790000102$antiport, 790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000919$membrane, 790001212$polymorphism, 790001418$Sodium, 790001421$Sodium transport, 790001555$transmembrane, 790001558$transport]
solute carrier family 9, member 11,UP_SEQ_FEATURE[850061264$chain:Sodium/hydrogen exchanger 11, 850105770$glycosylation site:N-linked (GlcNAc...), 850106279$nucleotide phosphate-binding region:cNMP, 850113218$region of interest:Ion transport-like, 850117295$sequence variant, 850118623$transmembrane region]
sorting nexin 15,INTERPRO[450001492$IPR001683:Phox-like, 450006694$IPR007330:MIT]
sorting nexin 15,SMART[760000282$SM00312:PX, 760000651$SM00745:MIT]
sorting nexin 15,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001558$transport]
sorting nexin 15,UP_SEQ_FEATURE[850061542$chain:Sorting nexin-15, 850104790$domain:MIT, 850105129$domain:PX, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
sorting nexin 9,INTERPRO[450001294$IPR001452:Src homology-3 domain, 450001492$IPR001683:Phox-like, 450013070$IPR014536:Sorting nexin, Snx9 type, 450017734$IPR019497:Sorting nexin protein, WASP-binding domain]
sorting nexin 9,PIR_SUPERFAMILY[630020991$PIRSF027744:Snx9, 630020992$PIRSF027744:sorting nexin, Snx9 type]
sorting nexin 9,SMART[760000282$SM00312:PX, 760000295$SM00326:SH3]
sorting nexin 9,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000356$complete proteome, 790001162$phosphoprotein, 790001266$protein transport, 790001398$sh3 domain, 790001558$transport]
sorting nexin 9,UP_SEQ_FEATURE[850061566$chain:Sorting nexin-9, 850105129$domain:PX, 850105350$domain:SH3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand]
spermatogenesis and centriole associated 1,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton]
spermatogenesis and centriole associated 1,UP_SEQ_FEATURE[850061779$chain:Speriolin, 850113697$region of interest:Necessary for targeting centrosomes, 850117294$sequence conflict]
spermatogenesis associated 5,COG_ONTOLOGY[90000095$Posttranslational modification, protein turnover, chaperones]
spermatogenesis associated 5,INTERPRO[450003154$IPR003593:ATPase, AAA+ type, core, 450003482$IPR003959:ATPase, AAA-type, core, 450003483$IPR003960:ATPase, AAA-type, conserved site]
spermatogenesis associated 5,PIR_SUPERFAMILY[630001318$PIRSF001172:AAA ATPase, Nsf/Cdc48/Vcp types]
spermatogenesis associated 5,SMART[760000335$SM00382:AAA]
spermatogenesis associated 5,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000138$atp-binding, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790000969$mitochondrion, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001426$spermatogenesis]
spermatogenesis associated 5,UP_SEQ_FEATURE[850061890$chain:Spermatogenesis-associated protein 5, 850106264$nucleotide phosphate-binding region:ATP 1, 850106265$nucleotide phosphate-binding region:ATP 2, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
sphingosine-1-phosphate receptor 1,BIOCARTA[30000088$h_edg1Pathway:Phospholipids as signalling intermediaries]
sphingosine-1-phosphate receptor 1,INTERPRO[450000240$IPR000276:7TM GPCR, rhodopsin-like, 450000859$IPR000987:EDG-1 sphingosine 1-phosphate receptor, 450003577$IPR004061:Sphingosine 1-phosphate receptor, 450015778$IPR017452:GPCR, rhodopsin-like superfamily]
sphingosine-1-phosphate receptor 1,KEGG_PATHWAY[470038833$hsa04080:Neuroactive ligand-receptor interaction]
sphingosine-1-phosphate receptor 1,PIR_SUPERFAMILY[630005359$PIRSF005435:LPAR1/S1PR1-like lysophospholipid receptor, 630031145$PIRSF501018:sphingosine 1-phosphate receptor 1-5, 630031207$PIRSF800006:rhodopsin-like G protein-coupled receptors]
sphingosine-1-phosphate receptor 1,SP_PIR_KEYWORDS[790000264$cell membrane, 790000356$complete proteome, 790000574$G protein-coupled receptor, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000881$lipoprotein, 790000919$membrane, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001546$transducer, 790001555$transmembrane, 790001556$transmembrane protein]
sphingosine-1-phosphate receptor 1,UP_SEQ_FEATURE[850061964$chain:Sphingosine 1-phosphate receptor 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850105898$lipid moiety-binding region:S-palmitoyl cysteine, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
spondin 2, extracellular matrix protein,INTERPRO[450000771$IPR000884:Thrombospondin, type 1 repeat, 450008568$IPR009465:Spondin, N-terminal]
spondin 2, extracellular matrix protein,OMIM_DISEASE[520004444$Sequence Variants in the RNF212 Gene Associate with Genomewide Recombination Rate]
spondin 2, extracellular matrix protein,SMART[760000182$SM00209:TSP1]
spondin 2, extracellular matrix protein,SP_PIR_KEYWORDS[790000002$3d-structure, 790000211$calcium, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000530$extracellular matrix, 790000616$glycoprotein, 790000763$immune response, 790000937$metal-binding, 790001212$polymorphism, 790001363$Secreted, 790001405$signal]
spondin 2, extracellular matrix protein,UP_SEQ_FEATURE[850062093$chain:Spondin-2, 850102883$disulfide bond, 850105381$domain:Spondin, 850105554$domain:TSP type-1, 850105756$glycosylation site:C-linked (Man), 850105852$helix, 850105909$metal ion-binding site:Calcium, 850105946$metal ion-binding site:Calcium; via carbonyl oxygen, 850105986$metal ion-binding site:Divalent metal cation, 850106259$mutagenesis site, 850117295$sequence variant, 850117814$signal peptide, 850118272$site:Important for metal ion-dependent interaction with integrin, 850118575$strand, 850118624$turn]
stathmin 1,BIOCARTA[30000279$h_stathminPathway:Stathmin and breast cancer resistance to antimicrotubule agents]
stathmin 1,INTERPRO[450000832$IPR000956:Stathmin]
stathmin 1,KEGG_PATHWAY[470038827$hsa04010:MAPK signaling pathway]
stathmin 1,PIR_SUPERFAMILY[630002409$PIRSF002285:Op18/stathmin, 630002410$PIRSF002285:Stathmin]
stathmin 1,SP_PIR_KEYWORDS[790000012$acetylation, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000411$cytosol, 790000428$developmental protein, 790000434$differentiation, 790000445$direct protein sequencing, 790000919$membrane, 790000960$microtubule, 790001016$neurogenesis, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
stathmin 1,UP_SEQ_FEATURE[850062394$chain:Stathmin, 850066270$chain:Transmembrane protein C1orf215, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
sterol carrier protein 2,INTERPRO[450001912$IPR002155:Thiolase, 450001950$IPR002198:Short-chain dehydrogenase/reductase SDR, 450002664$IPR003033:Sterol-binding, 450014425$IPR016038:Thiolase-like, subgroup]
sterol carrier protein 2,KEGG_PATHWAY[470038737$hsa00120:Primary bile acid biosynthesis, 470038821$hsa03320:PPAR signaling pathway]
sterol carrier protein 2,OMIM_DISEASE[520002884$Leukoencephalopathy with dystonia and motor neuropathy]
sterol carrier protein 2,PIR_SUPERFAMILY[630000504$PIRSF000429:Ac-CoA_Ac_transf]
sterol carrier protein 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000050$alternative initiation, 790000051$alternative initiators, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000875$lipid transport, 790000876$lipid-binding, 790000969$mitochondrion, 790001128$peroxisome, 790001162$phosphoprotein, 790001212$polymorphism, 790001547$transferase, 790001550$transit peptide, 790001558$transport]
sterol carrier protein 2,UP_SEQ_FEATURE[850034585$chain:Non-specific lipid-transfer protein, 850105274$domain:SCP2, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850117578$short sequence motif:Microbody targeting signal, 850118574$splice variant, 850118575$strand, 850118624$turn]
stimulated by retinoic acid gene 6 homolog (mouse),OMIM_DISEASE[520003312$Microphthalmia, syndromic 9]
stimulated by retinoic acid gene 6 homolog (mouse),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000264$cell membrane, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790000958$microphthalmia, 790001212$polymorphism, 790001301$receptor, 790001555$transmembrane, 790001558$transport]
stimulated by retinoic acid gene 6 homolog (mouse),UP_SEQ_FEATURE[850062501$chain:Stimulated by retinoic acid gene 6 protein homolog, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
stromal cell derived factor 4,INTERPRO[450001814$IPR002048:Calcium-binding EF-hand, 450010817$IPR011992:EF-Hand type, 450016532$IPR018247:EF-HAND 1, 450016534$IPR018249:EF-HAND 2]
stromal cell derived factor 4,SMART[760000046$SM00054:EFh]
stromal cell derived factor 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000522$exocytosis, 790000616$glycoprotein, 790000624$golgi apparatus, 790001212$polymorphism, 790001304$repeat, 790001405$signal]
stromal cell derived factor 4,UP_SEQ_FEATURE[850000616$calcium-binding region:1, 850000622$calcium-binding region:2, 850000626$calcium-binding region:3, 850000630$calcium-binding region:4, 850000631$calcium-binding region:5, 850000632$calcium-binding region:6, 850002116$chain:45 kDa calcium-binding protein, 850103572$domain:EF-hand 1, 850103583$domain:EF-hand 2, 850103585$domain:EF-hand 3, 850103587$domain:EF-hand 4, 850103588$domain:EF-hand 5, 850103589$domain:EF-hand 6, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850113661$region of interest:Necessary for intracellular retention in Golgi apparatus lumen, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant]
supervillin,INTERPRO[450002752$IPR003128:Villin headpiece, 450006496$IPR007122:Gelsolin, 450006497$IPR007123:Gelsolin region, 450014065$IPR015628:Supervillin]
supervillin,OMIM_DISEASE[520001996$Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis]
supervillin,SMART[760000135$SM00153:VHP, 760000234$SM00262:GEL]
supervillin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000019$actin-binding, 790000053$alternative splicing, 790000211$calcium, 790000264$cell membrane, 790000267$cell projection, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
supervillin,UP_SEQ_FEATURE[850062979$chain:Supervillin, 850104146$domain:HP, 850106258$modified residue, 850112574$region of interest:Interaction with MYLK, 850112602$region of interest:Interaction with NEB, 850116060$repeat:Gelsolin-like 1, 850116061$repeat:Gelsolin-like 2, 850116062$repeat:Gelsolin-like 3, 850116063$repeat:Gelsolin-like 4, 850116064$repeat:Gelsolin-like 5, 850117295$sequence variant, 850118574$splice variant]
suppressor of cytokine signaling 2,INTERPRO[450000852$IPR000980:SH2 motif, 450001330$IPR001496:SOCS protein, C-terminal]
suppressor of cytokine signaling 2,KEGG_PATHWAY[470038866$hsa04630:Jak-STAT signaling pathway, 470038882$hsa04910:Insulin signaling pathway, 470038887$hsa04930:Type II diabetes mellitus]
suppressor of cytokine signaling 2,OMIM_DISEASE[520001993$Genome-wide association analysis identifies 20 loci that influence adult height, 520003072$Many sequence variants affecting diversity of adult human height]
suppressor of cytokine signaling 2,PIR_SUPERFAMILY[630006289$PIRSF006354:suppressor of cytokine signaling (SOCS) 1-3]
suppressor of cytokine signaling 2,SMART[760000224$SM00252:SH2, 760000225$SM00253:SOCS]
suppressor of cytokine signaling 2,SP_PIR_KEYWORDS[790000002$3d-structure, 790000356$complete proteome, 790000635$growth regulation, 790001212$polymorphism, 790001397$SH2 domain, 790001408$Signal transduction inhibitor, 790001593$ubl conjugation pathway]
suppressor of cytokine signaling 2,UP_SEQ_FEATURE[850062984$chain:Suppressor of cytokine signaling 2, 850105346$domain:SH2, 850105375$domain:SOCS box, 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850118575$strand, 850118624$turn]
synapse defective 1, Rho GTPase, homolog 2 (C. elegans),INTERPRO[450000006$IPR000008:C2 calcium-dependent membrane targeting, 450000169$IPR000198:RhoGAP]
synapse defective 1, Rho GTPase, homolog 2 (C. elegans),SMART[760000211$SM00239:C2, 760000293$SM00324:RhoGAP]
synapse defective 1, Rho GTPase, homolog 2 (C. elegans),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000640$GTPase activation, 790001162$phosphoprotein, 790001212$polymorphism]
synapse defective 1, Rho GTPase, homolog 2 (C. elegans),UP_SEQ_FEATURE[850057561$chain:Rho GTPase-activating protein SYDE2, 850103199$domain:C2, 850105183$domain:Rho-GAP, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
taste receptor, type 2, member 3,INTERPRO[450007304$IPR007960:Mammalian taste receptor]
taste receptor, type 2, member 3,KEGG_PATHWAY[470038880$hsa04742:Taste transduction]
taste receptor, type 2, member 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000575$g-protein coupled receptor, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001301$receptor, 790001377$sensory transduction, 790001487$Taste, 790001546$transducer, 790001555$transmembrane]
taste receptor, type 2, member 3,UP_SEQ_FEATURE[850063573$chain:Taste receptor type 2 member 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tectonic family member 1,INTERPRO[450010505$IPR011677:Protein of unknown function DUF1619]
tectonic family member 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000428$developmental protein, 790000616$glycoprotein, 790001363$Secreted, 790001405$signal]
tectonic family member 1,UP_SEQ_FEATURE[850063710$chain:Tectonic-1, 850102480$compositionally biased region:Cys-rich, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118574$splice variant]
tetraspanin 14,INTERPRO[450000259$IPR000301:Tetraspanin, subgroup, 450016772$IPR018499:Tetraspanin, 450016776$IPR018503:Tetraspanin, conserved site]
tetraspanin 14,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001555$transmembrane]
tetraspanin 14,UP_SEQ_FEATURE[850063975$chain:Tetraspanin-14, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850118574$splice variant, 850118623$transmembrane region]
tetratricopeptide repeat domain 17,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
tetratricopeptide repeat domain 17,SMART[760000020$SM00028:TPR]
tetratricopeptide repeat domain 17,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat]
tetratricopeptide repeat domain 17,UP_SEQ_FEATURE[850064000$chain:Tetratricopeptide repeat protein 17, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117295$sequence variant]
thioredoxin domain containing 12 (endoplasmic reticulum),INTERPRO[450001169$IPR001327:Pyridine nucleotide-disulphide oxidoreductase, NAD-binding region, 450003614$IPR004099:Pyridine nucleotide-disulphide oxidoreductase, dimerisation, 450011036$IPR012335:Thioredoxin fold, 450011694$IPR013027:FAD-dependent pyridine nucleotide-disulphide oxidoreductase, 450016249$IPR017936:Thioredoxin-like, 450016250$IPR017937:Thioredoxin, conserved site]
thioredoxin domain containing 12 (endoplasmic reticulum),KEGG_PATHWAY[470038764$hsa00480:Glutathione metabolism]
thioredoxin domain containing 12 (endoplasmic reticulum),SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000466$dna-binding, 790000499$endoplasmic reticulum, 790000537$FAD, 790000559$Flavoprotein, 790000969$mitochondrion, 790001065$nucleus, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001302$Redox-active center, 790001405$signal, 790001550$transit peptide]
thioredoxin domain containing 12 (endoplasmic reticulum),UP_SEQ_FEATURE[850000341$binding site:FAD, 850000344$binding site:FAD; via amide nitrogen and carbonyl oxygen, 850000345$binding site:FAD; via carbonyl oxygen, 850005862$chain:Apoptosis-inducing factor 1, mitochondrial, 850064220$chain:Thioredoxin domain-containing protein 12, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850106285$nucleotide phosphate-binding region:FAD, 850111661$region of interest:FAD-dependent oxidoreductase, 850117294$sequence conflict, 850117610$short sequence motif:Nuclear localization signal, 850117653$short sequence motif:Prevents secretion from ER, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118617$transit peptide:Mitochondrion, 850118624$turn]
thyroid hormone receptor associated protein 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000020$activator, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000953$methylation, 790001063$nucleotide-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001539$Transcription, 790001543$transcription regulation]
thyroid hormone receptor associated protein 3,UP_SEQ_FEATURE[850064460$chain:Thyroid hormone receptor-associated protein 3, 850102404$compositionally biased region:Arg-rich, 850102597$compositionally biased region:Ser-rich, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850117295$sequence variant]
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila),INTERPRO[450001490$IPR001680:WD40 repeat, 450008266$IPR009146:Groucho/transducin-like enhancer, 450014355$IPR015943:WD40/YVTN repeat-like, 450016294$IPR017986:WD40 repeat, region, 450018010$IPR019775:WD40 repeat, conserved site]
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila),SMART[760000289$SM00320:WD40]
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001304$repeat, 790001638$wd repeat]
transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila),UP_SEQ_FEATURE[850065730$chain:Transducin-like enhancer protein 6, 850117171$repeat:WD 1, 850117182$repeat:WD 2, 850117193$repeat:WD 3, 850117195$repeat:WD 4, 850117196$repeat:WD 5, 850117197$repeat:WD 6, 850117198$repeat:WD 7]
translin-associated factor X,INTERPRO[450002520$IPR002848:Translin, 450014451$IPR016068:Translin, N-terminal, 450014452$IPR016069:Translin, C-terminal]
translin-associated factor X,PIR_SUPERFAMILY[630019500$PIRSF025022:Translin/Translin-associated factor x, 630030940$PIRSF500781:Translin-associated protein X]
translin-associated factor X,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm, 790000428$developmental protein, 790000434$differentiation, 790001065$nucleus, 790001162$phosphoprotein, 790001426$spermatogenesis, 790001592$ubl conjugation]
translin-associated factor X,UP_SEQ_FEATURE[850065864$chain:Translin-associated protein X, 850106258$modified residue, 850112135$region of interest:Interaction with C1D]
translocase of inner mitochondrial membrane 23 homolog (yeast); translocase of inner mitochondrial membrane 23 homolog B (yeast),INTERPRO[450002967$IPR003397:Mitochondrial import inner membrane translocase, subunit Tim17/22, 450002968$IPR003397:Mitochondrial inner membrane translocase complex, subunit Tim17/22, 450005131$IPR005681:Mitochondrial import inner membrane translocase, subunit Tim23, 450005132$IPR005681:Mitochondrial inner membrane translocase complex, subunit Tim23]
translocase of inner mitochondrial membrane 23 homolog (yeast); translocase of inner mitochondrial membrane 23 homolog B (yeast),SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790000970$mitochondrion inner membrane, 790001266$protein transport, 790001554$translocation, 790001555$transmembrane, 790001558$transport]
translocase of inner mitochondrial membrane 23 homolog (yeast); translocase of inner mitochondrial membrane 23 homolog B (yeast),UP_SEQ_FEATURE[850031923$chain:Mitochondrial import inner membrane translocase subunit Tim23, 850052729$chain:Putative mitochondrial import inner membrane translocase subunit Tim23B, 850117294$sequence conflict, 850118623$transmembrane region]
transmembrane 6 superfamily member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
transmembrane 6 superfamily member 1,UP_SEQ_FEATURE[850065900$chain:Transmembrane 6 superfamily member 1, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
transmembrane 9 superfamily member 3,INTERPRO[450003748$IPR004240:Nonaspanin (TM9SF)]
transmembrane 9 superfamily member 3,PIR_SUPERFAMILY[630012533$PIRSF015767:transmembrane 9 superfamily protein, member 3 type]
transmembrane 9 superfamily member 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
transmembrane 9 superfamily member 3,UP_SEQ_FEATURE[850065906$chain:Transmembrane 9 superfamily member 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118623$transmembrane region]
transmembrane and tetratricopeptide repeat containing 1,COG_ONTOLOGY[90000073$General function prediction only]
transmembrane and tetratricopeptide repeat containing 1,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450012242$IPR013618:Region of unknown function DUF1736, 450017972$IPR019734:Tetratricopeptide repeat]
transmembrane and tetratricopeptide repeat containing 1,SMART[760000020$SM00028:TPR]
transmembrane and tetratricopeptide repeat containing 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001555$transmembrane]
transmembrane and tetratricopeptide repeat containing 1,UP_SEQ_FEATURE[850065924$chain:Transmembrane and TPR repeat-containing protein 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850117119$repeat:TPR 1, 850117120$repeat:TPR 10, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117147$repeat:TPR 9, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
transmembrane and tetratricopeptide repeat containing 4,INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450011749$IPR013105:Tetratricopeptide TPR2, 450012242$IPR013618:Region of unknown function DUF1736, 450017972$IPR019734:Tetratricopeptide repeat]
transmembrane and tetratricopeptide repeat containing 4,SMART[760000020$SM00028:TPR]
transmembrane and tetratricopeptide repeat containing 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001537$tpr repeat, 790001555$transmembrane]
transmembrane and tetratricopeptide repeat containing 4,UP_SEQ_FEATURE[850065927$chain:Transmembrane and TPR repeat-containing protein 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
transmembrane emp24 protein transport domain containing 3,INTERPRO[450000299$IPR000348:emp24/gp25L/p24, 450008192$IPR009038:GOLD, 450014153$IPR015718:P24 related]
transmembrane emp24 protein transport domain containing 3,SP_PIR_KEYWORDS[790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001212$polymorphism, 790001266$protein transport, 790001405$signal, 790001555$transmembrane, 790001558$transport]
transmembrane emp24 protein transport domain containing 3,UP_SEQ_FEATURE[850065953$chain:Transmembrane emp24 domain-containing protein 3, 850104069$domain:GOLD, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118590$topological domain:Lumenal, 850118623$transmembrane region]
transmembrane protein 134,INTERPRO[450007853$IPR008590:Uncharacterised protein family UPF0414]
transmembrane protein 134,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001555$transmembrane]
transmembrane protein 134,UP_SEQ_FEATURE[850066040$chain:Transmembrane protein 134, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane protein 204,SP_PIR_KEYWORDS[790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001450$stress response, 790001555$transmembrane]
transmembrane protein 204,UP_SEQ_FEATURE[850066134$chain:Transmembrane protein 204, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane protein 59,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
transmembrane protein 59,UP_SEQ_FEATURE[850066201$chain:Transmembrane protein 59, 850105770$glycosylation site:N-linked (GlcNAc...), 850117294$sequence conflict, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
transmembrane protein 79,SP_PIR_KEYWORDS[790000356$complete proteome, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001555$transmembrane]
transmembrane protein 79,UP_SEQ_FEATURE[850066221$chain:Transmembrane protein 79, 850106258$modified residue, 850117295$sequence variant, 850118623$transmembrane region]
trinucleotide repeat containing 4,INTERPRO[450000430$IPR000504:RNA recognition motif, RNP-1, 450011357$IPR012677:Nucleotide-binding, alpha-beta plait, 450014322$IPR015903:Ribonucleoprotein, BRUNO-like]
trinucleotide repeat containing 4,SMART[760000328$SM00360:RRM]
trinucleotide repeat containing 4,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000988$mrna processing, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding]
trinucleotide repeat containing 4,UP_SEQ_FEATURE[850012824$chain:CUG-BP- and ETR-3-like factor 3, 850102485$compositionally biased region:Gln-rich, 850105212$domain:RRM 1, 850105213$domain:RRM 2, 850105214$domain:RRM 3, 850117294$sequence conflict, 850118574$splice variant]
tripartite motif-containing 3,INTERPRO[450000269$IPR000315:Zinc finger, B-box, 450001109$IPR001258:NHL repeat, 450001143$IPR001298:Filamin/ABP280 repeat, 450001628$IPR001841:Zinc finger, RING-type, 450003195$IPR003649:B-box, C-terminal, 450010012$IPR011042:Six-bladed beta-propeller, TolB-like, 450011685$IPR013017:NHL repeat, subgroup, 450012396$IPR013783:Immunoglobulin-like fold, 450016187$IPR017868:Filamin/ABP280 repeat-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site, 450017227$IPR018957:Zinc finger, C3HC4 RING-type]
tripartite motif-containing 3,PIR_SUPERFAMILY[630028828$PIRSF037280:tripartite motif protein 2]
tripartite motif-containing 3,SMART[760000158$SM00184:RING, 760000304$SM00336:BBOX, 760000445$SM00502:BBC, 760000496$SM00557:IG_FLMN]
tripartite motif-containing 3,SP_PIR_KEYWORDS[790000012$acetylation, 790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790000501$endosome, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001266$protein transport, 790001304$repeat, 790001558$transport, 790001648$zinc, 790001651$zinc-finger]
tripartite motif-containing 3,UP_SEQ_FEATURE[850066638$chain:Tripartite motif-containing protein 3, 850106258$modified residue, 850115954$repeat:Filamin, 850116579$repeat:NHL 1, 850116580$repeat:NHL 2, 850116581$repeat:NHL 3, 850116582$repeat:NHL 4, 850116583$repeat:NHL 5, 850116584$repeat:NHL 6, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118638$zinc finger region:B box-type, 850118911$zinc finger region:RING-type]
trophinin associated protein (tastin),SP_PIR_KEYWORDS[790000256$cell adhesion, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat]
trophinin associated protein (tastin),UP_SEQ_FEATURE[850063593$chain:Tastin, 850102480$compositionally biased region:Cys-rich, 850106258$modified residue, 850110377$region of interest:4 X 33 AA approximate tandem repeats, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850115467$repeat:4, 850117294$sequence conflict]
tryptophan 2,3-dioxygenase,INTERPRO[450004450$IPR004981:Tryptophan 2,3-dioxygenase]
tryptophan 2,3-dioxygenase,KEGG_PATHWAY[470038756$hsa00380:Tryptophan metabolism]
tryptophan 2,3-dioxygenase,PIR_SUPERFAMILY[630013551$PIRSF016768:PIRSF016768]
tryptophan 2,3-dioxygenase,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000437$dioxygenase, 790000652$heme, 790000802$iron, 790000937$metal-binding, 790001092$oxidoreductase, 790001162$phosphoprotein, 790001576$tryptophan catabolism]
tryptophan 2,3-dioxygenase,UP_SEQ_FEATURE[850000390$binding site:Heme, 850000555$binding site:Substrate, 850067006$chain:Tryptophan 2,3-dioxygenase, 850106026$metal ion-binding site:Iron (heme axial ligand), 850106258$modified residue, 850114716$region of interest:Substrate binding]
tryptophan rich basic protein,INTERPRO[450006868$IPR007514:CHD5-like protein]
tryptophan rich basic protein,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000919$membrane, 790001065$nucleus, 790001212$polymorphism, 790001555$transmembrane]
tryptophan rich basic protein,UP_SEQ_FEATURE[850067032$chain:Tryptophan-rich protein, 850117294$sequence conflict, 850117295$sequence variant, 850118623$transmembrane region]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,INTERPRO[450003853$IPR004344:Tubulin-tyrosine ligase, 450007661$IPR008384:ARP23 complex 20 kDa subunit]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,KEGG_PATHWAY[470038872$hsa04666:Fc gamma R-mediated phagocytosis, 470038881$hsa04810:Regulation of actin cytoskeleton, 470038898$hsa05130:Pathogenic Escherichia coli infection]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,SP_PIR_KEYWORDS[790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000267$cell projection, 790000321$cilium, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000859$ligase, 790000960$microtubule, 790001212$polymorphism]
tubulin tyrosine ligase-like family, member 3; actin related protein 2/3 complex, subunit 4, 20kDa,UP_SEQ_FEATURE[850003630$chain:Actin-related protein 2/3 complex subunit 4, 850067132$chain:Tubulin monoglycylase TTLL3, 850105582$domain:TTL, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain,INTERPRO[450001212$IPR001368:TNFR/CD27/30/40/95 cysteine-rich region]
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038843$hsa04210:Apoptosis, 470038868$hsa04650:Natural killer cell mediated cytotoxicity]
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain,SMART[760000181$SM00208:TNFR]
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain,SP_PIR_KEYWORDS[790000109$Apoptosis, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane]
tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain,UP_SEQ_FEATURE[850067193$chain:Tumor necrosis factor receptor superfamily member 10D, 850102573$compositionally biased region:Poly-Gly, 850102585$compositionally biased region:Poly-Val, 850102883$disulfide bond, 850103510$domain:Death; truncated, 850105770$glycosylation site:N-linked (GlcNAc...), 850117108$repeat:TNFR-Cys 1, 850117109$repeat:TNFR-Cys 2, 850117111$repeat:TNFR-Cys 3, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tumor necrosis factor receptor superfamily, member 9,BIOCARTA[30000001$h_41bbPathway:The 4-1BB-dependent immune response]
tumor necrosis factor receptor superfamily, member 9,INTERPRO[450001212$IPR001368:TNFR/CD27/30/40/95 cysteine-rich region]
tumor necrosis factor receptor superfamily, member 9,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction]
tumor necrosis factor receptor superfamily, member 9,PIR_SUPERFAMILY[630030268$PIRSF038814:tumor necrosis factor receptor superfamily member 9]
tumor necrosis factor receptor superfamily, member 9,SMART[760000181$SM00208:TNFR]
tumor necrosis factor receptor superfamily, member 9,SP_PIR_KEYWORDS[790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000919$membrane, 790001162$phosphoprotein, 790001212$polymorphism, 790001301$receptor, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
tumor necrosis factor receptor superfamily, member 9,UP_SEQ_FEATURE[850067221$chain:Tumor necrosis factor receptor superfamily member 9, 850102883$disulfide bond, 850105770$glycosylation site:N-linked (GlcNAc...), 850112493$region of interest:Interaction with LRR-1, 850117108$repeat:TNFR-Cys 1, 850117109$repeat:TNFR-Cys 2, 850117111$repeat:TNFR-Cys 3, 850117113$repeat:TNFR-Cys 4, 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
tumor protein p53 regulated apoptosis inducing protein 1,KEGG_PATHWAY[470038836$hsa04115:p53 signaling pathway]
tumor protein p53 regulated apoptosis inducing protein 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000109$Apoptosis, 790000356$complete proteome, 790000969$mitochondrion, 790001212$polymorphism]
tumor protein p53 regulated apoptosis inducing protein 1,UP_SEQ_FEATURE[850036662$chain:p53-regulated apoptosis-inducing protein 1, 850117295$sequence variant, 850118574$splice variant]
ubiquinol-cytochrome c reductase complex chaperone,INTERPRO[450006502$IPR007129:Ubiquinol-cytochrome C chaperone]
ubiquinol-cytochrome c reductase complex chaperone,OMIM_DISEASE[520001131$Common variants in the GDF5-UQCC region are associated with variation in human height, 520002597$Identification of ten loci associated with height highlights new biological pathways in human growth, 520003072$Many sequence variants affecting diversity of adult human height, 520004687$Stature quantitative trait locus 14]
ubiquinol-cytochrome c reductase complex chaperone,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000408$cytoplasmic vesicle, 790001212$polymorphism]
ubiquinol-cytochrome c reductase complex chaperone,UP_SEQ_FEATURE[850067925$chain:Ubiquinol-cytochrome c reductase complex chaperone CBP3 homolog, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
ubiquitin protein ligase E3 component n-recognin 1,INTERPRO[450002750$IPR003126:Zinc finger, N-recognin, 450003310$IPR003769:Adaptor protein ClpS, core, 450012587$IPR013993:Zinc finger, N-recognin,  metazoa, 450013171$IPR014719:Ribosomal protein L7/L12, C-terminal/adaptor protein ClpS-like, 450016222$IPR017907:Zinc finger, RING-type, conserved site]
ubiquitin protein ligase E3 component n-recognin 1,OMIM_DISEASE[520002692$Johanson-Blizzard syndrome]
ubiquitin protein ligase E3 component n-recognin 1,SMART[760000347$SM00396:ZnF_UBR1]
ubiquitin protein ligase E3 component n-recognin 1,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000446$disease mutation, 790000859$ligase, 790000937$metal-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001593$ubl conjugation pathway, 790001648$zinc, 790001651$zinc-finger]
ubiquitin protein ligase E3 component n-recognin 1,UP_SEQ_FEATURE[850016773$chain:E3 ubiquitin-protein ligase UBR1, 850102580$compositionally biased region:Poly-Pro, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118919$zinc finger region:RING-type; atypical, 850118948$zinc finger region:UBR-type]
ubiquitin-conjugating enzyme E2L 3,INTERPRO[450000520$IPR000608:Ubiquitin-conjugating enzyme, E2, 450014494$IPR016135:Ubiquitin-conjugating enzyme/RWD-like]
ubiquitin-conjugating enzyme E2L 3,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038892$hsa05012:Parkinson's disease]
ubiquitin-conjugating enzyme E2L 3,SMART[760000185$SM00212:UBCc]
ubiquitin-conjugating enzyme E2L 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790001063$nucleotide-binding, 790001593$ubl conjugation pathway]
ubiquitin-conjugating enzyme E2L 3,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068094$chain:Ubiquitin-conjugating enzyme E2 L3, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850118575$strand, 850118624$turn]
ubiquitin-like 3,INTERPRO[450015320$IPR017000:Membrane-anchored ubiquitin-fold protein, HCG-1, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
ubiquitin-like 3,PIR_SUPERFAMILY[630024807$PIRSF032572:membrane-anchored ubiquitin-fold protein, HCG-1 type, 630024808$PIRSF032572:MUB]
ubiquitin-like 3,SP_PIR_KEYWORDS[790000002$3d-structure, 790000264$cell membrane, 790000356$complete proteome, 790000881$lipoprotein, 790000919$membrane, 790000953$methylation, 790001236$prenylation]
ubiquitin-like 3,UP_SEQ_FEATURE[850068139$chain:Ubiquitin-like protein 3, 850105602$domain:Ubiquitin-like, 850105852$helix, 850105894$lipid moiety-binding region:S-geranylgeranyl cysteine, 850106258$modified residue, 850109701$propeptide:Removed in mature form, 850117294$sequence conflict, 850118575$strand]
ubiquitin-like 4B,INTERPRO[450000534$IPR000626:Ubiquitin, 450018184$IPR019954:Ubiquitin conserved site, 450018185$IPR019955:Ubiquitin supergroup]
ubiquitin-like 4B,SMART[760000186$SM00213:UBQ]
ubiquitin-like 4B,SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000407$cytoplasm]
ubiquitin-like 4B,UP_SEQ_FEATURE[850068141$chain:Ubiquitin-like protein 4B, 850105602$domain:Ubiquitin-like, 850106258$modified residue]
up-regulated during skeletal muscle growth 5 homolog (mouse),INTERPRO[450008245$IPR009125:DAPIT]
up-regulated during skeletal muscle growth 5 homolog (mouse),SP_PIR_KEYWORDS[790000012$acetylation, 790000356$complete proteome, 790000919$membrane, 790000969$mitochondrion, 790001555$transmembrane]
up-regulated during skeletal muscle growth 5 homolog (mouse),UP_SEQ_FEATURE[850083125$chain:Up-regulated during skeletal muscle growth protein 5, 850106258$modified residue, 850118623$transmembrane region]
vascular cell adhesion molecule 1,BBID[10000045$17.Activators-CAM, 10000046$18.Cytokine_astocytes, 10000078$58.(CD40L)_immnosurveillance, 10000117$96.Immune_injury_MS-lesions_genetic_environ]
vascular cell adhesion molecule 1,BIOCARTA[30000169$h_LairPathway:Cells and Molecules involved in local acute inflammatory response, 30000175$h_lympathway:Adhesion and Diapedesis of Lymphocytes]
vascular cell adhesion molecule 1,INTERPRO[450003159$IPR003598:Immunoglobulin subtype 2, 450003160$IPR003599:Immunoglobulin subtype, 450003510$IPR003987:Intercellular adhesion molecule/vascular cell adhesion molecule, N-terminal, 450003512$IPR003989:Vascular cell adhesion molecule-1, 450006486$IPR007110:Immunoglobulin-like, 450007701$IPR008424:Immunoglobulin C2-set, 450011742$IPR013098:Immunoglobulin I-set, 450011750$IPR013106:Immunoglobulin V-set, 450011788$IPR013151:Immunoglobulin, 450012396$IPR013783:Immunoglobulin-like fold]
vascular cell adhesion molecule 1,KEGG_PATHWAY[470038855$hsa04514:Cell adhesion molecules (CAMs), 470038873$hsa04670:Leukocyte transendothelial migration]
vascular cell adhesion molecule 1,PIR_SUPERFAMILY[630030191$PIRSF038689:vascular cell adhesion protein 1]
vascular cell adhesion molecule 1,SMART[760000356$SM00408:IGc2, 760000357$SM00409:IG]
vascular cell adhesion molecule 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000053$alternative splicing, 790000256$cell adhesion, 790000356$complete proteome, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000616$glycoprotein, 790000733$host-virus interaction, 790000768$Immunoglobulin domain, 790000919$membrane, 790001212$polymorphism, 790001304$repeat, 790001405$signal, 790001555$transmembrane, 790001556$transmembrane protein]
vascular cell adhesion molecule 1,UP_SEQ_FEATURE[850100065$chain:Vascular cell adhesion protein 1, 850102883$disulfide bond, 850104356$domain:Ig-like C2-type 1, 850104367$domain:Ig-like C2-type 2, 850104378$domain:Ig-like C2-type 3, 850104389$domain:Ig-like C2-type 4, 850104400$domain:Ig-like C2-type 5, 850104402$domain:Ig-like C2-type 6, 850104403$domain:Ig-like C2-type 7, 850105770$glycosylation site:N-linked (GlcNAc...), 850105852$helix, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118574$splice variant, 850118575$strand, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
vesicle-associated membrane protein 4,INTERPRO[450001233$IPR001388:Synaptobrevin, 450014766$IPR016444:Synaptobrevin, metazoa/fungi]
vesicle-associated membrane protein 4,KEGG_PATHWAY[470038838$hsa04130:SNARE interactions in vesicular transport]
vesicle-associated membrane protein 4,PIR_SUPERFAMILY[630005334$PIRSF005409:Synaptobrevin_euk]
vesicle-associated membrane protein 4,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000624$golgi apparatus, 790000919$membrane, 790001162$phosphoprotein, 790001555$transmembrane]
vesicle-associated membrane protein 4,UP_SEQ_FEATURE[850100234$chain:Vesicle-associated membrane protein 4, 850105618$domain:v-SNARE coiled-coil homology, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant, 850118577$topological domain:Cytoplasmic, 850118606$topological domain:Vesicular, 850118623$transmembrane region]
vinculin,BIOCARTA[30000058$h_cell2cellPathway:Cell to Cell Adhesion Signaling, 30000164$h_integrinPathway:Integrin Signaling Pathway, 30000261$h_rhoPathway:Rho cell motility signaling pathway]
vinculin,INTERPRO[450000541$IPR000633:Vinculin, conserved site, 450005513$IPR006077:Vinculin/alpha-catenin, 450016305$IPR017997:Vinculin]
vinculin,KEGG_PATHWAY[470038853$hsa04510:Focal adhesion, 470038856$hsa04520:Adherens junction, 470038873$hsa04670:Leukocyte transendothelial migration, 470038881$hsa04810:Regulation of actin cytoskeleton]
vinculin,OMIM_DISEASE[520000785$Cardiomyopathy, dilated, 1W]
vinculin,PIR_SUPERFAMILY[630002419$PIRSF002293:meta-vinculin]
vinculin,SP_PIR_KEYWORDS[790000002$3d-structure, 790000012$acetylation, 790000019$actin-binding, 790000053$alternative splicing, 790000245$Cardiomyopathy, 790000256$cell adhesion, 790000263$cell junction, 790000264$cell membrane, 790000356$complete proteome, 790000407$cytoplasm, 790000410$cytoskeleton, 790000445$direct protein sequencing, 790000446$disease mutation, 790000473$duplication, 790000867$lipid binding, 790000881$lipoprotein, 790000919$membrane, 790001004$myristate, 790001100$palmitate, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat]
vinculin,UP_SEQ_FEATURE[850100321$chain:Vinculin, 850102586$compositionally biased region:Pro-rich, 850105852$helix, 850106258$modified residue, 850110194$region of interest:3 X 112 AA tandem repeats, 850114848$region of interest:Talin-interaction, 850115074$repeat:1, 850115273$repeat:2, 850115417$repeat:3, 850117295$sequence variant, 850118574$splice variant, 850118575$strand, 850118624$turn]
zinc finger CCCH-type containing 10,INTERPRO[450000486$IPR000571:Zinc finger, CCCH-type]
zinc finger CCCH-type containing 10,SMART[760000324$SM00356:ZnF_C3H1]
zinc finger CCCH-type containing 10,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790000937$metal-binding, 790001162$phosphoprotein, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger CCCH-type containing 10,UP_SEQ_FEATURE[850101297$chain:Zinc finger CCCH domain-containing protein 10, 850102517$compositionally biased region:Gly-rich, 850102573$compositionally biased region:Poly-Gly, 850102586$compositionally biased region:Pro-rich, 850106258$modified residue, 850118752$zinc finger region:C3H1-type 1, 850118753$zinc finger region:C3H1-type 2, 850118754$zinc finger region:C3H1-type 3]
zinc finger and BTB domain containing 8A,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450006475$IPR007087:Zinc finger, C2H2-type, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger and BTB domain containing 8A,SMART[760000197$SM00225:BTB, 760000323$SM00355:ZnF_C2H2]
zinc finger and BTB domain containing 8A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger and BTB domain containing 8A,UP_SEQ_FEATURE[850101258$chain:Zinc finger and BTB domain-containing protein 8A, 850102572$compositionally biased region:Poly-Glu, 850103177$domain:BTB, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2]
zinc finger homeobox 2,INTERPRO[450001200$IPR001356:Homeobox, 450006475$IPR007087:Zinc finger, C2H2-type, 450010997$IPR012287:Homeodomain-related, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450016278$IPR017970:Homeobox, conserved site]
zinc finger homeobox 2,SMART[760000323$SM00355:ZnF_C2H2, 760000341$SM00389:HOX]
zinc finger homeobox 2,SP_PIR_KEYWORDS[790000020$activator, 790000356$complete proteome, 790000466$dna-binding, 790000699$Homeobox, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger homeobox 2,UP_SEQ_FEATURE[850101402$chain:Zinc finger homeobox protein 2, 850101626$chain:Zinc finger protein 409, 850102507$compositionally biased region:Glu-rich, 850102586$compositionally biased region:Pro-rich, 850102928$DNA-binding region:Homeobox 1, 850102929$DNA-binding region:Homeobox 2, 850102930$DNA-binding region:Homeobox 3, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6]
zinc finger protein 205,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 205,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 205,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 205,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 205,UP_SEQ_FEATURE[850101491$chain:Zinc finger protein 205, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8]
zinc finger protein 34,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 34,INTERPRO[450001661$IPR001878:Zinc finger, CCHC-type, 450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 34,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 34,SMART[760000311$SM00343:ZnF_C2HC, 760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 34,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 34,UP_SEQ_FEATURE[850101588$chain:Zinc finger protein 34, 850104552$domain:KRAB, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 365,INTERPRO[450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 365,OMIM_DISEASE[520001992$Genome-wide assocation defines more than 30 distinct susceptibility loci for Crohn's disease, 520003564$Nephrolithiasis, uric acid, susceptibility to, 520004984$uric acid nephrolithiasis]
zinc finger protein 365,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 365,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790001162$phosphoprotein, 790001212$polymorphism]
zinc finger protein 365,UP_SEQ_FEATURE[850048572$chain:Protein ZNF365, 850063511$chain:Talanin, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
zinc finger protein 385C,INTERPRO[450003164$IPR003604:Zinc finger, U1-type, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 385C,SMART[760000323$SM00355:ZnF_C2H2, 760000396$SM00451:ZnF_U1]
zinc finger protein 385C,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001304$repeat, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 385C,UP_SEQ_FEATURE[850101611$chain:Zinc finger protein 385C, 850102586$compositionally biased region:Pro-rich, 850118574$splice variant, 850118836$zinc finger region:Matrin-type 1, 850118837$zinc finger region:Matrin-type 2, 850118838$zinc finger region:Matrin-type 3]
zinc finger protein 408,COG_ONTOLOGY[90000118$Transcription / Cell division and chromosome partitioning]
zinc finger protein 408,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 408,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 408,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 408,UP_SEQ_FEATURE[850101625$chain:Zinc finger protein 408, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 643,COG_ONTOLOGY[90000073$General function prediction only, 90000118$Transcription / Cell division and chromosome partitioning]
zinc finger protein 643,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like, 450017991$IPR019756:Peptidase S26A, signal peptidase I, serine active site]
zinc finger protein 643,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 643,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 643,UP_SEQ_FEATURE[850101819$chain:Zinc finger protein 643, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 705A,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 705A,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 705A,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 705A,UP_SEQ_FEATURE[850101874$chain:Zinc finger protein 705A, 850104552$domain:KRAB, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3]
zinc finger protein 74,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 74,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 74,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 74,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001339$rna-binding, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 74,UP_SEQ_FEATURE[850101889$chain:Zinc finger protein 74, 850104552$domain:KRAB, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118656$zinc finger region:C2H2-type 1, 850118657$zinc finger region:C2H2-type 10, 850118660$zinc finger region:C2H2-type 11, 850118663$zinc finger region:C2H2-type 12, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
zinc finger protein 740,INTERPRO[450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 740,SMART[760000323$SM00355:ZnF_C2H2]
zinc finger protein 740,SP_PIR_KEYWORDS[790000356$complete proteome, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 740,UP_SEQ_FEATURE[850101890$chain:Zinc finger protein 740, 850106258$modified residue, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118720$zinc finger region:C2H2-type 3; atypical]
zinc finger, MYND domain containing 11,INTERPRO[450000267$IPR000313:PWWP, 450001324$IPR001487:Bromodomain, 450001628$IPR001841:Zinc finger, RING-type, 450001740$IPR001965:Zinc finger, PHD-type, 450002557$IPR002893:Zinc finger, MYND-type, 450018019$IPR019786:Zinc finger, PHD-type, conserved site, 450018020$IPR019787:Zinc finger, PHD-finger]
zinc finger, MYND domain containing 11,SMART[760000158$SM00184:RING, 760000221$SM00249:PHD, 760000264$SM00293:PWWP, 760000267$SM00297:BROMO]
zinc finger, MYND domain containing 11,SP_PIR_KEYWORDS[790000206$bromodomain, 790000258$cell cycle, 790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger, MYND domain containing 11,UP_SEQ_FEATURE[850101422$chain:Zinc finger MYND domain-containing protein 11, 850103166$domain:Bromo, 850105126$domain:PWWP, 850106258$modified residue, 850114256$region of interest:Required for binding to E1A, 850117610$short sequence motif:Nuclear localization signal, 850118853$zinc finger region:MYND-type, 850118877$zinc finger region:PHD-type]
zinc fingers and homeoboxes 1,INTERPRO[450001200$IPR001356:Homeobox, 450006475$IPR007087:Zinc finger, C2H2-type, 450010997$IPR012287:Homeodomain-related, 450014303$IPR015880:Zinc finger, C2H2-like, 450016278$IPR017970:Homeobox, conserved site]
zinc fingers and homeoboxes 1,SMART[760000323$SM00355:ZnF_C2H2, 760000341$SM00389:HOX]
zinc fingers and homeoboxes 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000196$bone, 790000356$complete proteome, 790000449$DNA binding, 790000466$dna-binding, 790000699$Homeobox, 790000937$metal-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001304$repeat, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001649$zinc finger, 790001651$zinc-finger]
zinc fingers and homeoboxes 1,UP_SEQ_FEATURE[850102140$chain:Zinc fingers and homeoboxes protein 1, 850102928$DNA-binding region:Homeobox 1, 850102929$DNA-binding region:Homeobox 2, 850102930$DNA-binding region:Homeobox 3, 850102931$DNA-binding region:Homeobox 4, 850102932$DNA-binding region:Homeobox 5, 850105852$helix, 850106258$modified residue, 850114286$region of interest:Required for dimerization, 850114365$region of interest:Required for interaction with NFYA, 850114436$region of interest:Required for nuclear localization, 850114466$region of interest:Required for repressor activity, 850117294$sequence conflict, 850118575$strand, 850118624$turn, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2]
